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Background: Care home residents with stroke-related disabilities have significant activity limitations.
Phase II trial results suggested a potential benefit of occupational therapy (OT) in maintaining residents’
capacity to engage in functional activity.
Objective: To evaluate the clinical effectiveness and cost-effectiveness of a targeted course of OT in
maintaining functional activity and reducing further health risks from inactivity for UK care home residents
living with stroke-related disabilities.
Design: Pragmatic, parallel-group, cluster randomised controlled trial with economic evaluation. Cluster
randomisation occurred at the care-home level. Homes were stratified according to trial administrative
centre and type of care provided (nursing or residential), and they were randomised 1 : 1 to either the
intervention or the control arm.
Setting: The setting was 228 care homes which were local to 11 trial administrative centres across
England and Wales.
Participants: Care home residents with a history of stroke or transient ischaemic attack, including
residents with communication and cognitive impairments, not receiving end-of-life care.
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Intervention: Personalised 3-month course of OT delivered by qualified therapists. Care workers
participated in training workshops to support personal activities of daily living. The control condition
consisted of usual care for residents.
Main outcome measures: Outcome data were collected by a blinded assessor. The primary outcome at
the participant level was the Barthel Index of Activities of Daily Living (BI) score at 3 months. The secondary
outcomes included BI scores at 6 and 12 months post randomisation, and the Rivermead Mobility Index,
Geriatric Depression Scale-15 and European Quality of Life-5 Dimensions, three levels, questionnaire scores
at all time points. Economic evaluation examined the incremental cost per quality-adjusted life-year (QALY)
gain. Costs were estimated from the perspective of the NHS and Personal Social Services.
Results: Overall, 568 residents from 114 care homes were allocated to the intervention arm and
474 residents from another 114 care homes were allocated to the control arm, giving a total of
1042 participants. Randomisation occurred between May 2010 and March 2012. The mean age of
participants was 82.9 years, and 665 (64%) were female. No adverse events attributable to the
intervention were recorded. Of the 1042 participants, 870 (83%) were included in the analysis of the
primary outcome (intervention, n= 479; control, n= 391). The primary outcome showed no significant
differences between groups. The adjusted mean difference in the BI score between groups was 0.19
points higher in the intervention arm [95% confidence interval (CI) –0.33 to 0.70, p= 0.48; adjusted
intracluster correlation coefficient 0.09]. Secondary outcome measures showed no significant differences at
all time points. Mean incremental cost of the Occupational Therapy intervention for residents with stroke
living in UK Care Homes intervention was £438.78 (95% CI –£3360.89 to £1238.46) and the incremental
QALY gain was 0.009 (95% CI –0.030 to 0.048).
Limitations: A large proportion of participants with very severe activity-based limitations and cognitive
impairment may have limited capacity to engage in therapy.
Conclusion: A 3-month individualised course of OT showed no benefit in maintaining functional activity in
an older care home population with stroke-related disabilities.
Future work: There is an urgent need to reduce health-related complications caused by inactivity and to
provide an enabling built environment within care homes.
Trial registration: Current Controlled Trials ISRCTN00757750.
Funding: This project was funded by the National Institute for Health Research Health Technology
Assessment programme and will be published in full in Health Technology Assessment; Vol. 20, No. 15.
See the Health Technology Assessment programme website for further project information.
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Plain English summary
Care home residents with stroke-related disabilities tend to be more disabled than those living in thecommunity. During the day, care home residents spend most of their time sitting down. This inactivity
can cause further health problems. Occupational therapy is a service that has been shown to help a person
perform everyday tasks, such as getting dressed. However, occupational therapy is rarely available in UK
care homes.
This study aimed to find out whether or not care home residents with stroke-related disabilities would
benefit from occupational therapy and if it would help them become more involved in everyday tasks.
Overall, 1042 stroke survivors from 228 care homes across England and Wales took part. The homes
were split randomly into two equal-sized groups. Stroke survivors in half of the care homes received
occupational therapy and those in the remaining care homes received their usual care. The two groups
were compared after 3, 6 and 12 months using a test that measured how much help they needed in
performing everyday tasks, such as washing and getting dressed. The cost of providing occupational
therapy in care homes was also measured.
The results showed that no extra benefit will be obtained by providing occupational therapy to stroke
survivors living in care homes, compared with their usual care. Offering this intervention does not
represent good value for money compared with other NHS services.
Referring UK care home residents with stroke-related disabilities to occupational therapy may be effective
on an individual basis, but this study suggests that making it a part of routine care will be of limited benefit.
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Scientific summary
Background
Advances in acute care have reduced mortality rates following stroke significantly. As a result, the number
of people living with stroke-related disabilities has increased. Approximately one-quarter of all stroke
survivors are unable to return home following their stroke and require long-term institutional care.
Care home residents living with stroke-related disabilities tend to have increased levels of dependence as
a result of cognitive and physical impairments compared with stroke survivors living in the community.
Occupational therapy (OT) aims to improve quality of life by providing assistance and guidance in carrying
out daily routines. OT is particularly relevant and applicable to a care home setting; however, access to
OT services as a part of routine practice in UK care homes is restricted. Findings from a pilot study
conducted by Sackley et al. (Sackley C, Wade D, Mant D, Atkinson J, Yudkin P, Cardoso K, et al. Cluster
randomized pilot controlled trial of an occupational therapy intervention for residents with stroke in UK care
homes. Stroke 2006;37:2336–41) confirmed the feasibility of a definitive trial evaluating the efficacy of
OT for care home residents living with stroke sequelae. The pilot trial suggested that a modest duration
of OT had both detectable and lasting effects on morbidity in care home residents with stroke-related
disabilities. However, prior to the Phase III trial reported here, the evidence was inconclusive of whether or
not OT is a service that is clinically effective and cost-effective in this population. This study represents the
largest cluster randomised controlled trial of OT in care homes to date.
Objectives
The predominant aim was to perform a definitive evaluation of OT for stroke and transient ischaemic
attack (TIA) survivors in long-term institutional care. The primary objective was to test the hypothesis that a
3-month course of OT provided by a trained therapist (involving personalised task training, provision of
adaptive equipment, minor environmental adaptations and staff education) would have a significant
clinical impact on activity-based measures of daily living, compared with usual care. Secondary objectives
aimed to explore the influence of the intervention on measures of mobility, depression and health-related
quality of life (HRQoL). In order to assess the influence of the 3-month intervention over time, outcome
measures were planned at 3-, 6- and 12-month follow-ups. In addition to the analysis of efficacy of OT in
this population, the Occupational Therapy intervention for residents with stroke living in UK Care Homes
(OTCH) study also contained a health economic evaluation that examined the mean incremental cost of
the intervention per quality-adjusted life-year (QALY) gained.
Methods
Design
The OTCH study was a pragmatic Phase III, parallel-group, cluster randomised controlled trial with an
economic evaluation.
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Setting
Eligible homes needed to provide care for older people (nursing or residential) and be registered with the
local authority. All care home funding models were included (e.g. local authority, private and not for
profit). Homes caring for residents with learning disabilities and drug addiction were excluded. A list of
care homes local to 12 trial administrative centres (TACs) were sourced via the Care Quality Commission
database. The TACs were based in the University of Birmingham; Bangor University; University of Central
Lancashire; Dorset Primary Care Trust (PCT); University of Nottingham; Solent Healthcare PCT; Plymouth
PCT; Wolverhampton PCT; Taunton PCT; Stoke-on-Trent PCT; Coventry & Warwickshire PCT; and
Bournemouth & Poole PCT. Care homes from each area were selected at random and invited to
participate. Care managers declaring interest were sent an information pack, and later visited by a member
of the research team, who answered the managers’ queries before they consented to participate. Any care
homes providing OT as part of routine care were excluded.
Participants
Residents were eligible for trial inclusion if they had had a confirmed or suspected stroke or TIA at any
point prior to study commencement. Residents receiving end-of-life care were excluded. Once written
consent from the care home manager had been received, staff at the home assisted the research team in
identifying eligible participants by searching residents’ notes to determine a diagnosis of stroke or TIA. If
required, residents’ general practitioners were contacted to confirm a diagnosis of stroke or TIA. Eligible
participants (or family members, if appropriate) were approached by a member of the research team
and given a full explanation of the study. A study information pack, which included details about the
intervention and treatment allocation, was left with prospective participants or family members. A second
visit to the care home was made by an assessor who collected written informed consent. As outlined in
the Mental Capacity Act 2005 (Great Britain. Mental Capacity Act 2005. London: The Stationery Office;
2005) for residents lacking the capacity to give informed consent, family members could provide consent
on a resident’s behalf. Following receipt of informed consent, the assessor conducted screening and
baseline measures.
Cognitive function and language impairment were assessed during screening; however, the results were
not used as exclusion criteria. Residents with cognitive and language impairments were purposefully
included as these characteristics are representative of the clinical population, thereby ensuring external
validity of trial results. Once all participating residents had completed baseline and screening assessments,
the care home was randomised. Care homes with a minimum of one consenting resident were eligible
for randomisation.
Screening measures
At baseline, the Sheffield Screening Test for Acquired Language Disorders was administered along with the
Mini-Mental State Examination. The tests provided an indication of the participant’s capacity to understand
instructions and directly engage in therapy, which informed the research team of whether or not a
consultee was required to assist the participant.
Baseline assessments
The primary measure administered at baseline was the Barthel Index of Activities of Daily Living (BI).
Secondary baseline measures included the Rivermead Mobility Index (RMI), Geriatric Depression Scale-15
items (GDS-15), and European Quality of Life-5 Dimensions, three levels (EQ-5D-3L) questionnaire. Proxy
data were collected for participants who required consultee assistance. We collected demographic details
including age, ethnicity, comorbidities and history of falls.
SCIENTIFIC SUMMARY
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Randomisation and masking
Randomisation occurred at the care-home level. To reduce the potential for bias, baseline assessments
were recorded prior to randomisation. Once all consenting participants in a care home had been assessed
at baseline, the home was randomised. Care homes were stratified according to the type of care provided
(nursing or residential) and the location of the TAC. Homes were randomised 1 : 1 and allocated to either
the active intervention group or the control group. The randomisation process was administered in
Birmingham by the Primary Care Clinical Research and Trials Unit. The allocation sequence was generated
by an independent statistician using nQuery Advisor version 7.0 (Statistical Solutions, Saugus, MA, USA).
The sequence was generated using randomised blocks (size= 2) within strata and concealed from the
research team. Once notification had been received that a care home was ready to be randomised, the
strata data for the home were logged and the allocation was revealed to the study co-ordinator. Allocation
information was then disclosed by the co-ordinator to the care home manger and the site therapist.
Site allocation was concealed from the independent assessors, who were specifically trained in
administering all primary and secondary outcome measures. Assessors were allocated to specific sites and
conducted all the measures in their designated homes. It was not possible to mask allocation from treating
therapists or residents.
Intervention and control
In the active intervention, an OT package was delivered by qualified therapists and assistants to both the
individual residents and the care home staff. The OT package for residents was targeted towards
maintaining abilities in functional activity; in particular, personal activities of daily living (ADL) such as
feeding, dressing, toileting, transferring and mobilising. This OT package followed a patient-centred
goal-setting approach. Agreed goals of therapy (within the framework of the care home) were established
between the resident and the therapist. The frequency and duration of therapy sessions were dependent
on the agreed goals of therapy, and therapists had one-to-one contact with each participant for a period
of up to 3 months.
Residents’ allocated to the intervention received task-specific training, guidance and supervision to promote
and support safe practice of personal ADL. The progress of the intervention was closely monitored by the
therapist, and if necessary the goals of therapy were modified accordingly. To assess compliance, the dose
and focus of the intervention for each resident was documented in a treatment log. When necessary,
adaptive equipment was provided (e.g. adaptive cutlery), the resident’s environment was altered slightly
(e.g. installing bed levers) and minor alterations were made to the care home (e.g. providing raised toilet
seats). In cases when a resident’s environment was altered or adaptive equipment introduced, participants
and care home staff were given relevant task-specific training. Any enabling features introduced to the
residents’ environment were not removed at the end of the intervention.
Staff in care homes allocated to the intervention received a group workshop, and personalised training for
individual staff where necessary. Training focused on facilitating functional activity, mobility and the use
of adaptive equipment relevant to residents with disabilities.
Residents in homes allocated to the control group received their usual care. Critically, this did not include
an OT component. Staff in care homes allocated to the control arm received training once the study
was completed.
Outcome measures
The primary outcome measure was the BI score at 3 months after randomisation. The BI assesses
dependency in 10 categories of self-care: feeding, grooming, transferring from bed to chair, toileting,
washing, walking indoors, continence of urine, continence of faeces, dressing and use of stairs.
An increase of 2 points in the BI score was identified as the minimal clinically important difference.
Secondary outcome measures included the RMI, the GDS-15 and the EQ-5D-3L. All measures were
administered at 3-, 6- and 12-month time points.
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Sample size
This sample size calculation was based on data obtained in several pilot trials. In order to observe a
clinically significant 2-point increase in the mean BI score at 3 months using a 1 : 1 randomisation
allocation ratio, it was estimated that a sample size of 330 participants in each randomisation arm was
required. This estimate was based on a standard deviation (SD) of 3.7 and an intracluster correlation
coefficient (ICC) of 0.4 with 90% power at the 5% significance level. Assuming an attrition rate of 26%,
with 10 eligible residents recruited per home, it was predicted that 45 care homes were required in each
arm of the study (n= 900 residents). The required sample size quoted in the original application was
840 residents from 84 care homes; however, this figure was amended at the start of the trial. The original
figure of 840 was not sufficiently inflated for attrition.
Economic evaluation
To assess economic viability of the OT package we conducted a within-trial cost–utility analysis. Costs
were assessed from a NHS and Personal Social Services perspective, and outcomes were based on the
EQ-5D-3L. In the base case, a complete case analysis was undertaken in order to estimate the mean
incremental cost per QALY gain for the OTCH programme, in relation to a threshold of £20,000–30,000
per QALY. Sensitivity analysis assessed the robustness of conclusions to different assumptions in relation to
the inclusion of high-cost participants, a more societal perspective and multiple imputations.
Results
Participating care homes were randomised between 4 May 2010 and 28 February 2012. Recruitment
exceeded the target. Additional care homes were recruited because the mean cluster size was lower than
predicted but was comparable between treatment arms. A total of 1042 participants, from 228 care
homes (114 homes in each condition), consented. No additional participants joined the trial following
randomisation. According to the patient-centred goal-setting approach 23,683 out of 103,443 minutes
(23%) of therapy time was spent on individual assessment, 50,188 out of 103,443 minutes (49%) on
communication, 7295 out of 103,443 minutes (7%) on ADL training, 8415 out of 103,443 minutes (8%)
on mobility training, 7681 out of 103,443 minutes (7%) on equipment and seating posture and 6181 out
of 103,443 minutes (6%) on treating specific impairments.
Baseline BI data for the primary outcome were recorded from 99% of participants. Over 70% of all
participants were graded as severe on the BI. BI severity was balanced between treatment arms. During the
intervention 2538 therapy visits were made to 498 residents (mean 5.1 residents, SD 3.04 residents).
Total therapy time was 1724 hours and median session duration was 30 minutes (interquartile range
15–60 minutes). Retention of care homes was high, with 204 out of 228 (89%) of homes providing data
up to the final 12-month assessment. Of the 1042 participants, 313 (30%) died during the 12-month
trial period. Prior to the primary outcome at 3 months, 64 out of 568 (11%) participants died in the
intervention arm and 52 out of 474 (11%) died in the control arm. No adverse events attributable to
the intervention were recorded.
Of the participants alive at 3 months, the BI was completed by 479 out of 504 (95%) in the intervention
arm and 391 out of 422 (93%) in the control arm. No statistically or clinically significant differences were
observed between groups for the BI at 3 months. The adjusted mean difference in BI score between
groups was 0.19 points higher in the intervention arm [95% confidence interval (CI) –0.33 to 0.70;
p= 0.48; adjusted ICC 0.09]. Furthermore, no significant differences were observed in the analyses of the
secondary outcome measures at 3 months that assessed mobility (mean difference in RMI of 0.02 units,
95% CI –0.28 to 0.31 units; p= 0.90), mood (mean difference in GDS-15 of –0.21 units, 95% CI –0.76 to
0.33 units; p= 0.44) and HRQoL (mean difference in EQ-5D-3L utility scores of 0.01, 95% CI –0.04 to
0.06; p= 0.65). Similarly, at the 6- and 12-month end points, no significant differences were observed
between groups across all outcome measures.
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Economic outcomes
In the base-case analysis, the mean incremental cost of the OTCH intervention was £438.78 (95% CI
–£360.89 to £1238.46) and the incremental QALY gain was 0.009 (95% CI –0.030 to 0.048), giving an
incremental cost of £49,825 per QALY. OT did not lead to any reduction in health-care expenditure in
the active intervention participants, and the quality-of-life improvement over usual care was negligible.
Sensitivity analyses supported these conclusions.
Discussion
The results of this large cluster randomised trial report neutral findings. The personalised, 3-month course
of OT intervention did not have a clinically significant impact on the abilities of older stroke survivors
residing in care homes to engage in self-care activities more independently, according to the results of the
BI. We also found no evidence of a significant influence of the intervention on any secondary outcome
measures. The OT package was not estimated to constitute a cost-effective use of scarce NHS resources.
The majority of participants were graded as severe on the BI at baseline. This level of physical frailty
may have limited residents’ capacity to engage in therapy. However, the large sample population is
representative of the UK care home population with regard to age, sex balance and levels of dependence
as a result of stroke-related disabilities.
Conclusion
We did not find evidence to suggest that a 3-month OT package designed for an older care home
population with stroke-related disabilities is clinically beneficial, or that it provides a cost-effective use
of resources.
Future work
Further research into the effectiveness of environmental adaptations and equipment in promoting
independence is required. Changing or adapting the environment rather than trying to retrain the
individual resident may be a more effective approach.
Trial registration
This trial was registered as ISRCTN00757750.
Funding
Funding for this study was provided by the Health Technology Assessment programme of the National
Institute for Health Research.
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Chapter 1 Background
Prevalence of stroke in the UK
The population of the UK and elsewhere is living longer. The average lifespan since 1960 in England
and Wales has increased by 10 years for men and 8 years for women.1 One in six members of the UK
population were aged over 65 years at the time of the 2011 census,2 and the over-85-year-old age bracket
is the fastest growing sector.3 It is predicted that, by 2031, 22% of the population will be over 65 years old.4
The incidence of stroke increases significantly with age.5 According to British Heart Foundation statistics
released in 2012, there are approximately 152,000 strokes in the UK5 and approximately 65,000 people
experience their first transient ischaemic attack (TIA) each year.6
Survival rates following stroke have improved significantly over the last 20 years because of medical advances
in acute care and increased public awareness of stroke symptoms. However, owing to the decreasing levels
of stroke mortality there is a significant rise in the number of people living with stroke-related disabilities.
In 2012, it was estimated that there are 1.2 million stroke survivors living in the UK.5 Stroke represents the
third most common cause of disability-adjusted life-years worldwide.7–9 The disabilities experienced as a
result of stroke are complex,10 potentially involving a multitude of physical and mental impairments,
including difficulties as detailed in Box 1.
Approximately 10% of patients are discharged from hospital directly to a long-term care facility,11,12 and
25% of stroke survivors require long-term institutional care as a result of the brain injury.13 Clearly,
clinically effective and cost-effective health technologies designed to ameliorate disability and improve
quality of life for a growing population of older stroke survivors are needed.
Long-term care descriptors
In England, at the end of 2012 there were 4675 care homes with nursing facilities (218,387 beds)
registered with the Care Quality Commission, and 12,917 residential care homes without nursing facilities
(245,942 beds).14 The distinction between homes that provide nursing care and those that offer only
residential care is dependent on the skills of the care home staff, and not necessarily associated with the
level of disability of the residents. Homes that provide nursing care employ qualified nurses, whereas
homes that provide residential care are not required to employ qualified health professionals. It is
estimated that between 20% and 45% of all people newly admitted to residential care settings in the
UK have stroke-related disabilities.11,15–17 The prevalence of stroke and dementia in the older population
suggests a huge demand for long-term care facilities, and the provision of effective health-care
technologies within those facilities, both now and in the future.18
Health-care services within care home settings
Older people with complex health conditions are the main users of health and social care services.19
From 1990 to 2010 in the UK there was a significant shift in long-term care for older adults away from
geriatric hospitals, and more towards care homes.20 Long-stay hospital wards benefit from established
auditing systems which, prior to recent developments in social care provision, care homes did not. As a
consequence, patients living in care homes have been described as ‘living on the margins of care’.21 During
this period there have been a number of initiatives, devised by government, in association with the Royal
College of Physicians (RCP), that have introduced care standards to regulate, and improve, health care for
the older population, and develop a more integrated service in care homes.3,19,20,22–24
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The National Service Framework for old age presented care standards with three themes: dignity in care;
joined-up care; and healthy ageing – promoting exercise and activity, independence, well-being and
choice.19 The joined-up care theme outlined reforms to ensure a comprehensive health assessment is
conducted prior to admission to a long-term residential facility, to establish individual health-care needs.3
The National Service Framework listed standards for four main components central to the development of
an integrated stroke service in older age: prevention, immediate care, early and continuing rehabilitation,
and long-term support.3,19
In addition to the National Service Framework, the RCP produced a series of guidelines to enhance the
health of older adults in long-term care.20 A component within these guidelines focused on ‘overcoming
disability’ from a therapeutic perspective.20 The guidelines highlighted the importance of the care home
environment, and the use of aids, equipment and adaptations to address disability and improve function in
long-term care facilities. The philosophy behind these guidelines was that small increases in functional
capacity of older people are deemed to impact positively on quality of life and cost of care.20 The section
on ‘overcoming disability’ concentrates on providing access to resources to improve or maintain
functioning in primary activities of daily living (ADL).
BOX 1 Physical and mental impairments
Arm and/or leg movement.
Balance.
Walking.
Swallowing.
Spasticity.
Cognition.
Depression.
Bowel control.
Performing personal activities of daily living (e.g. washing, bathing, dressing).
Pain.
Altered sensation.
Speaking.
Understanding the written or spoken word.
Urinary incontinence.
Vision.
BACKGROUND
NIHR Journals Library www.journalslibrary.nihr.ac.uk
2
For the purposes of this trial, primary ADL are referred to as personal or self-care ADL. Personal ADL are
defined as:
l mobility
l transfers (e.g. from bed to chair and back)
l using the toilet
l grooming
l bathing
l getting dressed
l feeding.
These initiatives have instigated considerable progress in raising standards, increasing awareness of
health-care issues in older age and lessening the long-standing stigma associated with this population.
However, despite this progress, care services for older adults with high support needs, such as stroke
survivors residing in care homes, are notoriously inconsistent, and most often dictated by financial
constraints at a regional level.25
More residents with a higher level of dependency and complex care needs are being admitted to care
homes than ever before.26 For residents with high levels of support needs, there is more of an emphasis on
providing specialist care for a short period towards the end of life to ease suffering and promote dignity
throughout.16 It is critical to design health services with the needs, circumstances and preferences of
the service users in mind.19,27 Establishing an evidence base for clinically efficacious and cost-effective
therapeutic health technologies, suitable for use by the NHS in care homes to promote dignity, joined-up
care and increased independence is a research priority.
Occupational therapy
Occupational therapy is the therapeutic intervention that promotes health by enhancing the
individual’s skills, competence and satisfaction in daily occupations . . . to act on the environment and
successfully adapt to its challenges.
Yerxa et al.28 p. 6
Activity is essential to health and well-being.29 In the re-drafted report published by the World Health
Organization entitled International Classification of Functioning, Disability and Health (ICF),30 the term
‘disability’ is described in reference to the interaction between an individual’s impairments, activity
limitations, participation restrictions and their environment. This definition focuses on the individual’s
capacity to engage in functional activity.
Occupational therapists aim to improve the quality of life of their patients by attempting to augment
functional activity and increase their capacity to engage in personal ADL.31 A philosophy of occupational
therapy (OT) is that the intervention is most effective when it is integrated into the context of the
individual.31 OT typically applies a patient-centred goal-setting approach, so that the therapy package is
individualised for each patient, and the goals of therapy are continually reviewed in relation to progress.32
The treatment programme is planned around the patient’s goals. The patient is given as much autonomy
as possible in maintaining or improving his or her own quality of life. Task-specific training, guidance and
supervision is given to reinforce safe and effective practice of personal ADL.33 Where necessary, training
involves the use of adaptive equipment (e.g. adapted cutlery or walking aids) to facilitate an increase
in capability, ameliorate activity limitations and provide therapeutic aid. Enabling modifications, tailored to
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individual needs, can be applied to the environment to promote safe and effective practice of ADL
(e.g. the installation of bed levers, grab rails or a raised toilet seat). Particular attention is given to
communication, to engender an informal atmosphere that will enable the exchange of ideas, and the
offering of peer support. In summary:
Occupational therapy is a complex intervention. Practice includes skilled observation; the use of
standardised and non-standardised assessments of the biological, psychiatric, social, and
environmental determinants of health; clarification of the problem; formulation of individualised
treatment goals; and the delivery of a set of individualised problem solving interventions.34
Historically, OT services within the NHS have been situated in acute hospital services; however, nowadays
therapists also operate as a part of local authority social care services throughout the UK. The ‘joined-up
care’ initiative has helped instigate service reform to better suit the needs of users in the local
community.3,19 A review of the effectiveness of OT administered by local authority social services to older
people at home has shown high satisfaction levels for the service.34 It has also been suggested that the
provision of adapted equipment to reduce dependency on additional services may be cost-effective.35
Occupational therapy for stroke rehabilitation
The National Institute for Health and Care Excellence guidelines for stroke rehabilitation recommend that
OT should be provided for people after stroke to help ameliorate difficulties with personal ADL.36 The
guidelines also stipulate that stroke survivors should be monitored regularly by occupational therapists with
core competencies in this area.36
Occupational therapy delivered to stroke survivors in their own homes has good evidence of benefit.34,37
A systematic review and meta-analysis were conducted by members of the research team to determine
whether or not OT, focused on promoting increased activity and independence in performing personal
ADL, improves recovery for stroke survivors.34 Analysis of nine trials (1258 participants) found that OT
increased personal ADL scores, measured using the Barthel Index of Activities of Daily Living (BI). The
standardised mean difference was 0.18 [95% confidence interval (CI) 0.04 to 0.32; p= 0.01] in favour of
OT, compared with receiving no intervention or usual care. This equates to a single-point difference (5%)
on the BI (20-point scale). Furthermore, for every 100 people who received OT after a stroke, 11 (95% CI
7 to 30) would be spared a poor outcome, defined as death or deterioration in abilities to perform ADL
[odds ratio (OR) 0.67, 95% CI 0.51 to 0.87; p= 0.003].34 The review concluded that targeted OT should
be available to everyone who has had a stroke, to reduce disability and increase independence in
performing personal ADL.
Although the systematic review concluded that OT is effective when administered in patients’ homes,34 the
clinical efficacy and cost-effectiveness of OT administered to stroke survivors living in a care home setting
was not known. Differentiating stroke survivors who live in their own homes from stroke survivors residing
in care homes is important. Typically, stroke survivors living in care homes have increased physical and
mental limitations as a result of their brain injury, and their functional capacity to perform personal ADL is
often restricted. For instance, 78% of residents in a care home have cognitive impairment, 76% need
some form of assistance with ambulation and 71% are incontinent.17 Reduced functional capacity may
limit stroke survivors’ ability to engage in, and respond to therapy. As a result, generalisation of results
from community studies to care home settings should be treated with caution.
BACKGROUND
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Occupational therapy for care home residents with stroke-related
disabilities
In the Netherlands, 93% of care home residents regularly receive some form of OT;38 however, in the UK
it is available to as few as 3–6% of residents.39,40 An audit of over 1000 residents in England found that
none had been assessed for OT.41 The most recent stroke guidelines recommend reducing nationwide
variability in rehabilitative care after stroke,42 including the care home setting.43 Owing to the number of
patients transferring directly from hospital to a care home environment following a stroke, as opposed to
returning home,13,44 it is necessary for rehabilitation and social care services to achieve equivalent
standards, especially for those patients with increased dependence.
Following admission to a care home, stroke survivors’ health state typically follows a downward trajectory.
Observational data suggest that care home residents spend 97% of their daytime hours sitting inactive
with eyes open or eyes closed.45 Inactivity in older care home residents can pose further health risks, such
as pressure ulcers, joint contractures, pain, incontinence and low mood.46 The provision of OT as a means
of augmenting levels of functional activity may reduce the likelihood of these further health conditions and
reduce unnecessary dependence.
Current evidence evaluating the efficacy of OT across the whole care home population, not restricted to
residents who have experienced a stroke, has shown conflicting results.47,48–51 The evidence relating
specifically to stroke survivors living in care homes is extremely limited. A systematic review considering
the efficacy of providing OT to stroke survivors living in care homes was conducted by our research team.52
Literature searches were performed within: MEDLINE, EMBASE, the Cumulative Index to Nursing and Allied
Health Literature, the Cochrane Central Register of Controlled Trials, six trials registers and 10 additional
bibliographic databases (all searches ended in September 2012).52 The review process revealed only one
relevant randomised controlled trial (RCT) conducted to date; this was the OT intervention for residents
with stroke living in UK Care Homes (OTCH) cluster randomised Phase II pilot trial discussed in full in
Chapter 2. No firm conclusions of efficacy of OT provided to care home residents with stroke-related
disabilities could be drawn from the systematic review.52
Depression in stroke survivors residing in care homes
Symptoms of depression are common in older residents residing in care homes,53–57 and very common
following stroke.58 Experiences of depression following stroke may be directly attributable to the brain
injury or an adverse psychological response to trauma.58 Communication problems following stroke limit
residents’ ability to express feelings of low mood and may be difficult to recognise by unqualified members
of staff.59 Presence of depression in care home residents is associated with poor outcomes and increased
mortality.57 Symptoms of depression include:
l losing interest in everyday activities
l finding it difficult to concentrate or make decisions
l feeling worthless, guilty, helpless, hopeless or in despair
l changes in appetite.58
A previous study, assessing the feasibility of a trial evaluating the effectiveness of an OT programme at
reducing levels of depression in a care home population, found no significant effects.60 However, the trial
was not powered to evaluate the efficacy of OT in alleviating in symptoms of depression. The OTCH
trial sought to assess the influence of OT on levels of depression as a secondary outcome measure to the
performance of personal ADL.
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Assessing health-related quality of life in stroke survivors
residing in care homes
A central philosophy underpinning OT is that the intervention involves engaging in activities that hold
meaning for the individual. The personalised meaning behind the activities is thought to help promote
increased quality of life for that individual.31 Health-related quality of life (HRQoL), assessed according to a
number of physical and emotional dimensions of interest,61 can be used to measure the perceived impact
of a chronic disease.62 The purpose of including a measure of HRQoL was to provide an additional
multidimensional scale that considers both physical and emotional functioning to evaluate potential effects
of the OT intervention not captured by the BI.
Training for care home staff
In the UK, the majority of care for older stroke survivors living in long-term care institutions is provided by
the staff of those institutions.63 During the OTCH Phase I stage, a number of care home staff in one area
of the UK were interviewed.41 From the staff responses, it was evident that none of the care homes was
providing aids and appliances effective in reducing physical decline, that is there was a difference between
policy and practice. It is therefore doubtful whether or not the RCP guidelines on ‘overcoming disability’
could be universally implementable across the UK.20 The guidelines highlight the importance of the care
home environment and the use of aids, equipment and adaptations to address disability and improve
function in long-term care facilities. The results from the Phase I interviews were a strong indication that
any development of health services in care homes needs to directly involve the staff who provide the
majority of residents’ care.
A later report highlighted several aspects of staff involvement deemed fundamental in establishing a
more positive culture in care homes.64 It promoted the importance of staff training to move away from the
prevalent model of task-based care system of doing things ‘for’ residents, and more towards a system with
a shared commitment (‘doing with’) that includes emotional care. Consequently, the involvement of care
home staff in the evaluation of OTCH was regarded as integral, in order to increase awareness of the
broad spectrum of stroke-related disabilities and to provide continuity in care practices between staff and
visiting therapists.
Aims and objectives of the Occupational Therapy intervention
for residents with stroke living in UK Care Homes trial
Disabilities affecting ADL are commonplace for stroke survivors living in UK care homes, and yet access to
rehabilitation services, particularly OT, is very restricted. The purpose of the study was to conduct a Phase III
RCT to evaluate the effects of a targeted 3-month course of OT (with provision of adaptive equipment,
minor environmental adaptations and staff education) for people with stroke sequelae living in care homes.
The primary outcome measure assessed was the capacity to perform personal ADL.
The secondary outcome measures assessed were mobility, depression and health-related quality of life.
An economic evaluation of the intervention was conducted in parallel with the evaluation of clinical
efficacy as part of the health technology assessment. Providing an OT service to stroke survivors resident in
care homes was compared against usual care. The trial aimed to evaluate whether or not there is sufficient
evidence to advocate the routine implementation of OT for all stroke survivors living in care homes.
BACKGROUND
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Chapter 2 Methods
Trial design
The OTCH study was a Phase III, pragmatic, multisite, cluster RCT with economic evaluation, across several
regions in England and Wales. The cluster design was justified because of the inclusion of an education
component for care home staff and the potential need to apply minor modifications to the care home
environment (e.g. install raised toilet seats). Furthermore, cluster randomisation at a care-home level
reduced the potential for between-group data contamination during interaction between carers, therapists
and residents. The flow diagram for this trial followed the Consolidated Standards of Reporting Trials
(CONSORT) extension for cluster randomised trials.65
Setting
Local care homes for older people in the UK were located in the following 12 trial administration
centres (TACs):
i. University of Birmingham
ii. Bangor University
iii. University of Central Lancashire
iv. University of Nottingham
v. Solent Healthcare Primary Care Trust (PCT)
vi. Plymouth PCT
vii. Wolverhampton PCT
viii. Taunton PCT
ix. Stoke-on-Trent PCT
x. Coventry & Warwickshire PCT
xi. Bournemouth and Poole PCT
xii. Dorset PCT.
Recruitment and consent
Care homes
Residential homes with and without nursing care with more than 10 beds, local to the 12 TACs, were
identified from the Care Quality Commission website. Homes were identified randomly, to ensure a
non-biased selection, using published care home lists. All funding models of care home were included
(i.e. private, charitable, not for profit and local authority). Institutions for people with learning disabilities or
drug addiction were excluded from the study. Homes were telephoned by a member of the research team
and the trial was explained briefly. No homes were actively delivering OT as a component of standard care.
A recruitment pack was mailed to interested homes. This included an invitation letter, a leaflet describing
OT, study information sheets, designed in collaboration with service users, and a response form. Another
telephone call was made to arrange a convenient time for the assessor to visit, and the homes were asked
to consider which residents may be eligible. At the visit, the care home managers were given a full verbal
explanation of the study and the opportunity to ask questions. If managers were interested in the study,
they were asked to sign a written agreement for their home to participate. Following receipt of care home
consent, residents were considered individually.
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Residents
Care home managers assisted to identify potential participants. To be eligible for entry into the study
potential participants were required to be resident in a care home and to have a history of stroke
(ischaemic or haemorrhagic) or TIA. The inclusion of residents with a history of TIA was warranted because
of the growing evidence that TIA can cause long-term problems.66,67 All efforts were made to include
participants with communication and cognitive impairments to increase external validity of the trial as
these symptoms are commonplace following stroke. Residents receiving end-of-life care were excluded.
Care home members of staff searched residents’ files to determine a diagnosis of stroke or TIA. If required,
the research team sought confirmation of this diagnosis with general practice records [see Appendix 1 for
general practitioner (GP) correspondence details]. When a potential participant was identified as being
eligible for the study they, and their family (when appropriate),68 were approached by the assessor or a
senior member of the care home staff. Prospective participants (and their family) were given a full
explanation of the study. This included a discussion of the treatment options in the trial and the method
of treatment allocation. Potential participants (and family, if appropriate) were given an invitation pack
consisting of an invitation letter, consent form and participant information sheet, designed in collaboration
with service users (see Appendices 2–4 for participant information sheets and consent form). For eligible
residents needing the assistance of a consultee (family member), a consultee package was mailed, which
included a consultee invitation letter, consultee declaration form and consultee information sheet
(see Appendices 5 and 6 for consultee information sheet and declaration form, respectively). Residents
were given sufficient time to decide (at least 24 hours) whether or not they would like to join the study.
A follow-up telephone call was made by the assessor to arrange a return visit to the care home.
Participants and consent
During a second visit to the care home the independent assessors obtained consent from all eligible
residents who had indicated interest. If the resident was considered to be incapacitated, according to
guidelines listed in the Mental Capacity Act 2005,68 a consultee was approached for consent. If the
resident or consultee consented, the participant’s GP was informed in writing of their involvement in
the trial. Following the consent procedure, baseline assessments were administered by the assessor.
When all participating individuals in a home had completed baseline assessments, the care home was
randomised. If a care home had at least one consenting resident, it was eligible for randomisation.
Randomisation, stratification and blinding
Care homes and participants were recruited and consented into the study before the randomisation process
commenced to reduce bias.69,70 Once the study co-ordinator received confirmation from assessors that all
residents in a participating home had given their consent and completed a baseline assessment, the homes
were grouped and randomised (1 : 1) to receive either the OT intervention or usual care (control). The
allocation sequence was generated in software (nQuery Advisor version 7; Statistical Solutions, Saugus,
MA, USA) by an independent statistician using blocked randomisation (block size 2) within strata [type of
care home (with or without provision of nursing care)] and geographical location of the TAC at the Primary
Care Clinical Research and Trials Unit, University of Birmingham, independent from the research team.
Blocked randomisation was used to ensure groups were balanced with respect to the stratification variables.
The details of the sequence were concealed from the research team, independent assessors and the study
co-ordinator. Once the study co-ordinator received notification that all consenting participants in a care
home had completed baseline measures and that the strata data had been logged, care homes were
randomised. Care home allocation was revealed to the study co-ordinator, who then informed the care
home manager and corresponding site therapist. If a care home had been allocated the OT intervention, the
site occupational therapist then contacted the manager of the home to make arrangements for them to
visit and commence the intervention. Treatment allocation was concealed from the independent assessors,
but it was not possible to mask aspects of the intervention from staff or residents.
METHODS
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Procedure
The trial protocol is published elsewhere.71
Control: usual care
Care homes in the control arm of the study continued to provide their usual care to residents. None of the
participating homes provided OT as a component of routine care. After all the final outcome assessments
had been conducted at 12 months, the care homes in the control arm were offered a 2-hour group
training session for care home staff. The session was led by an occupational therapist and focused on
promoting and supporting activity for care home residents after stroke.72 It was based on the key principles
of OT, such as the facilitation of independent daily living and promotion of activity among residents.
Occupational therapy intervention
We developed an OT intervention package for residents in a care home using evidence and expert
occupational therapist consensus opinion, details of which are summarised below and presented in full in a
previous publication.73 The OT intervention was delivered by a qualified occupational therapist and/or an
assistant, and it was targeted towards maintaining the stroke survivors’ capacity to engage in personal
ADL, such as:
l feeding
l dressing
l toileting
l bathing
l transferring
l mobilising.
In order to promote external validity, the therapy a resident received was not dictated by the trial, but
decided on by the therapy professional, in collaboration with the resident or consultee.
Patient-centred goal-setting
The OT intervention employed a patient-centred goal-setting approach to establish an individualised
treatment plan for each participant. Goal-setting involves establishing mutually agreed targets between
patient and therapist that will be aimed for over a specified duration of therapy.42 In the initial assessment
the therapist met with the participant (and/or carer/family member when appropriate) and recorded
demographic details, current medication and discussed challenges experienced with daily activities (see
Appendices 7–9). Together they agreed a treatment plan that was reviewed after each session. Two
examples of the patient-centred goal-setting approach and treatment plan are presented in Table 1.
Intensity of occupational therapy (number of visits)
The frequency and duration of the OT was dependent on the resident’s and therapist’s agreed goals
(within the framework of the home). In a study that piloted the intervention on a population of care home
residents (not limited to stroke survivors), the number of face-to-face sessions ranged from 1 to 25 per
resident over a 3-month period (median time 8.5 hours and mean time 4.7 hours), dependent on the
individual needs of the resident.73 The OT intervention included a continuous process of assessment,
treatment and reassessment.73 In line with current evidence on effective treatment, the intervention adopted
a task-specific training approach.33 Treatment logs were developed, and each occupational therapist was
required to document the time spent and content of each individual therapy session. An example of the
treatment log is given in Appendix 10.
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Occupational therapy content
The content of therapy for the OTCH intervention was assigned to categories, and the time spent on each
category was documented in the treatment log. Categories of therapy identified in the intervention design
were listed as:73
l assessment/reassessment and goal-setting – involving the assessment of a resident’s current levels of
functional activity in personal ADL and mutually identifying functional goals of therapy
l communication – including listening to residents’ concerns about personal ADL, providing information
and guidance to residents, staff or relatives, initiating referrals to other agencies and
ordering equipment
l ADL training (cognitive and functional) – involving techniques to assist with feeding, bathing, using the
toilet, getting dressed and grooming
l transfers and mobility (cognitive and functional) – involving bed mobility, standing, walking and
transfers to/from a chair
l environment – involving environmental adaptations (e.g. adaptive equipment)
l other – involving treating impairments directly, such as joint contracture.
Equipment provision
Adaptive equipment was provided as part of the study, which included personal items such as adapted
cutlery and walking aids. If required, adaptations to the individual’s environment were made, such as
provision of chair raisers, bed levers, raised toilet seats or grab rails. The occupational therapist
demonstrated to the participant, and care staff, how to use adaptive equipment effectively, while adhering
to safety regulations.
TABLE 1 Examples of the patient-centred goal-setting approach and treatment plan
Participant ID Needs identified Goals Action
*** Maintenance of mobility Check use of walking equipment Checked ferrules
Improve body strength Checked height of walking aid
Improve posture and balance Encourage to mobilise
Exercises to improve strength
and balance
Discussed armchair
Difficulties with transfers Improve bed and toilet transfer
technique
To try equipment to assist toilet
transfers and bed transfers
To try toilet seat equipment
Difficulties with personal care To improve independence in
personal care
To try use of perching stool
*** Difficulties with sit-to-stand
transfers
Improve transfer technique Assess dining room chair and
armchair
Practice transfers
Slow, shuffling walking pattern Improve walking pattern Check shoes and walking stick
Improve body strength and
balance
Implement exercise regime
Reduce tightness of hamstrings Advice on walking technique
Elevate feet on footstool to feel
stretch on posterior thigh
Difficulties keeping food on
plate during meal times
Facilitate feeding technique Assess use of plate guard
METHODS
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Examples of the type of such equipment are listed below:20
l mobility: wheelchair, walking stick or walking frame
l transfers: chairs/beds – correct height to suit different needs
l toilet aids: includes raised seats and rails
l bathing: grab rails, bath board, specialist baths and showers
l getting dressed: dressing aids and clothing adaptations
l washing: adapted taps
l eating: adapted cutlery.
Involvement of care home staff
The implementation of the intervention required direct involvement of the care home staff to continue
therapy practices, and use of adaptive equipment initiated during treatment visits. Therapists wrote in
participants’ care plan after each visit. The care plans summarised the therapist’s assessment of the
participant and provided recommendations for the staff to implement in order to maximise participants’
levels of functional activity. Examples of care plans left for care home staff are given in Table 2. The care
home manager was continually updated on the progress of the intervention, and the research team
adapted therapy visits around care home routines (e.g. meal times and leisure activities).
TABLE 2 Summary of OT assessments: care plans and recommendations for carers
Participant ID Activity
*** Mobility
Following walking practice over the last few weeks, and provision of a three-wheeled walker by the
physiotherapist, Mr x is able to walk to the dining room from his bedroom, as his pain allows
Recommendation: please continue to provide opportunities for Mr x to walk rather than use
the wheelchair
Transfers
Mr x is able to manage all his transfers independently, as long as his pain is under control, including
sitting up in bed and moving his legs round to the floor, standing from the bed (can be unsteady so
supervision needed), standing from a chair, sitting on a chair and getting on and off the toilet
Recommendation: please continue to offer verbal support rather than physical support as much as
possible to facilitate Mr x’s transfers
Personal care
When provided with a bowl of soapy water and a flannel, Mr x is able to wash his upper body mainly
independently, needing help with his back, bottom, legs and feet. He currently has help shaving, but
may be able to manage this himself if provided with a shaving mirror
Mr x is able to take off his nightwear independently with prompting. He is able to put on a vest and
shirt by himself. He can manage some buttons himself, but needs some help with this. Mr x can dress
in pants and trousers with minimal help to get these past his heels. He needs full assistance to put his
socks and shoes on. Mr x is able to put his cardigan on with minimal help
Recommendation: please continue to maximise Mr x’s participation in his personal care by providing
verbal prompts and encouragement rather than physical help as much as possible
*** Eating/drinking
Mr x is able to eat and drink independently when positioned correctly in his bed, and with his table
positioned to give him best access to his food. The Nursing sister and a member of care staff have been
shown how best to position Mr x for eating/drinking
Recommendation: please ensure Mr x is always positioned correctly and his food placed within reach to
maximise his independence with eating and drinking
continued
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TABLE 2 Summary of OT assessments: care plans and recommendations for carers (continued )
Participant ID Activity
Personal care
Mr x is able to wash his face when provided with a cloth, prompting and encouragement
Recommendation: please continue to enable Mr x to wash his face independently by providing a cloth,
verbal prompts and encouragement rather than physical help as much as possible
*** Personal care
When provided with a bowl of soapy water and a cloth, Mrs x is able to wash her face and upper body
mainly independently, needing help with her back, bottom, legs and feet
Recommendation: please continue to maximise Mrs x’s participation in her personal care by providing
verbal prompts and encouragement rather than physical help as much as possible
Eating
Mrs x has been provided with a ‘Knork’ fork to enable her to cut up food independently
Recommendation: please ensure Mrs x has her adapted cutlery at meal times
*** Personal care
The occupational therapist assessment observed that Mrs x is able to participate in washing her face
and top half, needing some help because of her right-side weakness. The occupational therapist
supplied a suction cup denture brush to enable Mrs x to brush her dentures independently using one
hand. Mrs x likes to have some buttons left undone on her cardigan, so she can spend time over the
day doing them up herself
Recommendation: please ensure Mrs x is always given time and opportunity to participate as much as
possible in her personal care routine. A member of care staff at time of assessment gave excellent
support, enabling Mrs x to do as much for herself as possible. Please ensure the denture brush is stuck
to the wash basin so that Mrs x can access it easily to clean her dentures
Seating/positioning
Mrs x sits in a reclining chair. She is not currently adequately supported in a good seating position by
this chair, which may be contributing to the high tone in her right leg, as she is having to try to hold
herself up on her weak side. Mrs x does not want to try using pillows for support in her chair, but is
willing to be assessed for more suitable seating
Recommendation: Mrs x would benefit from assessment for specialist seating, to maximise her comfort
and ability to function and minimise the risk of increased tone/contractures
*** Mobility
Mrs x has good movement in her legs, and is able to weight bear enough to use a standing hoist. She
is keen to try walking again. As she has not walked for many months, however, this may or may not
be possible
Recommendation: Mrs x may benefit from a referral to community physiotherapists for a full
assessment with a view to a period of rehabilitation
Personal care
When provided with a bowl of soapy water and a cloth, Mrs x is able to wash her face and upper body
mainly independently, needing help with her back, bottom and legs and feet
Recommendation: please continue to maximise Mrs x’s participation in her personal care by providing
verbal prompts and encouragement rather than physical help as much as possible
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Training for care home staff
Providing regular staff development exercises in long-term care facilities is recommended within RCP
guidelines.20 A specific training workshop was provided to staff directly involved in the care of the residents
receiving the OT intervention.72 The workshop aimed to increase awareness of stroke, and the range of
stroke-related disabilities residents may experience. Risks associated with inactivity were highlighted as well
as describing the carer’s role in:
l supporting mobility (e.g. safe and effective methods of transfer)
l preventing accumulative problems from poor positioning (e.g. unsuitable armchairs)
l facilitating resident participation in self-care activities.72
The workshop promoted strategies for staff to improve residents’ capacity in performing personal ADL.
A key message in the workshop was to encourage residents’ functional activity, and to create a suitable
enabling environment to achieve maximum independence in performing personal ADL. It was expected
that inviting care home staff to engage in further training would facilitate compliance and reduce loss to
follow-up. A copy of the training workbook appears in Appendix 11. The training given to care home staff
received UK Stroke Forum Education and Training endorsement. Training for staff allocated to the control
arm was offered following completion of the 12-month follow-up assessments.
Quality assurance
Training of site assessors and occupational therapists
When a TAC initiated work on the trial, it received a trial set-up visit from a senior member of the research
team and a trial occupational therapist. A full explanation of the study protocol was given to the trial
assessors and occupational therapists. Details of the information passed on to the regional therapists
during training are contained in Appendix 12. The assessors were provided with training on the trial
paperwork and assessments. Completed examples of the paperwork were provided, including instructions
on coding for missing data. The occupational therapists received training on completing the OT-specific
paperwork, and the process of ordering specific therapy equipment.
Site monitoring and communication
Site recruitment rates were monitored, and the data uploaded onto the centralised trial database were
reviewed when a home was ready for randomisation. If inadequate data had been entered, the TAC was
contacted and asked to collect and enter the missing data. The process of randomisation was delayed if
the site had missing data to upload.
Any amendments to the study protocol or processes were communicated directly to the sites after ethical
approval was received. Acknowledgement was sought to clarify that research staff comprehended the
amendments. Members of the research team were invited to attend study meetings, which were specific to
their role in the study (e.g. assessors and occupational therapists). This provided an opportunity to discuss
general challenges occurring in the study and clarify the trial protocol in relation to site-specific cases.
Compliance
Compliance was estimated by the number of intervention sessions recorded in the OT treatment logs
(see Appendix 10), which also described the focus and content of each therapy session.
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Outcome assessments
Assessment schedule
An overview of the assessment schedule is given in Table 3. A description of each of the assessment
measures is listed in Appendix 13. Baseline assessments were conducted prior to randomisation to reduce
possible recruitment bias.69 The primary measurement end point was 3 months after randomisation.
Additional assessments were conducted at 6 and 12 months after randomisation. Data were collected
from participants where they were currently residing. If a participant moved to another home between
assessments, then every attempt was made by the assessors to collect follow-up data from the participant.
To maximise efficiency in data collection and reduce potential disruption to the care home’s daily routine,
assessors visited a particular care home and tried to complete all follow-up assessments for participating
residents in a single day. If a participant was unwell, in hospital or unavailable on the day of the assessment,
the assessor returned to the care home within a 4-week window. Efforts were made for all participants to
complete the primary outcome measure at each time point. However, if it was foreseen that participants
would be unavailable, a proxy response was obtained from a member of the care home staff.
Demographic data and screening measures
An assessor collected demographic data directly from the participant or consultee, which included age,
sex, ethnicity, comorbidities, history of falls and intake of current medication. A member of staff from the
care home provided initial information about the participant’s stroke, such as the date, type and location
of stroke. If this information was unavailable at the care home or additional clarification was required, the
participant’s general practitioner was contacted to obtain the data. At baseline, the assessor administered
the Sheffield screening test for acquired language disorders to assess receptive/expressive aphasia74 and
the Mini-Mental State Examination (MMSE) to assess cognitive function.75 These assessments were not
used to exclude individuals. The tests provided an indication of the participant’s capacity to understand
instructions and directly engage in therapy. The screening tests also informed the research team if
consultee assistance was required during recruitment.
TABLE 3 Assessment schedule
Assessment
Time of administration
Baseline 3 months 6 months 12 months
Demographics ✓
Sheffield Screening Testa ✓
Mini-Mental State Examination ✓
BI ✓ ✓ ✓ ✓
RMI ✓ ✓ ✓ ✓
Geriatric Depression Scale-15 ✓ ✓ ✓ ✓
EQ-5D-3L ✓ ✓ ✓ ✓
Resource use log ✓ ✓ ✓
Adverse event log ✓ ✓ ✓
EQ-5D-3L, European Quality of Life-5 Dimensions, three levels; RMI, Rivermead Mobility Index.
a Full name of the test is Sheffield Screening Test for Acquired Language Disorders.
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Primary outcome measure
The primary outcome measure was the BI,76–78 which is regarded as the gold standard measure for
assessing functional capacity in rehabilitation outcomes.20,36,79 It is commonly used to assess stroke
survivors.80,81 The BI measures specific aspects of self-care targeted by the therapy, such as transfers
(e.g. from bed to chair) and grooming, and how much help people need in completing personal ADL.79
Furthermore, the BI was used in previous studies assessing the efficacy of OT, and the data from our study
are suitable to be incorporated into meta-analyses.34,48,49 For pragmatic reasons, we chose to use the
shortened BI scale between 0 and 20.77 A higher score signifies that a person has more independence in
ADL. A 2-point change in score is widely accepted as having clinical meaning.82 It equates to a change that
is perceived by stroke survivors and clinicians as a step change in function. For example, a patient may
change from being unable to dress and feed to being able to manage with some help or from being able
to manage the toilet with some help to being able to manage alone.
Secondary outcome measures
Secondary outcome measures assessed mobility, mood and HRQoL. The HRQoL measure [European Quality
of Life-5 Dimensions, three levels (EQ-5D-3L)] is discussed in Chapter 4, Measuring outcomes. Mobility was
assessed with the Rivermead Mobility Index (RMI),83 a 15-item measure of functional mobility. It is scored
from 0 to 15 and a higher score denotes better mobility. It was deemed important to assess the RMI
alongside the BI to increase responsiveness to change.79 According to previous research that assessed the
sensitivity of the RMI and BI in capturing change,79 both tests measure similar constructs but have the
potential for floor and ceiling effects. The BI is geared more towards assessing global function, but the RMI
relates specifically to mobility. The RMI is regarded as a more sensitive measure than the BI, but has the
potential for floor effects (i.e. high percentage of scores at the low end of the scale). The BI, on the other
hand, has the potential to give rise to ceiling effects (i.e. high percentage of scores at the top end of
the scale).79 Attempting to maximise responsiveness to change was a critical issue in the evaluation of the
OTCH intervention because small increases in functional capacity of older people are deemed to impact
positively on quality of life and cost of care.20
The Geriatric Depression Scale (GDS) was administered to measure mood.84 One point is assigned to each
answer in accordance with the mark scheme. A higher score denotes more severe depression. The full
30-item version was initially administered with participants.84 If residents were unable to self-complete or
follow the interview process, the consultee version, which consisted of 15 items, was completed.85
However, during the study it was decided to replace the full 30-item GDS with the shortened 15-item
GDS,85 to reduce the burden on the residents and assessors. The protocol amendment occurred in 2010.
Adverse events
An adverse event was defined as an injury attributable to the intervention requiring a visit to a hospital
or GP. A risk assessment found that there was a small increased risk of falling as a result of the OT
intervention (e.g. because of an increase in use of ambulatory aids). This small increased risk was stated
clearly in the participant information sheet. Every effort was made to minimise the risk of falls throughout
the treatment of the participant and by training the care home members of staff (see Appendix 14 for the
adverse event reporting form).
Sample size
A change of 2 points on the BI is widely accepted as being clinically meaningful.82 In order to detect a
difference of this magnitude between the treatment arms, a sample of 72 participants in each arm was
required, based on an estimate of standard deviation (SD) of 3.7 points,47,48,49 90% power and 5%
significance level. However, residents in this trial were cluster randomised by care home and, therefore, the
sample size was inflated by a factor of 4.6, resulting in an increase to 330 residents per randomisation
arm. This design factor was based on an estimate of intracluster correlation coefficient (ICC) of 0.4 and an
average of 10 residents per care home observed in previous research.48,49 The ICC used in the sample size
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calculation was estimated from data related to several pilot studies from a single site with relatively small
numbers of care homes. A larger estimate of ICC was used than the ICC observed during the OTCH
pilot trial in the interest ensuring an adequately powered study.48 Based on the attrition rate of 26% from
the OTCH pilot study,48 it was estimated that 45 homes with 10 residents per home would be required
in each arm of the study (900 residents in total) to detect a clinically meaningful difference using the BI.
The sample size quoted in the original proposal was estimated at 840 residents from 84 care homes;
however, this sample size was initially incorrectly inflated for expected attrition (26%). The correct figure
should have been 900 residents from 90 homes. The revised estimate was identified at the start of the trial.
Occupational Therapy intervention for residents with stroke
living in UK Care Homes pilot study
A pilot study of the OT intervention for residents in care homes with stroke-related disabilities was
conducted in Oxfordshire, UK, and published prior to the trial.48 The pilot study was undertaken to refine
trial procedures and ensure the OT intervention was acceptable to residents and deliverable in the intended
format. The design was a cluster RCT with the unit of randomisation trial at the care home level. Twelve
homes (118 residents) were randomly allocated to either the OT intervention (six homes, 63 residents) or
control (six homes, 55 residents). The control group received usual care. Usual care did not include OT.
In the intervention group, a 3-month course of individualised one-to-one OT was provided to residents with
stroke-related disabilities. The aim of the therapy was to maintain levels of functional activity in self-care
tasks, adapt the physical environment (when necessary) and address specific impairments that limit
performance in ADL or cause discomfort.
In addition, the OT intervention included training for care home staff directly involved in the care of the
residents. Assessments were made at baseline and at 3-month (immediately following the intervention)
and at 6-month follow-up. The measures used were the BI and RMI. The trial indicated a potential for the
OT intervention to have detectable and lasting effects on morbidity. From baseline to the primary end
point at 3 months the mean BI score increased by 0.6 points (SD 3.9 points) in the OT arm, but decreased
by 0.9 points (SD 2.2 points) in the control arm. The mean difference between the groups was 1.5 points
(95% CI –0.5 to 3.5 points, allowing for cluster design). The between-group difference in BI score was
maintained at 6 months (difference of 1.9 points, 95% CI –0.7 to 4.4 points).
The analysis of the data suggested that OT may have a significant influence on maintaining functional
independence in personal ADL for residents living with stroke-related disabilities within care homes.
However, the analysis was exploratory because of its small sample size. The pilot study demonstrated
feasibility of the research design. The method was practical and provided the relevant information to
conduct a formal sample size calculation for a subsequent suitably powered definitive trial.
Data management
All pre- and post-randomisation data were initially captured by a blinded assessor on paper forms. The
data were then entered manually onto the purposefully designed trial database system, which was located
in the Primary Care Clinical Research and Trials Unit at the University of Birmingham. The data entry
application server was accessible over the internet via secure remote access. All traffic through the data
entry application to the database was automatically encrypted using 128-bit secure sockets layer. The
database was only accessible from within the University of Birmingham’s information technology network.
Only senior members of the research team had access to the database. The firewall for the database was
configured to allow access from specific machines only. The data entry application and database used
role-based security controls, which restricted access to parts of the data (i.e. uploading, editing and
viewing). The data entry application forms were designed and set up by a data manager and computer
programmers in collaboration with members of the research team.
METHODS
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Queries about data completeness were referred by the study statistician to the trial co-ordinator. Any
missing data that needed to be clarified were obtained by telephone call with the participant or a care
home member of staff. Completed questionnaires were entered onto the trial’s secure database by the
assessor or a member of the research team. If changes were required on the paper questionnaires, they
were formally documented and subsequently uploaded onto the database. The baseline and follow-up
data were validated continuously throughout the trial for correctness and completeness. Furthermore,
computerised validation checks were incorporated to minimise errors in the data sets (i.e. ranges, limitations
and categorisation). Interim summary reports were generated for the Data Monitoring Committee.
Statistical analysis
Analyses were conducted according to a pre-specified statistical analysis plan.71
Recruitment
Recruitment rates and cluster size were analysed according to the stratification variables of type of care
home (nursing or residential) and geographical location (TAC).
Analysis of baseline assessments
Baseline characteristics of participants were tabulated by treatment arm. Items included demographic
details, including age, ethnicity and comorbidities. In addition, the screening measures assessing cognitive
function and language impairment were summarised to gauge mean levels of stroke-affected disabilities
between treatment arms.
Intention to treat
All analyses were performed using an intention-to-treat approach. All participants, including those who
died, withdrew or were lost to follow-up, were analysed according to the intervention to which they were
randomised, regardless of whether or not they complied with treatment. Participants who moved care
homes during the course of the trial were analysed by the home to which they were originally randomised.
Statistical analysis was carried out using Proc Mixed and Proc Glimmix in SAS version 9.2 (SAS Institute Inc.,
Cary, NC, USA). Multiple imputation was performed using the ICE command in Stata version 12
(StataCorp LP, College Station, TX, USA).
Primary analysis
Outcome measures were compared at the level of the participant. The primary outcome was the BI score
at the 3-month follow-up (immediately after the intervention). Linear mixed model analysis with identity
link was used to compare the BI between the two arms. The analysis was adjusted for care home
(as a random effect), baseline BI score and stratification factors [TAC (geographical location) and type of
care home (nursing or residential)]. It was expected that there would be a significant number of deaths in
this study during the follow-up phase; therefore, it was agreed, a priori, that participants who died
before their follow-up date would be given a BI score of zero at all subsequent follow-ups. This approach
was discussed at Trial Steering Committee (TSC) meetings and agreed by the independent Data
Monitoring Committee. A Barthel score of zero represents complete dependency, which was thought to
reflect the participant’s health state if they had been alive. This method of analysis has been used
previously in a stroke population.86 The influence this may have on the results was examined via a
complete case analysis that did not impute BI scores for participants that died.
In addition, participants were categorised into three outcome groups based on an individual’s change in BI
score at 3 months from baseline (below 0 or death, ‘poor’; 0 to 1, ‘moderate’; 2 and above, ‘good’) for a
BI composite analysis. A non-linear mixed-effects model with cumulative logit link was used to compare
this ordinal outcome between the groups. Adjustments were made for care home as a random effect,
and TAC and type of care home as fixed effects.
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Secondary analysis
Secondary outcomes: RMI (mobility), GDS (mood) and EQ-5D-3L (HRQoL) measures were compared at the
participant level at the 3-month follow-up using mixed modelling with identity link. Adjustments were made
by care home as a random effect and baseline score, with type of care home and TAC as fixed effects.
To examine whether or not there was an effect of the intervention on outcomes over the longer term,
treatments were compared using a repeated measures mixed model across all 3-, 6- and 12-month time points.
For the continuous measures, adjusted mean differences between the treatment arms are reported with
corresponding 95% CIs. Positive mean differences favour the intervention. Results for the categorical
outcomes are presented as ORs with 95% CIs when an OR > 1 favours the intervention.
Subgroup analysis
Exploratory subgroup analyses were performed to further evaluate whether or not the effect of the OT
intervention on BI differed by participants’ age, the type of care home in which participants’ resided,
the severity rating of participants’ BI scores, the level of cognitive impairment (derived from the MMSE
screening measure), and whether or not the measures were completed by the participant or a consultee.
The subgroups were evaluated by the inclusion of covariate by treatment interactions in the mixed modelling.
Sensitivity analysis
Several sensitivity analyses were carried out to test the robustness of the conclusions.
(a) Statistical methodology: to test the validity of the mixed modelling approach when many clusters had
only one or two participants, the primary and secondary analyses were repeated excluding clusters
with fewer than three participants.
(b) Ceiling effects: to test the potential ceiling effect of the BI, participants with a baseline score of 18 or
above were excluded from the primary analysis.
(c) Missing Barthel data because of death: the primary analysis was repeated without imputing missing BI
data following the death of a participant (complete case analysis).
(d) Missing data: the effects of missing data were examined using various imputation methods including:
best case (last observation carried forward); worst case (zero) and multiple imputation methods.
Missing Barthel data following death were imputed with zeros for all imputation methods.
Intracluster correlation coefficient
The ICCs were calculated to quantify the effect of clustering, which arose from the care home effects in
the primary outcome. The smaller the ICC, the less effect the clustering had on the precision of
parameter estimates.
Falls
The proportion of falls in each treatment group during the first 3 months of the trial were compared using
generalised mixed modelling with logit link. The number of falls in each treatment group that occurred in
this period were compared using a negative binomial model. This method was chosen rather than a
Poisson model because of the over dispersion of the falls data. Adjustments were made for care home,
TAC and type of care home as previously described.
METHODS
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Ethical approval
Potential risks/benefits
The intervention itself was not experimental. OT is readily available for stroke survivors and their families
in other settings. The intervention has been demonstrated by meta-analysis to be of benefit to stroke
survivors and their families in these settings.34,37 However, OT is not readily available in a care setting, and
the efficacy and cost-effectiveness have not been assessed in long-term care.40 Very few adverse events
have been recorded through OT interventions. It is possible that walking aids can have a manufacturing
fault, but this risk was carefully monitored and publicised. None of the aids or equipment used in this
study was experimental. All equipment was in routine use throughout the NHS and social care services.
Ethical approval for this study was obtained from the National Research Ethics Service, Coventry Research
Ethics Committee (Reference 09/H1210/88) in October 2009.
Trial registration
This trial was registered as ISRCTN00757750 on 21 October 2009.
Governance
A TSC was established to monitor the governance of the study. The Trial Steering Group comprised
the main research team, an independent chairperson, a geriatrician, an occupational therapist, a
physiotherapist with expertise in rehabilitation research, a patient representative and a representative from
the NIHR. A Data Monitoring and Ethics Committee (DMEC) was also established. This committee was
independent of the trial and monitored accrued data at regular intervals to assess ethical, safety and data
integrity aspects of the trial. The DMEC consisted of an independent geriatrician as chair, a statistician and
an occupational therapist.
Amendments to the study protocol during the trial
The first substantial amendment was submitted on 15 March 2010 to approve changes to (1) the protocol
to clarify the recruitment and randomisation process, the statistical analysis and the TACs and (2) the
demographic front sheet, MMSE, OTCH resource usage form and the care home invitation letter.
Furthermore, the substantial amendment included the addition of the OT treatment log, adverse events
reporting form, OT leaflet and consultee Geriatric Depression Scale-15 items (GDS-15) to the study.
The first substantial amendment was approved 23 March 2010.
A second substantial amendment was approved on 21 October 2010. This amendment included (1) a
clarification of the consultee’s responsibilities and duties in the declaration process; (2) an update of the
consent form and participant information sheet with grammatical changes for clarity; (3) a redesign of
the resource usage questionnaire to capture the OT data after the 12-month follow-up assessment to
ensure assessors remained blinded; (4) new paperwork including a GP letter notifying them that their
patient was randomised to the control arm of the study; and (5) care home letters notifying them of the
randomisation outcome.
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On 17 August 2011, a third substantial amendment was approved and included (1) changes to the
participant and consultee information sheets to provide more information regarding the security of the
trial’s database; (2) a new covering letter and form to the participant’s GP to ask for confirmation of their
patient’s diagnosis; and (3) shortening the GDS from the 30-item version to 15-item version to reduce the
burden on participants and assessors, and to bring the questionnaire in line with the consultee GDS.
A further minor amendment was submitted to revise the consent and declaration forms for version control,
which was approved on 22 August 2011.
A final substantial amendment was approved on 26 July 2013 that confirmed the transfer in sponsorship
of the OTCH trial from the University of Birmingham to the University of East Anglia.
Patient and public involvement
Patient and public involvement was an integral part of the OTCH trial. Patients and carers were directly
involved as research ‘partners’ and not just as ‘data providers’ (using the INVOLVE guidance; see
www.invo.org.uk). A representative from the local stroke community was involved in the study design,
listed as a co-applicant on the funding submission, recruited as a member of the TSC and is a co-author of
this report. An additional stroke survivor was recruited onto the TSC which convened regularly throughout
the course of the trial. Service users (and carers) were directly involved in developing the written material
contained in the study protocol and participant information sheets. All support for patient and carer
involvement was provided by the Stroke Research Network members. The Stroke Research Network team
had expertise in training and supporting service users (and carers) for involvement in NHS, service
evaluation and development. A wider patient/carer audience was consulted about the findings and
recommendations drawn from the project. This occurred at meetings convened by West Midlands Stroke
Research Network, The Stroke Association and Different Strokes.
METHODS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
20
Chapter 3 Results
The results are summarised, below, in Box 2.
BOX 2 Results summary
Participating care homes were randomised equally to the two treatment arms (114 in each). The number of
participants randomised to the intervention arm was larger than that randomised to the control arm, resulting
in 568 residents randomised to the OT group and 474 to the control group. The two groups were comparable
with respect to baseline characteristics. The majority of participants recruited were resident in nursing homes
(64%). Over 70% of participants were rated as severe or very severe on the BI (primary measure) at baseline.
Primary outcome
Among surviving participants, similar rates of completion of the BI were observed in each randomisation arm.
Overall, 94% of survivors completed the primary outcome measure at 3 months, 94% at 6 months and 88% at
12 months. No significant differences were found in the primary outcome at 3 months. The 95% CI did not
contain the clinically important difference of 2 units. The OR for the Barthel composite outcome, which took
account of the change in Barthel score from baseline to 3 months, was 0.96. The OR CI at the 95% level
crossed the null (0.70 to 1.33). No between-group differences were observed at later end points.
Sensitivity analysis
Exclusion of scores above 18 or clusters with fewer than three residents did not alter the results. Imputation of
missing Barthel scores using three methods (best case, worst case and multiple imputation) did not change the
conclusions. None of the exploratory subgroup analyses indicated a significant effect of treatment.
Secondary outcomes
No significant influences of the intervention were found on measures of mobility, depression or HRQoL at any
of the follow-up time points.
Adverse events
No adverse events attributable to the intervention were reported.
Retention
Participant retention was good. Among the participants alive at 12 months, 355 out of 407 (87%) in
the intervention arm had completed the BI and 285 out of 322 (89%) in the control arm had done so.
Lost-to-follow-up data are presented in the CONSORT diagram (see Figure 1). A total of 313 (30%) participants
died during the 12-month duration (161 from the intervention arm and 152 from the control arm).
Falls
A significantly higher (adjusted) fall rate per resident was reported in the intervention arm (rate ratio 1.74,
95% CI 1.09 to 2.77; p= 0.02). The odds of residents experiencing a fall were not significant between groups
at the 0.05 level (OR= 1.55, 95% CI 0.96 to 2.53; p= 0.07).
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Randomisation
Participating care homes were randomised between 4 May 2010 and 28 February 2012. Participants were
followed up at 3, 6 and 12 months after randomisation.
Recruitment at a cluster level according to stratification factors:
geographical location and type of care home
Twelve TACs across England and Wales were involved (with locations at the University of Birmingham,
Coventry PCT, Dorset PCT, Wolverhampton PCT, University of Central Lancashire, University of
Nottingham, Solent Healthcare PCT, Bournemouth and Poole PCT, Stoke-on-Trent PCT, Taunton PCT,
Bangor University and Plymouth PCT).
The distribution of care homes according to the geographical location of the TACs is shown in Table 4.
A total of 237 care homes gave consent. The average number of beds in consenting homes was 42
(SD 18.6 beds). Nine homes did not continue to the randomisation stage:
l One TAC, involving four homes, withdrew prior to randomisation because of administrative problems.
As a result, 11 TACs proceeded to the randomisation phase.
l Four care homes with consent at a managerial level did not provide any consenting participants and
were excluded.
l One home was excluded after the two consenting residents were withdrawn by the care home
manager, in order for the participants to receive end-of-life care.
Sample size
The sample size calculation was based on an ICC of 0.4. The unadjusted ICC for the BI in this trial was 0.36 at
baseline; however, for BI at 3 months, allowing for the effect of baseline BI score, treatment arm, location and
type of care home, the ICC reduced to 0.09.
BOX 2 Results summary (continued)
TABLE 4 Cluster (care home) distribution (n= 228) at the level of the TAC
TAC Total (%) Intervention (%) Control (%)
Bournemouth and Poole PCT 12 (5) 7 (6) 5 (4)
University of Central Lancashire 16 (7) 8 (7) 8 (7)
Coventry PCT 14 (6) 7 (6) 7 (6)
University of Nottingham 22 (10) 10 (9) 12 (11)
Plymouth PCT 14 (6) 8 (7) 6 (5)
Solent Healthcare PCT 26 (11) 13 (11) 13 (11)
Stoke-on-Trent PCT 10 (4) 4 (4) 6 (5)
Taunton PCT 8 (4) 4 (4) 4 (4)
Bangor University 17 (7) 8 (7) 9 (8)
University of Birmingham 73 (32) 37 (32) 36 (32)
Wolverhampton PCT 16 (7) 8 (7) 8 (7)
Total 228 114 114
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A total of 228 care homes proceeded to the randomisation stage. Care homes were randomised 1 : 1 to
receive the intervention or usual care (114 in each arm). The data for the type of care home are presented
in Table 5. Of the care homes recruited, 121 (53%) provided nursing care. The distribution of residential
and nursing homes was balanced between treatment arms. Retention of care home participation was
good throughout the study. Data were collected from 204 homes (89% of homes randomised) at the
12-month end point (104 in the intervention group and 100 in the control group).
Participant recruitment within clusters: sample size
The flow of participants throughout the duration of the trial is depicted in the CONSORT diagram (Figure 1).
Within the 237 consenting care homes there were 1556 out of 9840 (16%) eligible residents. The 16%
figure represents the prevalence of stroke in the consenting care homes. Of those identified as eligible,
1055 out of 1556 (68%) were registered into the trial and 501 out of 1556 (32%) did not offer consent.
A total of 13 participants (nine care homes) did not progress to the randomisation stage, two were
withdrawn by the care home manger to receive end-of-life treatment and the remaining 11 participants
were excluded because of the withdrawal of the regional TAC described above. Table 6 summarises
participant and care home recruitment levels according to regional TACs.
Participant recruitment exceeded the original target of 900. More care homes were recruited because the
average cluster size was lower than predicted, but comparable between the two arms (intervention mean
5.0 participants, control mean 4.2 participants). The slight over-recruitment of 1042 participants was
also because of staggered closure of sites that had already consented residents to the trial. Cluster size
information is presented in Table 7. The number of care home residents with a history of stroke was lower
than expected. A total of 1042 participants were randomised. More eligible residents resided in clusters
randomised to the intervention arm (n= 568) than in clusters randomised to the control arm (n= 474), see
Table 8. The disparity in participant numbers between the two treatment arms was a chance occurrence.
Consent was obtained prior to randomisation. There were more eligible residents in care homes randomised
to the intervention arm than in care homes randomised to the control arm. A larger percentage of
participating care homes (53%) provided nursing care (see Table 5), and from these a larger percentage
of participants (64%) were recruited (see Table 8).
Consent type
The majority of participants (61%) required the assistance of a consultee to offer consent on their behalf,68
indicating a lack of autonomy. The level of need for consultee assistance was similar across treatment arms
(Table 9).
TABLE 5 Type of care home by randomisation arm (n= 228)
Type of care home Total (%) Intervention (%) Control (%)
Residential 107 (47) 53 (46) 54 (47)
Nursing 121 (53) 61 (54) 60 (53)
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Eligible 
(n = 1556) from 237 homes
Consent before randomisation
(n = 1042) from 228 homes
Allocated to occupational
therapy group
(n = 568) in 114 homes
Allocated to control group
(n = 474) in 114 homes
Excluded
(n = 514)
• Refused, n = 501
• Withdrawals, n = 13 
   (from 9 homes)
Received allocation
(n = 545)
Received allocation
(n = 458)
• Completed primary outcome,
   n = 479 (from 113 care homes)
• Incomplete, n = 3
• Missing, n = 9
• Completed primary outcome,
   n = 391 (from 111 care homes)
• Incomplete, n = 12
• Missing, n = 14
Assessment at 3 months 
(n = 491)
Assessment at 3 months 
(n = 417)
• Completed primary outcome,
   n = 424 (from 111 care homes)
• Incomplete, n = 7
• Missing, n = 14
• Completed primary outcome,
   n = 369 (from 109 care homes)
• Incomplete, n = 2
• Missing, n = 8
Assessment at 6 months 
(n = 445)
Assessment at 6 months 
(n = 379)
• Completed primary outcome,
   n = 355 (from 104 care homes)
• Incomplete, n = 14
• Missing, n = 15
• Completed primary outcome,
   n = 285 (from 100 care homes)
• Incomplete, n = 7
• Missing, n = 11
Assessment at 12 months 
(n = 384)
Assessment at 12 months 
(n = 303)
Did not proceed
(n = 16)
• Died, n = 15
• Withdrawal, n = 1
   (died within 3 months)
Excluded
(n = 41)
• Died, n = 36
• Withdrawals, n = 2
• Lost to follow-up, n = 3
Excluded
(n = 38)
• Died, n = 34
• Withdrawals, n = 3
• Lost to follow-up, n = 1
Excluded
(n = 76)
• Died, n = 66
• Withdrawals, n = 5
• Lost to follow-up, n = 5
Did not proceed
(n = 23)
• Died, n = 16
• Withdrawals, n = 7
   (1 died within 3 months)
Excluded
(n = 54)
• Died, n = 47
• Withdrawals, n = 5
• Lost to follow-up, n = 2
Excluded
(n = 46)
• Died, n = 42
• Withdrawals, n = 4
Excluded
(n = 61)
• Died, n = 55
• Withdrawals, n = 3
• Lost to follow-up, n = 3
FIGURE 1 Consolidated Standards of Reporting Trials diagram.
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TABLE 6 Trial administrative centre recruitment figures
TAC
Care home recruitment Participant recruitment
Consenting
care homes
Beds in
consenting
homes
Randomised
care homes
Eligible
residents
screened
Consenting
residents
Randomised
residents
Bournemouth and Poole PCT 12 434 12 55 48 48
University of Central
Lancashire
16 954 16 142 86 86
Coventry PCT 14 537 14 107 56 56
Dorset PCTa 4 179 0 11 11 0
University of Nottingham 22 897 22 175 126 126
Plymouth PCT 16 556 14 68 40 40
Solent Healthcare PCT 28 1006 26 180 110 108
Stoke-on-Trent PCT 10 400 10 76 48 48
Taunton PCT 8 392 8 71 45 45
Bangor University 17 604 17 119 104 104
University of Birmingham 74 3098 73 427 323 323
Wolverhampton PCT 16 783 16 125 58 58
Total 237 9840 228 1556 1055 1042
a TAC withdrew prior to randomisation.
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TABLE 8 Distribution of participants by randomisation arm and type of care home (n= 1042)
Type of care home
Randomisation arm
Intervention (N= 568), n (%) Control (N= 474), n (%)
Residential 207 (36) 166 (35)
Nursing 361 (64) 308 (65)
TABLE 9 Consent type according to randomisation arm
Consenter Intervention (N= 568), n (%) Control (N= 474), n (%) Total (N= 1042), n (%)
Participant 230 (40) 174 (37) 404 (39)
Consultee 338 (60) 300 (63) 638 (61)
TABLE 7 Cluster size frequency (n= 228)
Cluster size (number of participants) Frequency (%)
Randomisation arm
Intervention, n (%)a Control, n (%)a
1 29 (13) 11 (10) 18 (16)
2 38 (17) 17 (15) 21 (18)
3 28 (12) 13 (11) 15 (13)
4 43 (19) 20 (18) 23 (20)
5 30 (13) 18 (16) 12 (11)
6 15 (7) 9 (8) 6 (5)
7 10 (4) 5 (4) 5 (4)
8 11 (5) 6 (5) 5 (4)
9 9 (4) 8 (7) 1 (1)
10 4 (2) 3 (3) 1 (1)
11 3 (1) 0 (0) 3 (3)
12 2 (1) 1 (1) 1 (1)
13 1 (0) 0 (0) 1 (1)
14 1 (0) 0 (0) 1 (1)
15 1 (0) 0 (0) 1 (1)
19 1 (0) 1 (1) 0 (0)
21 1 (0) 1 (1) 0 (0)
23 1 (0) 1 (1) 0 (0)
Total number of care homes 228 114 114
Median participants per home (interquartile range) 4 (2–6) 4 (3–6) 4 (2–5)
Mean participants per home (SD) 4.6 (3.3) 5 (3.7) 4.2 (3.0)
a Percentages may not total 100 because of rounding.
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Participant characteristics
The demographic information listed in Table 10 indicates that age, sex and ethnicity were balanced across
treatment arms. Of the 1042 participants, 962 (92%) were white and 665 (64%) were female. The mean
age of all participants was 82.9 years (SD 9.2 years, range 43–102 years). The distribution of age groups
was similar across care home type and randomisation arm (Table 11). Stroke or TIA was present in care
home notes for all participants; however, confirmation from GP surgeries was received in 721 out of 1042
(69%) cases. The details regarding the distribution of stroke and TIA among participants are given in
Table 12.
TABLE 10 Participant demographics by randomisation arm
Variable
Randomisation arm
Intervention (n= 568) Control (n= 474)
Mean age in years (SD) 82.8 (9.1) 83.1 (9.4)
Male, n (%) 203 (35.7) 174 (36.7)
Ethnicity, n (%)
White 517 (91.0) 445 (93.9)
Mixed 2 (0.4) 3 (0.6)
Asian 10 (1.8) 5 (1.1)
Black 13 (2.3) 7 (1.5)
Chinese 1 (0.2) 1 (0.2)
Unknown 25 (4.4) 13 (2.7)
TABLE 11 Age breakdown by type of care home and randomisation arm
Age group (years)
Type of care home
Residential Nursing
Intervention (n= 207),
n (%)
Control (n= 166),
n (%)
Intervention (n= 361),
n (%)
Control (n= 308),
n (%)
Under 65 10 (4.8) 5 (3.1) 17 (4.7) 11 (3.6)
65–69 9 (4.4) 0 (0) 14 (3.9) 22 (7.1)
70–74 13 (6.3) 11 (6.6) 30 (8.3) 25 (8.1)
75–79 28 (13.5) 25 (15) 38 (10.5) 55 (17.9)
80–84 43 (20.8) 26 (15.7) 85 (23.6) 55 (17.9)
85–89 52 (25.1) 33 (19.9) 105 (29.1) 77 (25)
90–94 33 (15.9) 43 (25.9) 53 (14.7) 44 (14.3)
≥ 95 19 (9.2) 21 (12.7) 17 (4.7) 19 (6.2)
Not known 0 (0) 2 (1.2) 2 (0.6) 0 (0)
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Time of stroke and care home length of stay
The median length of stay prior to trial randomisation was 2.35 years (interquartile range 0.96–4.49 years)
for the intervention group and 2.16 years (interquartile range 1.04–4.12 years) for the control group.
The exact dates of participants’ stroke obtained from medical records via correspondence with GP
surgeries were limited to approximately 50% of all participants. Date of stroke was confirmed for 225 out
of 568 (40%) participants in the intervention arm and 250 out of 474 (53%) participants in the control
arm. The median duration between residents’ stroke and trial randomisation was 3.17 years (interquartile
range 1.30–7.12 years) in the intervention arm and 2.82 years (interquartile range 1.18–5.83 years) in the
control arm.
The prevalence of participant comorbidities reported in Table 13 was similar between treatment arms.
High percentages of comorbidity were recorded in the cardiovascular, neurological and musculoskeletal
categories, as well as in history of falls.
TABLE 12 Stroke details
Stroke detail
Randomisation arm
Intervention (n= 568), n (%) Control (n= 474), n (%)
Confirmed stroke 329 (58) 317 (67)
Confirmed TIA 47 (8) 28 (6)
Suspected stroke/TIA 73 (13) 66 (14)
Missing 119 (21) 63 (13)
Locus of stroke in confirmed cases (n= 318) (n= 283)
Left hemisphere 161 (51) 154 (54)
Right hemisphere 148 (46) 108 (39)
Bilateral 9 (3) 21 (7)
TABLE 13 Participant comorbidities across treatment arms
Comorbidity
Randomisation arm
Intervention (n= 568), n (%) Control (n= 474), n (%)
Cardiovascular disease 342/530 (64.5) 278/446 (62.3)
Respiratory disease 90/484 (18.6) 76/415 (18.3)
Hepatic disease 6/471 (1.3) 8/406 (2.0)
Gastrointestinal disease 96/485 (19.8) 78/421 (18.5)
Renal disease 38/461 (8.2) 51/410 (12.4)
Urological disease 92/475 (19.4) 80/411 (19.5)
Neurological disease 371/505 (73.5) 296/424 (69.8)
Musculoskeletal problems 214/474 (45.2) 199/425 (46.8)
Dermatological problems 86/459 (18.7) 71/403 (17.6)
Fall history 203/495 (41.0) 200/427 (46.8)
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Screening measures administered at baseline
Table 14 lists the results from screening measures administered at baseline. The Sheffield Screening test for
Acquired Language Disorders was completed by 424 out of 568 (75%) participants randomised to the
intervention arm and by 374 out of 474 (79%) participants in the control arm. In total, 458 out of 798
(57%) participants across both randomisation arms scored below 15, indicating significant language
impairment.74 The MMSE screening test was completed by 398 out of 568 (70%) participants in the
intervention arm and 362 out of 474 (76%) in the control arm. Overall, 542 out of 760 (71%) participants
across both treatment arms scored in the range signifying cognitive impairment.87 Results from these
screening measures were incorporated into the exploratory subgroup analyses.
Retention
Retention throughout the trial was good. In the intervention arm, 21 participants moved home during the
trial, three died, one was lost to follow-up and the remainder (17) completed outcome assessments at
the 12-month end point. In the control arm, 16 participants moved homes, all of whom provided data
at the 12-month end point (see Appendix 15).
Withdrawal and lost-to-follow-up data, as well as completion rates for the primary outcome measure at
all time points, are presented in Table 15. A total of 313 out of 1042 (30%) participants died during the
12-month trial duration. The percentage of participants that died were balanced between treatment arms
at all time points (see Table 14). Two participants (one in each treatment arm) were withdrawn by the care
home manager to receive end-of-life care and died within 3 months. These two participants have been
included in the number of deaths (see Figure 1 and Table 15).
TABLE 14 Participant performance on screening measures by randomisation arm
Screening measure
Randomisation arm
Intervention Control
Sheffield screening test (0–20)
n 424 374
Mean (SD) 10.9 (7.1) 11.0 (6.9)
Median (interquartile range) 13 (3–17) 13 (5–17)
Language impairment (< 15), n (%) 245 (57.8) 213 (57.0)
MMSE (0–30)
n 398 362
Mean (SD) 13.6 (9.5) 13.2 (9.0)
Median (interquartile range) 14.5 (4–22) 14 (6–21)
Cognitive impairment (0–20), n (%) 279 (70.1) 263 (72.7)
Borderline cognitive impairment (21–23), n (%) 40 (10.1) 42 (11.6)
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Baseline primary and secondary measures
Primary measure
At baseline the BI was completed by 1029 out of 1042 (99%) participants.76–78 Performance on the BI
indicated that 735 out of 1029 (71%) participants in both treatment arms scored in the severe or very
severe range, signifying significant disability. Table 16 indicates that levels of impairment were comparable
between randomisation arms. The mean BI score for both treatment arms was in the severe range (see
Table 16). Across treatment arms, 560 out of 663 (84%) participants resident in care homes providing
nursing care scored in the severe or very severe range (Table 17).
Secondary measures
Rivermead Mobility Index
Baseline RMI scores are presented in Table 18. The measure was completed by 1033 out of 1042 (99%)
participants. The mean mobility score was low and comparable between treatment groups.
Figure 2 displays the baseline RMI data plotted as a function of the baseline BI data. The plot indicates that
a high proportion of participants had significant limitations on functional activity at the beginning of the
trial. This plot includes data from 1012 out of 1042 (97%) participants who completed both baseline
BI and RMI measures. A total of 493 out of 1012 (49%) participants scored below 4 on both the RMI and
the BI, suggesting that half of the sampled population had severe limitations on engaging with personal
ADL and severe limitations on mobility (see Table 44 in Appendix 16).
TABLE 15 Retention statistics and completion rate data for the primary outcome measure at all time points
Follow-up BI Intervention (N= 568), n (%) Control (N= 474), n (%)
Baseline Fully completed 562 (99) 467 (98.5)
Partially completed 3 (0.5) 7 (1.5)
Missing 3 (0.5) 0 (0)
3 months Fully completed 479 (84.3) 391 (82.5)
Partially completed 3 (0.5) 12 (2.5)
Missing 9 (1.6) 14 (2.8)
Withdrew/lost 13 (2.3) 5 (1.1)
Died 64 (11.3) 52 (11.0)
6 months Fully completed 424 (74.6) 369 (77.8)
Partially completed 7 (1.2) 2 (0.4)
Missing 14 (2.5) 8 (1.7)
Withdrew/lost 16 (2.8) 9 (1.9)
Died 106 (18.7) 86 (18.1)
12 months Fully completed 355 (62.5) 285 (60.1)
Partially completed 14 (2.5) 7 (1.5)
Missing 15 (2.6) 11 (2.3)
Withdrew/lost 23 (4.0) 19 (4.0)
Died 161 (28.3) 152 (32.1)
RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
30
TABLE 16 Baseline BI category by randomisation arm (n= 1029)
BI score
Randomisation arm
Intervention (N= 562), n (%) Control (N= 467), n (%)
0–4 (very severe) 268 (47.7) 234 (50.1)
5–9 (severe) 129 (23.0) 104 (22.3)
10–14 (moderate) 91 (16.2) 76 (16.3)
15–19 (mild) 64 (11.4) 46 (9.9)
20 (independent) 10 (1.8) 7 (1.5)
Mean (SD) 6.5 (5.8) 6.3 (5.7)
Median (interquartile range) 5 (1–11) 4 (1–10)
TABLE 17 Baseline BI category by type of care home and randomisation arm (n= 1029)
BI
Type of care home
Residential Nursing
Randomisation arm Randomisation arm
Intervention
(N= 204), n (%)
Control
(N= 162), n (%)
Intervention
(N= 358), n (%)
Control
(N= 305), n (%)
Very severe 62 (30.4) 31 (19.1) 206 (57.5) 203 (66.6)
Severe 42 (20.6) 40 (24.7) 87 (24.4) 64 (21)
Moderate 51 (25) 49 (30.3) 40 (11.2) 27 (8.9)
Mild 42 (20.6) 35 (21.6) 22 (6.2) 11 (3.6)
Independent 7 (3.4) 7 (4.3) 3 (0.8) 0 (0)
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FIGURE 2 The relationship between baseline RMI scores and baseline BI scores (n= 1012). BI 0–20, 20 signifying
maximum ability; RMI 0–15, 15 signifying maximum ability.
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Baseline GDS-15 scores were recorded from 913 out of 1042 (88%) participants (Table 19). The measures
of central tendency for the baseline GDS-15 scores were in the range indicative of mild depression, and
comparable between randomisation arms. Twenty-four per cent of participants scored in the 10–15 score
range, suggesting severe depression.
Intervention
Overall, 2538 visits were made to 498 residents in the intervention arm (mean 5.1 visits, SD 3.0 visits).
Total therapy time was 1724 hours. Median session duration was 30 minutes (interquartile range
15–60 minutes). Therapy was administered according to categories. Table 20 shows a summary of the
time allocated to each category.
The 3-month follow-up
Primary outcome measure
Of the participants alive at 3 months, the BI was completed by 479 out of 504 (95%) in the intervention
arm, and 391 out of 422 (93%) in the control arm (870 participants in total). The denominator for these
calculations includes those participants who withdrew. Participants for whom BI data were missing or
incomplete were excluded from the primary analysis. Following imputation of zero for deaths that occurred
prior to 3 months, the unadjusted mean for the intervention arm was 5.39 (SD 5.73) and 4.96 (SD 5.51)
for the control arm. No significant differences were observed between groups in BI at the primary outcome
end point of 3 months. The adjusted mean difference in BI score between groups was 0.19 points higher
in the intervention arm (95% CI –0.33 to 0.70; p= 0.48). The mean was adjusted for baseline score, type
of care home and TAC as fixed effects and by care home as a random effect to account for effects of
clustering. This difference did not represent a significant impact clinically.82 The composite BI outcome
analysis revealed that in the intervention arm 54% had a poor outcome (BI score change of zero or below)
and 15% had a good outcome (BI score increase of two or above), compared with 52% and 14%,
respectively, in the control arm. The odds of improvement in outcome were not significantly different
between the groups (OR 0.96, CI 0.70 to 1.33) (Table 21).
TABLE 18 Baseline RMI scores by randomisation arm (n= 1033)
RMIa
Randomisation arm
Intervention (n= 557) Control (n= 456)
Mean (SD) 3.12 (3.81) 2.85 (3.70)
Median (interquartile range) 1 (0–6) 1 (0–5)
a 0–15, 15 indicates maximum ability.
TABLE 19 Baseline GDS-15 scores by randomisation arm (n= 913)
GDS-15 score
Randomisation arm
Intervention (N= 498), n (%) Control (N= 415), n (%)
0–4 (normal) 157 (32) 131 (32)
5–9 (mild depression) 205 (41) 200 (48)
10–15 (severe depression) 136 (27) 84 (20)
Mean (SD) 6.8 (3.9) 6.4 (3.5)
Median (interquartile range) 6.0 (4–10) 6.0 (4–9)
RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
32
TABLE 20 Occupational therapy intervention summary
Provision of therapy Detail
Participants n= 498
Visits 2538
Mean visits per participant (SD, minimum–maximum) 5.1 (3.0, 0–18)
Median visits per participant (interquartile range) 5.0 (3–7)
Total duration of therapy 103,443 minutes (1724 hours)
Mean duration of therapy per participant (SD, minimum–maximum) 208 minutes (208 minutes,
10–1380 minutes)
Median duration of therapy per participant (interquartile range) 145 minutes (85–255 minutes)
Mean visit duration (SD) 41 minutes (34 minutes)
Median visit duration (interquartile range) 30 minutes (15–60 minutes)
Category of therapy Duration % of total
Assessment/reassessment and goal-setting: involving the assessment of a resident’s
current levels of functional activity and identifying/modifying goals of therapy
23,683 minutes 23
Communication: including listening to residents’ concerns about personal ADL, providing
information and guidance to residents, staff, or relatives, initiating referrals to other
agencies, and ordering equipment
50,188 minutes 49
ADL training (cognitive and functional): involving techniques to assist with feeding,
bathing, using the toilet, getting dressed and grooming
7295 minutes 7
Transfers and mobility (cognitive and functional): involving bed mobility, standing,
walking and transfers to/from a chair
8415 minutes 8
Equipment and environment: involving environmental adaptations 7681 minutes 7
Other: involving treating impairments directly – such as joint contracture 6181 minutes 6
TABLE 21 Comparison of BI composite outcome at 3 months
BI compositea
Randomisation arm
OR (95% CI)b p-valueIntervention (N= 540), n (%) Control (N= 436), n (%)
Poor 293 (54.3) 227 (52.1) 0.96 (0.70 to 1.33) 0.81
Moderate 164 (30.4) 150 (34.4)
Good 83 (15.4) 59 (13.5)
a Based on change in BI score at 3 months from baseline (below 0 or death, poor; 0 to 1, moderate; 2 and above, good).
b Proportional odds of improvement in outcome after OT compared with control; adjusted by care home as a random
effect and type of care home and centre as fixed effects.
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Secondary outcome measures
Unadjusted means at 3-, 6- and 12-month follow-up for measures assessing mobility (RMI) and mood
(GDS-15) are presented in Tables 22 and 23. Summary statistics for the HRQoL data are presented in
Chapter 4, Economic evaluation results to prevent duplication. The adjusted analyses, comparing mobility,
mood and HRQoL, showed no significant influence of the OT intervention at 3 months (Table 24).
TABLE 22 Mean RMI scores for all outcome end points
Assessment RMI score (0–15)
Randomisation arm
Intervention Control
3 months n 472 372
Mean (SD) 2.80 (3.71) 2.54 (3.65)
Median (interquartile range) 1 (0–4.5) 1 (0–4)
6 months n 427 363
Mean (SD) 2.71 (3.69) 2.51 (3.57)
Median (interquartile range) 1 (0–5) 1 (0–4)
12 months n 360 285
Mean (SD) 2.39 (3.51) 2.46 (3.70)
Median (interquartile range) 1 (0–3.5) 1 (0–4)
TABLE 23 Geriatric Depression Scale-15 for all outcome end points
Assessment GDS-15 (0–15)
Randomisation arm
Intervention Control
3 months n 415 345
Normal (0–4) 155 (37.3%) 141 (40.9%)
Mild depression (5–9) 172 (41.4%) 118 (34.2%)
Severe depression (10–15) 88 (21.2%) 86 (24.9%)
Mean (SD) 6.3 (3.8) 6.3 (3.9)
6 months n 363 308
Normal (0–4) 146 (40.2%) 114 (37%)
Mild depression (5–9) 124 (34.2%) 107 (34.7%)
Severe depression (10–15) 93 (25.6%) 87 (28.2%)
Mean (SD) 6.4 (4.0) 6.7 (4.1)
12 months n 319 237
Normal (0–4) 131 (41.1%) 101 (42.6%)
Mild depression (5–9) 115 (36.1%) 80 (33.8%)
Severe depression (10–15) 73 (22.9%) 56 (23.6%)
Mean (SD) 6.2 (4.1) 6.2 (3.8)
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The 6- and 12-month follow-up
Primary and secondary outcome measures
At the two additional end points, the BI data showed no significant differences between groups (see Table 24).
There was no evidence of any difference between the arms from the BI composite analyses at 6 and
12 months, presented in Table 25. In addition, the results from the secondary outcome measures assessing
mobility (RMI, see Table 22), and mood (GDS-15; see Table 23), showed no significant differences between
groups, at the 6- and 12-month follow-up time points (Table 26). The BI scores grouped according to severity
rating for both treatment arms across all time points are presented in Figure 3.
TABLE 24 Comparison of secondary outcomes at 3-month follow-up
Outcome
Randomisation arm
Adjusted ICC
(95% CI)b
Baseline ICC
(95% CI)
Difference in
adjusted means
(95% CI) p-value
Intervention Control
Adjusted
mean (SE)a n
Adjusted
mean (SE)a n
RMI 2.74 (0.11) 465 2.73 (0.12) 382 0.04 (0.01
to 0.15)
0.28 (0.21
to 0.36)
0.02 (–0.28
to 0.31)
0.90
GDS-15 6.09 (0.21) 383 6.30 (0.22) 324 0.07 (0.03
to 0.17)
0.11 (0.06
to 0.18)
–0.21 (–0.76
to 0.33)
0.44
EQ-5D-3Lc 0.238 (0.018) 409 0.227 (0.019) 338 0.06 (0.02
to 0.17)
0.25 (0.18
to 0.33)
0.011 (–0.037
to 0.059)
0.65
SE, standard error.
a Adjusted for care home as a random effect and baseline score, type of care home and centre as fixed effects.
b Adjusted for baseline score, treatment arm, type of care home and TAC.
c EQ-5D-3L calculated using the UK tariff.
TABLE 25 Comparison of Barthel composite outcome at 6- and 12-month end points
BI compositea
Randomisation arm
OR (95% CI)b p-valueIntervention Control
6-month assessment
n 526 449 0.95 (0.71 to 1.27) 0.74
Poor, n (%) 306 (58.2%) 269 (59.9%)
Moderate, n (%) 161 (30.6%) 122 (27.2%)
Good, n (%) 59 (11.2%) 58 (12.9%)
12-month assessment
n 513 432 0.84 (0.61 to 1.15) 0.27
Poor, n (%) 350 (68.2%) 314 (72.7%)
Moderate, n (%) 121 (23.6%) 77 (17.8%)
Good, n (%) 42 (8.2%) 41 (9.5%)
a Based on change in BI score at 3 months from baseline (below 0 or death, ‘poor’; 0 to 1, ‘moderate’; 2 and
above, ‘good’).
b Proportional odds of improvement in outcome after OT compared with control; adjusted for care home as a random
effect and type of care home and centre as fixed effects.
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Sensitivity analyses
Sensitivity analyses were performed on all primary and secondary outcome measures at the primary end
point of 3 months that excluded small clusters of size n< 3 residents. Owing to the number of small
clusters with one or two participants, this form of sensitivity analysis was suggested (by the TSC) as an
approach to test the validity of the mixed modelling approach. Results were consistent with the main
analyses, wherein no statistically significant or clinically important differences were observed (Table 27).
In addition, a sensitivity analysis excluding clusters of n< 3 was performed on the composite BI outcome at
3 months. Results were similar to the main analysis, no significant differences between the groups were
found (Table 28).
The potential ceiling effect of BI was explored by repeating the primary analyses excluding 52 participants
with a baseline BI score of 18 or above. The adjusted BI mean score for the intervention group was 4.96
[standard error (SE) 0.19] and for the control group was 4.82 (SE 0.20), with a difference of 0.12 points
(95% CI –0.38 to 0.61 points; p= 0.64), indicating no evidence of a difference between the groups.
A complete case analysis, testing the robustness of the BI analysis, by not imputing zero for those with
missing data because of death, gave similar results. The adjusted BI mean score for the intervention group
was 6.19 (SE 0.19) and for the control group was 6.04 (SE 0.20), with a difference of 0.15 points (95% CI
–0.33 to 0.64 points; p= 0.53).
Further sensitivity analyses of missing data were performed using three methods of imputation [best case
(last observation carried forward), worst case (zero) and multiple imputation] of missing BI scores at all end
points (Table 29). Data imputation did not change the conclusions.
In order to examine potential ceiling effects, a further analysis considered excluding participants with a
baseline BI score of ≥ 18. Fifty-two (5%) participants had a baseline BI score of ≥ 18. Exclusion of these
cases from the primary analysis did not change the conclusions (difference in adjusted means 0.12,
95% CI –0.38 to 0.61; p= 0.64).
TABLE 26 Comparison of primary and secondary outcomes at 6- and 12-month end points
Outcome Follow-up
Randomisation arm
Difference in adjusted
means (95% CI)a p-valueb
Group × time
interaction
Intervention Control
Adjusted
mean (SE)a n
Adjusted
mean (SE)a n
BIc 6 months 4.78 (0.20) 525 4.78 (0.22) 448 0.004 (–0.52 to 0.53) 0.99 0.35
12 months 3.93 (0.21) 512 3.77 (0.22) 430 0.16 (–0.40 to 0.72) 0.58
RMI 6 months 2.64 (0.11) 421 2.67 (0.12) 346 –0.03 (–0.33 to 0.27) 0.84 0.23
12 months 2.19 (0.13) 354 2.46 (0.14) 271 –0.26 (–0.62 to 0.09) 0.15
GDS-15 6 months 6.20 (0.21) 338 6.68 (0.22) 284 –0.48 (–1.04 to 0.09) 0.10 0.57
12 months 6.22 (0.22) 297 6.40 (0.25) 219 –0.18 (–0.80 to 0.43) 0.56
EQ-5D-3Ld 6 months 0.218 (0.017) 363 0.226 (0.017) 315 –0.008 (–0.052 to 0.036) 0.72 0.56
12 months 0.202 (0.018) 316 0.184 (0.019) 244 0.018 (–0.031 to 0.067) 0.48
SE, standard error.
a Adjusted for care home as a random effect and baseline score, type of care home and centre as fixed effects.
b Tukey–Kramer-adjusted CIs and p-values.
c Participants who died before follow-up are given a BI score of zero.
d EQ-5D-3L calculated using the UK tariff.
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TABLE 27 Sensitivity analyses excluding small clusters (< 3 residents): comparison of primary and secondary
outcomes at 3-month follow-up
Outcome
Randomisation arm
Difference in
adjusted means
(95% CI) p-value
Intervention Control
Adjusted mean (SE)a n Adjusted mean (SE)a n
Primary
BIb 5.28 (0.21) 495 5.17 (0.22) 381 0.12 (–0.42 to 0.65) 0.67
Secondary
RMI 2.62 (0.11) 427 2.64 (0.12) 333 –0.02 (–0.31 to 0.28) 0.91
GDS-15 6.09 (0.24) 346 6.51 (0.25) 278 –0.42 (–1.03 to 0.19) 0.18
EQ-5D-3Lc 0.23 (0.02) 375 0.22 (0.02) 292 0.01 (–0.04 to 0.06) 0.63
SE standard error.
a Adjusted for care home as a random effect and baseline score, type of care home and centre as fixed effects.
b Participants who died before follow-up are given a BI score of zero.
c EQ-5D-3L calculated using the UK tariff.
TABLE 28 Sensitivity analysis excluding small clusters (< 3 residents): comparison of BI composite outcome at
primary time point
BI compositea
Randomisation arm
OR (95% CI)b p-valueIntervention (n= 496), n (%) Control (n= 381), n (%)
Poor 276 (55.7) 197 (51.7) 1.06 (0.74 to 1.50) 0.76
Moderate 147 (29.6) 132 (34.7)
Good 73 (14.7) 52 (13.7)
a Based on change in BI score at 3 months from baseline (poor, below 0 or death; moderate, 0 to 1; good, 2 and above).
b Proportional odds of improvement in outcome after OT compared with control; adjusted for care home as a random
effect and type of care home and centre as fixed effects.
TABLE 29 Imputation of BI at 3-, 6- and 12-month follow-up
Follow-up
assessmenta
Imputation
method
Randomisation arm
Difference in adjusted
means (95% CI) p-value
Intervention,
adjusted
mean (SE)b
Control, adjusted
mean (SE)b
3 months Best case (LVCF) 5.36 (0.17) 5.20 (0.18) 0.16 (–0.33 to 0.66) 0.52
Worst case (zero) 5.10 (0.19) 4.74 (0.20) 0.35 (–0.20 to 0.91) 0.21
Multiple imputation 5.32 (0.19) 5.08 (0.21) 0.24 (–0.31 to 0.78) 0.39
6 months Best case (LVCF) 4.79 (0.18) 4.71 (0.19) 0.08 (–0.44 to 0.60) 0.77
Worst case (zero) 4.28 (0.20) 4.47 (0.21) –0.20 (–0.76 to 0.37) 0.50
Multiple imputation 5.13 (0.18) 4.93 (0.19) 0.20 (–0.33 to 0.72) 0.47
12 months Best case (LVCF) 3.95 (0.19) 3.77 (0.20) 0.18 (–0.37 to 0.73) 0.53
Worst case (zero) 3.37 (0.20) 3.35 (0.22) 0.02 (–0.57 to 0.60) 0.96
Multiple imputation 4.84 (0.19) 4.64 (0.19) 0.20 (–0.32 to 0.73) 0.45
LVCF, last observation carried forward.
a Participants who died before follow-up are given a BI score of zero.
b Adjusted for care home as a random effect and baseline score, type of care home and centre as fixed effects.
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Subgroup analysis
Subgroup analyses were performed according to a predefined list of variables to further evaluate potential
influences of the OT intervention. Analyses considered participants’ age, the type of care home in which
participants’ resided, the severity rating of participants’ BI scores, the level of cognitive impairment (derived
from the MMSE screening measure), and whether the measures were completed by the participant or a
consultee. The forest plot (Figure 4) shows no significant findings across all subgroup interactions (Table 30).
Intracluster correlation coefficient
The sample size calculation was based on an unadjusted ICC of 0.4 from previous pilot studies.49 The
unadjusted ICC for the BI measure in the present trial was 0.36 at baseline and 0.10 for baseline to
3 months. After allowing for the effect of the treatment arm, TACs and type of care home, the ICC for the
primary BI measure reduced to 0.09 (95% CI 0.05 to 0.17). Table 31 provides the unadjusted and adjusted
ICC results for all measures at the primary 3-month end point.
Difference in
 adjusted means
(95% CI)n
Questionnaire completion
Barthel Index (1–20)
p-value for 
interaction
–0.17 (–0.91 to 0.57)
0.43 (–0.20 to 1.06)
425
551
Consultee
Resident 0.19
Cognitive Impairment (MMSE)
–0.02 (–0.92 to 0.88)
0.84 (0.06 to 1.62)
258
330
Very cognitively impaired (0 to 9)
Rest (10 to 30) 0.13
Type of care home
0.40 (–0.41 to 1.22)
0.05 (–0.61 to 0.70)
350
626
Residential
Nursing
All participants 0.19 (–0.33 to 0.70)
Favours control Favours intervention
976
0.51
Baseline Barthel Index
0.06 (–0.63 to 0.75)
–0.28 (–1.21 to 0.65)
0.27 (–0.81 to 1.35)
1.23 (–0.06 to 2.52)
479
220
159
118
Very severe (0 to 4)
Severe (5 to 9)
Moderate (10 to14)
Mild to independent (15 to 20)
0.29
Age (years)
–0.42 (–1.53 to 0.69)
–0.02 (–0.79 to 0.75)
0.46 (–0.25 to 1.17)
0.07 (–1.53 to 1.66)
154
334
417
69
< 75
75 to 84
85 to 94
95+
0.53
0.5–0.5–1.0–1.5–2.0 0.0 1.0 1.5 2.0 2.5 3.0
FIGURE 4 Subgroup analysis: comparison of BI at 3 months. Participant numbers for age and MMSE reflect data
missing at baseline.
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TABLE 30 Subgroup analysis: comparison of BI at 3 months
Outcome
Randomisation arm
Difference in adjusted
means (95% CI)
p-value
(Interaction)
Intervention Control
Adjusted
mean (SE)a n
Adjusted
mean (SE)a n
Respondent
Consultee 5.27 (0.30) 193 5.30 (0.32) 144 –0.04 (–0.85 to 0.77) 0.48
Resident 5.58 (0.23) 346 5.28 (0.33) 292 0.30 (–0.30 to 0.89)
Level of BI
Very severe (0–4) 5.21 (0.44) 256 5.15 (0.44) 222 0.06 (–0.63 to 0.75) 0.29
Severe (5–9) 5.03 (0.33) 126 5.31 (0.37) 94 –0.28 (–1.21 to 0.65)
Moderate (10–14) 5.42 (0.57) 87 5.15 (0.59) 72 0.27 (–0.81 to 1.35)
Mild/independent (15–20) 7.35 (0.91) 70 6.12 (0.96) 48 1.23 (–0.06 to 2.52)
Level of MMSE
Very cognitively impaired (0–9) 4.48 (0.36) 133 4.50 (0.36) 125 –0.02 (–0.92 to 0.88) 0.13
Rest (10–30) 5.49 (0.31) 175 4.65 (0.32) 155 0.84 (0.06 to 1.62)
Type of care home
Residential 5.70 (0.31) 197 5.30 (0.33) 153 0.40 (–0.41 to 1.22) 0.50
Nursing 5.28 (0.24) 342 5.23 (0.26) 283 0.05 (–0.61 to 0.70)
Age group (years)
< 75 5.55 (0.38) 88 5.97 (0.44) 66 –0.42 (–1.53 to 0.69) 0.53
75–84 5.41 (0.28) 189 5.44 (0.30) 145 –0.02 (–0.79 to 0.75)
85–94 5.55 (0.26) 228 5.09 (0.28) 188 0.46 (–0.25 to 1.17)
≥ 95 5.29 (0.59) 34 5.22 (0.57) 35 0.07 (–1.53 to 1.66)
a Type of care home means were adjusted for baseline BI score and site as fixed effects and care home as a random
effect. All other subgroup means were adjusted for baseline BI score, TACs and type of care home as fixed effects and
care home as a random effect.
TABLE 31 Intracluster correlation coefficients at 3-month follow-up
Measure ICC baseline (95% CI)
ICC baseline to
3 months (95% CI)
Adjusteda ICC baseline
to 3 months (95% CI)
BI 0.36 (0.29 to 0.43) 0.10 (0.06 to 0.18) 0.09 (0.05 to 0.17)
RMI 0.28 (0.21 to 0.36) 0.05 (0.02 to 0.15) 0.04 (0.01 to 0.15)
GDS-15 0.11 (0.06 to 0.18) 0.07 (0.02 to 0.16) 0.07 (0.03 to 0.17)
EQ-5D-3Lb 0.25 (0.18 to 0.33) 0.10 (0.05 to 0.20) 0.06 (0.02 to 0.17)
a Adjusted for baseline score, treatment arm, type of care home and TACs.
b EQ-5D-3L calculated using the UK tariff.
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Adverse events
There were no reported treatment-related adverse events.
Falls
Unadjusted data regarding the number of falls experienced by participants between randomisation arms
are presented in Table 32. Comparison of the frequency of falls per resident showed a significantly higher
(adjusted) fall rate per resident was reported in the intervention arm [rate ratio 1.74, 95% CI 1.09 to 2.77;
p= 0.02] (Table 33). When adjusted for care home, TACs and type of care home there was a suggestion
of greater odds of falling in the OT arm (OR 1.55, 95% CI 0.96 to 2.53; p= 0.07) (Table 34).
TABLE 32 Falls during the first 3 months of the trial
Falls
Randomisation arm
Intervention Control
Number of residents with falls data collected 482 408
Number of falls (%)
0 419 (86.9%) 373 (91.4%)
1 45 (9.3%) 28 (6.9%)
2 12 (2.5%) 4 (1.0%)
3 6 (1.2%) 3 (0.7%)
Mean number of falls per resident (SD) 0.18 (0.52) 0.11 (0.40)
Number of residents who had a fall resulting in injury and/or medical attention
during first 3 months
63/482 (13.1%) 35/408 (8.6%)
Seen by GP only 11 12
Seen by ambulance staff only 18 4
Seen by GP and ambulance staff 10 4
Not known 24 15
Hospital episode for any reason (including falls) 107/482 (22.2%) 90/408 (22.1%)
TABLE 33 Comparison of the mean number of falls per resident at 3 months
Falls
Randomisation arm
Rate ratioa (95% CI) p-value
Intervention, adjusted
mean (SE)
Control, adjusted
mean (SE)
Number of falls 0.17 (0.03) 0.10 (0.02) 1.74 (1.09 to 2.77) 0.02
a Negative binomial mixed model adjusted for care home as a random effect and type of care home and centre as
fixed effects.
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Process evaluation: summary
A more detailed report of the process evaluation is reported elsewhere.88 Qualitative evaluation of
intervention fidelity was also investigated in semistructured interviews (n= 17) with all occupational
therapists, and critical incident reports from the trial (n= 20). These data demonstrated four identified
mechanisms through which intervention fidelity was maintained:
1. Occupational therapists described managing a shift from their earlier roles as therapists to their ‘new’
role as experimental occupational therapists within a clinical trial. This was characterised as balancing
work in which, over time, they had developed a sense of equilibrium between their professional
responsibility as therapists and the tightly defined therapy outlined within the study protocol.
2. A considerable amount of time was spent by some therapists building rapport with care home staff,
developing an organisational context more conducive to rehabilitation in general and the trial
intervention in particular. This was felt to be important in establishing the foundations on which trial
interventions could then be established. One strategy through which this mechanism operated was
through therapists ‘mucking in’ and working as a team with members of care home staff.
3. The work focused on re-engineering the personal environments of care home residents. The work that
therapists undertook to re-engineer the care home environment around their rehabilitation plans for
patients was completed at different degrees of scale, depending on local circumstances. Generally,
therapists were careful to propose realistic intervention plans that could be carried out within available
resources such as funding, skills availability and access to external services. Through careful assessment
and the provision of aids and minor environmental adaptations, the trial interventions intended to
provide patients with an environment that best matched their needs.
4. The data clearly demonstrate that therapists were not passive participants in the delivery of the OTCH
interventions. Therapists appeared to have learned through their experience of the interventions over
time with individual patients and across waves of recruitment within the trial. Therapists modified the
way they worked with care homes and patients, adapting to new situations and learning how to carry
out their work more effectively. This was important in enabling therapists’ confidence in their work
within the trial to grow with time.
These findings from the OTCH process evaluation characterise the real-world nature of fidelity within the
OTCH rehabilitation intervention, and specifically the negotiated nature of implementation within clinical
settings, and around individual patients’ needs.
TABLE 34 Comparison of the proportion of residents who have suffered a fall at 3 months
Number of falls
Randomisation arm
ORa (95% CI) p-valueIntervention, adjusted % (SE) Control, adjusted % (SE)
Proportion having a fall 12.6 (2.2) 8.5 (1.8) 1.55 (0.96 to 2.53) 0.07
a Logistic mixed model adjusted for care home as a random effect and type of care home and centre as fixed effects.
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Chapter 4 Economic evaluation: methods and
results
Overview
To assess the economic viability of delivering OT to stroke survivors in care homes, we conducted a
within-trial cost–utility analysis. Costs and quality-adjusted life-years (QALYs) for individuals in the OT
intervention group were compared with equivalent data for those receiving usual care. For our base case,
we conducted intention-to-treat analysis using ‘complete case’ data. This included participants who died
during follow-up, provided that they had returned all costs and outcomes data in the intervention period
before their death. As all trial follow-up was completed within 12 months, no discounting was applied
to either costs or outcomes.
Estimating costs
In line with the National Institute for Health and Care Excellence methods guide,89 we sought to estimate
costs from an NHS and Personal Social Services perspective. This included the cost of the intervention,
hospital contacts and community health and social services, and any ADL equipment costs incurred within
the intervention or as part of usual care. In deriving costs for the OT intervention, we considered staff
training (for therapists who provided the intervention), care home staff training (workshops), participant
contact and non-contact time, and equipment and travel costs. Each therapist in the study team completed
a ‘Treatment Log’ timesheet (see Appendix 10) to record the number of minutes spent on specific aspects
of therapy (such as communication, adaptive equipment or cognitive training) at each session with each
participant. To estimate non-contact time spent on the intervention, we also interviewed by telephone
two senior occupational therapists who delivered the intervention and training for all aspects of the study.
Cost assumptions used here were based on information retrieved in these discussions and confirmed with
the principal investigator.
Across all sites, 29 occupational therapists delivered the OTCH intervention. All study staff attended a
group training day at the central site (Birmingham). Two such days took place, each run by three senior
occupational therapists. Training included adapting OT for the care home environment. Costs were
apportioned equally to all participants in the intervention arm. This was estimated as a full working day
(7.5 hours) for each of the 29 OT staff (NHS band 6), with average travel to Birmingham estimated as
100 miles. Six days of senior occupational therapist time was also included.
For the workshops attended by nursing and care staff in each care home, it was estimated that the three
course co-ordinators (senior occupational therapists) spent one week developing training documents.
Although some care homes may have had repeat training (e.g. because of high staff turnover) it was
assumed that all care staff from each care home in the intervention arm attended the workshop only once.
Seminars lasted 2 hours and were delivered by one senior occupational therapist. Costs were apportioned
equally to all participants in the intervention arm. In an additional sensitivity analysis, we included the
opportunity cost of time spent by care home staff attending these workshops (assuming workshops would
be delivered once every 3 years).
The OTCH intervention was delivered by NHS community occupational therapists, with level of experience
ranging from band 5 to 7. In deriving costs, we assumed that the intervention was delivered only by
occupational therapists at NHS band 6.90 For every intervention session spent with each individual
participant, the approximate time (in minutes) spent on specific tasks was recorded in the treatment log.
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As the treatment log recorded only face-to-face time with participants, we ascribed additional time per
task for non-contact time – including initial risk assessment for each participant, general administration,
liaising with care home staff and collecting and demonstrating the equipment to care home staff. Based
on estimates from both of the therapists interviewed and estimates reported in Personal Social Services
Research Unit (PSSRU) costs,91 it was estimated that for every hour of contact time there was an additional
40 minutes (67% of contact time) of non-contact time.
Travel time
Although the intervention was delivered to individuals, and not as a group, therapists tried to see all
participants in a specific care home on the same day each week. Economies of scale were therefore
possible when apportioning travel costs to care homes in which there was more than one participant who
received the intervention on the same day. As the date of each OTCH session was recorded, we could
monitor how many participants were treated every time a therapist attended a particular care home.
Travel costs were ascribed to each care home attendance. These were then divided among each of the
participants who were treated in the care home on that date. We estimated each care home visit would
entail a 10-mile round trip, at a cost to the NHS of 54p/mile.92 We also estimated and attributed costs to
travel time (30 minutes per round trip).
Finally, within the OTCH intervention, there was provision to fund adaptive equipment and aids to daily
living such as cutlery, arm supports or palm protectors. We were unable to retrieve equipment costs from
all centres. Instead, we used costs from two larger centres (Birmingham and Nottingham). The total cost
of all equipment was estimated for these two centres and then divided by the number of sessions in
which equipment provision was noted. Where time spent with adaptive equipment was recorded on the
treatment log, this mean equipment cost was added to the cost of that session.
Non-intervention NHS costs
Care home staff were asked to complete Health Resource Use Questionnaires (see Appendix 17) for each
resident at months 3, 6 and 12, based on care home records. We did not have access to routine primary
care medical records data. Health resource use included visits to GP and other community health-care
workers, outpatient appointments, accident and emergency (A&E), inpatient stays and any adaptive
equipment paid for by care homes, social services or privately funded which had not been ordered as part
of the OT intervention. Unit costs for health professional contacts were obtained from the national health
and social care services reference costs,93 and PSSRU for the financial year 2010–11,91 and are reported
in Table 35. Unit costs for adaptive equipment were derived from the Nottingham Integrated Community
Equipment Service (ICES)/NRS Healthcare catalogue (www.nrs-uk.co.uk), assuming private (non-discounted)
prices for all items. When the item listed was ambiguous or unknown, we used mean imputation of all
other equipment. We assumed a lifespan of 5 years for all adaptive equipment94 and applied a discount
rate of 3.5%.95
Overall costs
Total costs were calculated by combining all intervention costs, non-intervention health resource use costs
and the cost of equipment provision. As no one in the control arm received any form of intervention
during the trial period, only wider NHS resource use was valued in this group.
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Measuring outcomes
Our principal measure of benefit was expressed as QALYs. Health utility was estimated using the EQ-5D-3L,96
a generic measure of HRQoL that generates a single index score. This outcome measure has been successfully
applied in previous studies with nursing home residents.97,98 We applied the Measurement and Valuation
of Health Group’s A1 tariff, which used time trade-off data obtained from a sample of approximately
3000 members of the general population in UK.99 Participants were asked to complete (self-complete or by
proxy) the EQ-5D-3L questionnaire at baseline and at 3, 6 and 12 months. Life-years were weighted by these
utility scores and linear interpolation was used to generate QALYs per patient using area under the curve
methods. If a participant died during the follow-up period, EQ-5D-3L values (and costs) were set to zero at the
point of death.
Analysis
The use of regression analysis is advocated to account for potential baseline differences and/or
confounders when comparing costs and outcomes between treatment arms, and is essential to formally
take account of the cluster-randomised design.100 We regressed (1) costs and (2) QALYs against treatment
arm with covariate adjustment for sex, age and baseline EQ-5D-3L, with cluster-adjustment based on care
home. The regression coefficients for costs and outcomes were then used to estimate the incremental
cost-effectiveness ratio (ICER), dividing the mean difference in costs by the mean difference in QALYs
between the groups. In line with National Institute for Health and Care Excellence guidance, we compared
ICERs with a cost-effectiveness threshold (λ) of £20,000 and £30,000 per QALY.89
TABLE 35 Unit costs (GBP, 2010–11)
Item Estimated unit cost per visit (£) Source
GP visit 36.00 PSSRU91
District/practice nurse 13.18
Physiotherapist 34.00
Social worker 25.16
Chiropodist 47.00
Speech and language therapist 35.00
Dietitian 35.00
Dentist 78.00
Psychiatrist 209.00
Clinical psychologist 112.50
Community psychiatric nurse 76.00
Other health professionals 27.39 (range 15–115)
A&E visita 116.90 NHS Reference Costs 2011–1293
Outpatient appointment 104.52 (range 21–205)
Cost per day in hospitalb 543.55
Cost per day in hospital (day case)c 663.68
OTCH therapist cost per hour (NHS band 6) 50.00 PSSRU91
a Weighted average of all A&E visits leading/not leading to admission.
b Weighted average of all elective/non-elective long/short stays.
c Weighted average of all NHS Trusts day cases.
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Uncertainty and sensitivity analysis
To obtain a graphical representation of the sampling uncertainty of our cost-effectiveness estimates,
incremental costs and incremental QALY estimates were generated using bootstrapped output
(1000 replications) from our cost and outcome regressions. We plotted our bootstrap samples on a
cost-effectiveness plane, showing the spread of incremental costs and incremental effectiveness across four
quadrants. Plots on the north-west quadrant are said to be ‘dominated’ (less effective and more costly
than usual care), whereas south-eastern plots are said to be dominant (more effective and less costly than
usual care). The same bootstrap samples were used to estimate the cost-effectiveness acceptability curve
(CEAC) for each group, where the CEAC depicts the probability that an intervention is cost-effective at
varying levels of λ.101
To assess the robustness of the analysis to changes of key input values and assumptions, we considered
the following sensitivity analyses:
l Excluding participants with extremely high costs (> £20,000). The rationale for this is that a small
number of very high-cost participants may overinfluence total costs.
l Including selected societal costs, specifically time spent by care home staff during OTCH training
workshops and non-intervention adaptive equipment which may have been privately provided.
Cost-effectiveness of the full data set (n= 1042) following multiple imputation of missing data. Multiple
imputation was performed in a single model using the mi impute command in Stata version 12. The model
included predictors of total costs (health-care resource utilisation costs at 3 months, 6 months and 12 months),
predictors of outcomes (EQ-5D-3L and BI at baseline and at 3 months, 6 months and 12 months), treatment
group, care home (cluster), age, sex, death status and withdrawn status. Imputation took place in five cycles,
the estimates from which were then pooled and calculated using Rubin’s rules.102 With complete cost and
EQ-5D-3L scores at all four time points, we used area under the curve analysis to generate a QALY value for all
participants. This enabled paired cost and outcome data for the entire study population.
Economic evaluation results
All treatment logs were returned and intervention costs were therefore available for all participants in the
intervention arm (Table 36). The estimated cost of training occupational therapists to deliver the
intervention was £28.62 per participant, while providing the training workshop to care home staff was
estimated to cost £36.99 (or £69.83 per participant when also including cost of care home staff who
received the training). In total, 2538 therapy sessions were recorded in the OTCH intervention, with an
average duration of 41 minutes (SD 34.0 minutes) each. The mean number of sessions per participant was
5.1 (SD 3.0 sessions). The cost of the OTCH intervention per participant varied considerably based on the
number of therapy sessions, whether or not other participants were also treated in their care home on
the same day and how long each session lasted. Seventy (12.3%) participants in the intervention arm did
not receive any treatment, whereas the most intensive treatment involved 18 visits in the 3-month period.
A large cost contributor in the intervention was travel costs by therapists to each care home; this ranged
from £0.00 to £371.62 per participant. In total, we estimated the mean intervention cost per participant in
the active treatment arm to be £398.98 (SD £347.00).
NHS resource use
A substantial proportion (n= 313) of participants in both treatment arms died during the study period,
meaning that their follow-up time was < 1 year. In addition, a smaller proportion of participants did not
return their questionnaires at all three time points (Table 37). Health resource use was recorded for
388.5 person-years from 511 respondents in the intervention arm and for 317.25 person-years from
424 respondents in the control arm.
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TABLE 36 Breakdown of intervention costs
Resource item Level of resource
Associated unit cost
(UK GBP, 2010–11)
Associated
total cost
Per-participant
cost (n= 568)
OT training
Provision of training 45 hours (2 days – three
senior therapists)
£50.00 per hour £2250.00 £3.96
Receipt of training 29 staff × 1 day £50.00 per hour £10,875.00 £19.15
29 staff × 100 miles to/from
Birmingham (£0.54/mile)
£108 per person £3132.00 £5.51
Total OT training £16,257.00 £28.62
Care home staff training
Provision of training 112.5 hours (5 days – three
senior therapists)
£50.00 per hour £5625.00 £9.90
OT staff × 2-hour workshop
to 118 care homes
£50.00 per hour £11,800 £20.77
OT staff travel to 118 care
homes
£5.40 mileage; £25 time £3587.00 £6.32
Total workshops £21,012.00 £36.99
Receipt of training
(sensitivity analysis)
12 staff per home, training
once every 3 yearsa
PSSRU 11.6= home care
worker £18/hour
£18,651.00 £32.84
Total workshops: (sensitivity analysis) £39,663.00 £69.83
Intervention
Contact time 1724 hours on treatment log £50.00 per hour £86,200.00 £151.76
(£0.00–1150.00)
Non-contact time 67%×1724 hours on
treatment log
£50.00 per hour £57,754.00 £101.68
(£0.00–770.00)
Travel time 10 miles, 17 minutes to/from
care home
£10.80 mileage; £28.33
travel time
£33,817.00 £59.54
(£0.00–371.62)
Equipment costs
Adaptive equipment 74 items over two large study
centres, mean cost £20.75
£27.16 per participant,
with allocated
‘equipment time’
£11,787.00 £20.75
(£0.00–217.28)
Intervention costs Mean cost per participant £398.98 (range £0.00–2267.31)
Control costs We did not attribute any intervention costs to the control arm
a Includes 3.5% discount rate, annuitised over 3 years.
TABLE 37 Completion of health resource-use questionnaires at each time point
Time point
Intervention health resource
use questionnaires returned
(% of 568 randomised)
Control health resource
use questionnaires returned
(% of 474 randomised)
3 months 469 (83%) 391 (82%)
6 months 415 (73%) 356 (75%)
12 months 335 (59%) 261 (55%)
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Resource use was broadly similar in the control and intervention homes (Tables 38 and 39). The provision
of OT delivered at care homes was not associated with the level of other health-care use, and the cost of
the intervention was not offset by lower costs in terms of GP visits, inpatient stays or contact with other
therapists. Participants made frequent visits to GPs, chiropodists and GP practice nurses, whereas visits to
A&E, outpatient appointments and inpatient stays were relatively infrequent.
TABLE 38 One-year health resource use
Type of resource use
Resource use
(visits reported) Mean visits per person
Mean difference
between groups
Intervention Control Intervention Control
Mean
difference 95% CI
GP visits 2961 2354 6.13 5.76 0.37 –0.49 to 1.21
Practice nurse 1171 1024 2.44 2.53 –0.09 –0.99 to 0.81
Physiotherapist 740 895 1.53 2.19 –0.66 –1.62 to 0.30
Social worker 213 162 0.44 0.40 0.04 –0.08 to 0.17
Chiropodist 1518 1231 3.14 3.02 0.12 –0.24 to 0.49
Speech therapist 155 116 0.32 0.28 0.04 –0.14 to 0.21
Dietitian 147 199 0.30 0.49 –0.19 –0.31 to –0.05
Dentist 323 197 0.67 0.48 0.19 0.05 to 0.32
Psychiatrist 44 45 0.09 0.11 –0.02 –0.10 to 0.07
Community psychiatric nurse 71 109 0.15 0.27 –0.12 –0.29 to 0.05
Inpatient bed-daysa 970 913 2.01 2.24 –0.23 –1.06 to 0.60
A&E episode 109 94 0.23 0.23 0.00 –0.07 to 0.06
Outpatient appointments 663 533 1.37 1.31 0.06 –0.03 to 0.25
Large adaptive equipment 22 26 0.06 0.08 –0.02 –
a Includes day cases.
TABLE 39 One-year health costs (GBP 2010–11)
Health resource cost (total over 12 months)
Intervention
mean (£, 2011)
Control mean
(£, 2011)
Mean
difference (£)
95% CI of
difference (£)
OTCH intervention costs 398.98 0.00 398.98 367 to 430
Health professional visit costs 482.82 497.19 –14.37 –122 to 108
Inpatient costs 1003.27 1124.05 –120.78 –559 to 323
Outpatient costs 120.64 104.54 16.10 –19 to 68
A&E costs 25.91 26.75 –0.84 –8 to 7
Total health resource costs 2031.61 1752.52 279.09 –217 to 714
Care home staff traininga 32.84 0.00 32.84 33 to 33
Adaptive equipment 13.87 24.47 –10.60 –33 to 13
Selected societal costs 2078.32 1777.00 301.32 –187 to 745
a See Table 36.
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Quality-adjusted life-years
Outcomes data, namely QALYs based on the EQ-5D-3L, are reported in Tables 40 and 41. Owing to the
high mortality rates in both arms, we report the patient-reported outcomes and also the adjusted
outcomes when deaths have been included. The inclusion of patients who died lowered the overall QALYs
in both treatment arms, but the difference between arms remained negligible.
Cost–utility analysis
Excluding participants for whom we did not have complete paired costs and outcomes data, the remaining
‘complete case’ data set, which was used in subsequent regression analyses, consisted of 581 out of
1042 (55.8%) participants (329 out of 568 in the intervention arm; 252 out of 474 in the control arm) in
177 out of 228 care homes (77.6%). The full data set (1042 participants) was considered in subsequent
sensitivity analysis, following multiple imputation.
Total costs and QALYs were assessed using ordinary least squares regression, with cluster option to
account for randomisation at care home level. This produced a mean incremental cost of £438.78 (95% CI
–£360.89 to £1238.46). The mean incremental QALY gain was 0.009, with wide CIs (95% CI –0.030 to
0.048). Neither the mean incremental cost nor the mean incremental QALYs reached an arbitrary 5%
significance level. The ICER was estimated to be £49,825.
A summary of costs and effects at base-case and sensitivity analyses, along with cost-effectiveness ratios,
is shown in Table 42. In sensitivity analysis, removal of high-cost participants did not change overall
cost-effectiveness results, with both incremental costs and incremental QALYs reduced very slightly.
Inclusion of care worker time increased intervention costs slightly without affecting outcomes; therefore,
the cost-effectiveness of intervention was less favourable.
TABLE 40 The EQ-5D-3L scores excluding patients who died. See Appendix 18 for a further breakdown by
EQ-5D-3L dimension
Time point n
Intervention EQ-5D-3L tariff
unadjusted mean (SD) n
Control EQ-5D-3L tariff
unadjusted mean (SD)
Baseline 506 0.198 (0.38) 421 0.236 (0.36)
3 months 433 0.212 (0.37) 365 0.194 (0.37)
6 months 392 0.196 (0.37) 341 0.200 (0.36)
12 months 342 0.183 (0.37) 265 0.183 (0.34)
QALYs gained over 1 year 285 0.233 (0.33) 221 0.235 (0.32)
TABLE 41 The EQ-5D-3L scores including patients who died
Time point n
Intervention EQ-5D-3L tariff
unadjusted mean (SD) n
Control EQ-5D-3L tariff
unadjusted mean (SD)
Baseline 523 0.198 (0.38) 437 0.236 (0.36)
3 months 497 0.176 (0.35) 417 0.168 (0.35)
6 months 498 0.156 (0.33) 427 0.162 (0.33)
12 months 503 0.125 (0.32) 417 0.120 (0.29)
QALYs gained over 1 year 446 0.162 (0.30) 373 0.153 (0.27)
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When we repeated our regression using imputed data sets, incremental costs were slightly lower at £339
(95% CI –£133.60 to £811.98). Incremental QALYs were slightly higher at 0.013 (95% CI –0.015 to
0.041), leading to a slightly more favourable ICER of £26,770. However, this is still higher than the current
threshold, and our conclusions regarding cost-effectiveness remained unchanged. In all sensitivity analyses
incremental cost and QALY differences were not significantly different between arms.
The bootstrapped replications for costs and QALYs are shown on a cost-effectiveness plane in Figure 5.
The majority are located on the north-east quadrant, suggesting the OTCH intervention is associated with
better outcomes and higher costs than usual care. However, most of the dots lie very close to both axes,
indicating that the cost and outcome differences between groups are very small. The CEAC (Figure 6)
shows the probability of the intervention being more cost-effective than usual care at various
willingness-to-pay thresholds. At £20,000 per QALY, this probability was 29.2% and at a threshold of
£30,000 the probability was 39.2%. The incremental cost is more than £20,000/QALY in all analyses;
therefore, based on current cost-effectiveness thresholds,89 we would not endorse the OTCH programme.
TABLE 42 Summary: ICERs
Scenarios
Complete case data set (n= 581)
Incremental
cost (£) 95% CI (£)
Incremental
QALY 95% CI ICER
Base case (n= 581) 438.78 –360.89 to 1238.46 0.009 –0.030 to 0.048 £49,824.81
Remove high-cost patients
(n= 573)
412.71 –77.642 to 903.06 0.008 –0.031 to 0.048 £49,402.53
Include social care costs
(n= 581)
469.23 –271.25 to 1209.72 0.009 –0.030 to 0.048 £53,282.71
Imputed data set n= 1042 × 5 iterations
Imputed data set (n= 1040) 339.19 –133.60 to 811.98 0.013 –0.015 to 0.041 £26,769.91
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Chapter 5 Discussion
Occupational Therapy intervention for residents with stroke
living in UK Care Homes trial design summary
The OTCH study was a Phase III pragmatic parallel-group cluster RCT with an economic evaluation.
The evaluation assessed the clinical efficacy and economic impact of providing an OT service for stroke
survivors living in care homes. The primary research objective was to assess the influence of a 3-month
course of OT, according to whether or not it helped participants maintain levels of independence in ADL
compared with usual care. Secondary outcome measures assessed the influence of the OT intervention on
participants’ mobility, mood and HRQoL.
More care homes were recruited than originally planned because of a larger than expected number of
small clusters. The number of eligible residents within each care home with a history of stroke was lower
than expected.11,15–17 All baseline characteristics were similar across randomisation arms in regards to age,
sex, ethnicity and comorbidities. A large proportion of the participant population had significant physical
disabilities, substantial limitations on activity (see Figures 2 and 3) and increased dependence for personal
ADL. Moreover, the assistance of a consultee to consent on the participant’s behalf was needed in 61% of
cases,68 indicative of reduced autonomy. There was a high prevalence of cognitive and language
impairment: 57% of participants scored below 15 points on the Sheffield screening test, indicative of
significant language impairment, and 70% of participants scored in the range signifying cognitive
impairment on the MMSE. The participant profile overall is suggestive of significant frailty.
Principal findings
Primary outcome at 3 months
The principal findings are neutral. The 3-month course of individualised OT for care home residents living
with stroke, involving patient-centred goal-setting staff training, provision of facilitatory equipment and
environmental adaptation, showed no benefit on participants’ capacity to engage in personal ADL at each
of the trial end points. Findings observed in the pilot phase were not replicated.48 OT provision did not
help maintain independence in personal ADL compared with usual care. The number of participants with a
poor outcome (intervention 54% vs. control 52%), moderate outcome (intervention 30% vs. control 34%)
and good outcome (intervention 15% vs. control 14%) at the primary end point was similar between
treatment arms.
Exploratory subgroup analyses focused on the primary outcome did not reveal any interactions of interest.
The forest plot in Figure 4 indicates that participants’ age, severity on the BI at baseline, type of care
home, proxy data and severity of cognitive impairment had no discernible influence on the primary
outcome at 3 months. However, there is a suggestion from this exploratory analysis that the OT
intervention may be effective at maintaining functional activity for residents that have less severe
limitations on activity. Referring stroke survivors on an individual basis as opposed to a routine basis may
still be of benefit.
Additional sensitivity analyses which included a complete case analysis, tested the potential ceiling effect,
imputed missing data and removed clusters with fewer than three residents, did not change the neutral
findings. A process evaluation that examined the fidelity of the OTCH intervention is presented in more
depth elsewhere.88 The process evaluation summary presented here indicates that the intervention was
implemented as intended.
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Primary outcome assessed at 6 and 12 months
At the 6- and 12-month follow-up stages, the BI data showed no significant differences between groups.
The results from the composite BI analyses, employing the change in BI score from baseline at 6 and
12 months, were similar between groups (see Table 26). The data did not support the hypothesis that a
3-month course of OT for care home residents living with stroke-related disabilities will help maintain levels
of function activity in self-care tasks over the longer term compared with usual care.
Secondary outcomes
Analyses assessing mobility, mood, and HRQoL showed no benefit of the OT intervention at 3 months
(see Table 24). Similarly, the secondary outcome measures at the 6- and 12-month follow-up showed no
evidence of benefit of the intervention (see Table 25). Mean mobility scores decreased over the course of
the trial in both randomisation arms (see Table 22). The mean mood scores on the GDS-15 remained
similar for both treatment arms across all end points (see Table 23). The mean mood scores are indicative
of mild depression.85
Further exploratory analyses
These additional exploratory analyses considered the potential dose effect of OT on depression scores, and
the relationship between baseline RMI score and survival. No evidence of an association between OT dose
and GDS-15 score was observed. However, there was strong evidence that mobility is associated with
survival. Participants with a mobility score of 2 or below at baseline were 1.57 times as likely to die than
those with greater mobility over the course of the 12-month trial duration (hazard ratio 1.57, 95% CI
1.15 to 2.15).
Economic evaluation discussion
Based on the mean incremental cost per QALY gain, it is unlikely that the OTCH intervention is
cost-effective when compared with usual treatment. Although outcomes were virtually equivalent in both
arms, costs were higher in the intervention arm and the intervention did not lead to a reduction in health
resource use from other sources.
We acknowledge some limitations in this economic analysis. We requested information on equipment on
the assumption that this would have been purchased by the NHS or personal social services. However, it
became apparent that some of this equipment may have been purchased by the care home (although who
purchased it was not systematically recorded), and that this could be considered outside of the NHS and
personal social services perspective. In addition, apart from the training of care home staff, we did not
consider all wider social costs, although we considered that, as all participants were in residential care, the
burden on community care workers, friends and family would be likely to be less than if the participants
lived in their own homes.
Death rates were similar between study arms. We tested the robustness of our estimates by performing
multiple imputation for missing data and also running a sensitivity analysis excluding participants who died
during follow-up (not reported); our cost-effectiveness conclusions were consistent.103
Despite these limitations, the cost-effectiveness results were conclusive. At £20,000 per QALY, this
probability was 29.2% and at a threshold of £30,000 the probability was 39.2%. Based on the results of
this RCT, OT was not a cost-effective routine intervention for stroke survivors living in care homes.
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Strengths and weaknesses
This was the largest cluster randomised trial conducted in care homes to date. The potential pitfalls of the
cluster design associated with the provision of informed consent, identification of the unit of inference and
methods of stratification were addressed in the trial protocol.71,104 The trial was sufficiently powered to
detect a clinically significant change in the BI measure following a 3-month course of individualised OT,82
involving task-related ADL practice, provision of adaptive equipment, adaptations to the individual’s
environment and caregiver training. The unadjusted ICC for BI scores was 0.36 at baseline; however, for
the change in scores from baseline to 3 months, allowing for the effect of treatment, TACs and type of
care home, it decreased to 0.09. The mixed modelling approach has been shown to be a reasonable
method of analysis when some cluster sizes are small, allowing for appropriate inferences to be made in
relation to fixed effects.105 There is additional evidence that even with small cluster sizes, mixed modelling
is a better approach than an analysis that ignores clustering.106 Furthermore, results of the sensitivity
analysis showed that the conclusions were robust when small clusters were excluded. Results from the
complete case analysis, where BI scores were not imputed for participants who died before the primary
end point revealed similar neutral results to the primary analysis.
The OT administered to participants was similar to a standard NHS intervention,88 shown to be of benefit
to stroke survivors living in their own homes.34 Compliance over the course of the trial was good, resulting
in high completion rates among survivors for all assessments at each end point. On average, participants in
the intervention arm were visited on five occasions with visits lasting a median of 30 minutes. Retention
of care home participation was good throughout the study, with 204 (89%) homes providing data at the
final 12-month end point. The main reason for care home withdrawal was the death of all participating
residents. A total of 313 out of 1042 (30%) participants died during the trial. Overall, we regard the
findings to be robust and conclusive.
We acknowledge several potential limitations. The percentage of care home residents affected by stroke
was less than expected, which resulted in a larger number of small clusters than was originally expected.
Previous research suggested the incidence of stroke in care home residents to be approximately
20–40%.11,15–17 However, this trial observed incidence of stroke in care home residents to be approximately
16% (1556 out of 9840; see Table 6). This figure concurs with results from a recent census of care homes
in the UK.107 In addition, GP surgeries’ response rate to trial correspondence requesting from confirmation
of participants’ stroke was low despite multiple attempts.
There were a high proportion of participants with cognitive impairment, and GDS scores were indicative
of moderate and severe depression. If these participants had been excluded during recruitment, it would
have reduced the external validity of the trial. However, we acknowledge that these participants may have
had potentially limited engagement in therapy, as demonstrated by the observed distribution of therapy
content (see Table 20). Approximately half of all therapy hours were spent on communication with
participants, carers and consultees, as opposed to ADL training (see Table 20). Therapy time attributed
to this category was spent on providing information and guidance to residents, staff or relatives on
personal ADL, initiating referrals to other agencies and ordering equipment. In the pilot phase the
duration of the intervention was also 3 months.48 The median number of visits per resident per month was
2.7 (interquartile range 1–4.2), and the median duration of therapy time per resident per month was
4.5 hours (interquartile range 2–6.9 hours).48 This represents a significant difference in the amount of
therapy received by residents in the two trials. Residents received more therapy in the pilot phase. In
the main trial, the median number of visits was 5 (interquartile range 3–7 visits) over 3 months and the
median duration of therapy per resident was 145 minutes (interquartile range 85–255 minutes). The mean
duration of therapy listed in Table 20 is 208 minutes (SD 208 minutes; minimum 10 minutes, maximum
1380 minutes). The difference in the amount of therapy administered between the pilot trial and the main
trial indicates that the high levels of disability among participants may have prevented engagement in
personal ADL training and reduced therapy time as a result.
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When viewing these figures it is also important to acknowledge differences in eligibility criteria between
the two trials. The pilot trial included 118 residents with a moderate to severe BI score that was
between 4 and 15 out of 20. The Phase III definitive trial reported here used a pragmatic approach and
included residents with a BI score between 0 and 20. As a consequence the mean baseline BI scores
differed between the two trials. In the pilot trial, the mean baseline BI score in the intervention arm was
10.1 (SD 5.7) and 9.5 (SD 5.2) in the control arm. The mean baseline BI scores in both arms in the pilot
trial are classed as moderate. The mean baseline scores in the main trial were in the severe range across
both arms. Table 16 displays the baseline BI scores. Overall, 48% of participants in the intervention
arm had a BI score between 0 and 4, indicating very severe limitations when engaging in personal ADL.
It is also important to reflect on the conclusions from the pilot trial.48 After receiving a higher dose of
therapy, participants in the intervention arm showed a tendency for improvement between baseline and
the primary outcome time point at 3 months for the Barthel composite measures only (see Table 21
and Table 25 for similar results from this trial). However, participants in the intervention arm deteriorated
in a similar way to the control group at all subsequent follow-up time points.48 Therefore, despite the
difference in the amount of therapy administered between the two trials potentially being viewed as a
limitation, the main trial has provided a realistic portrayal of the high level of impairment exhibited by care
home residents living with stroke-related disabilities throughout England and Wales (see Table 16 and
Figures 2 and 3). A realistic conclusion is that the majority of participants may have lacked the capacity to
directly engage with structured, repetitious activity-based therapy.
Safety
The OT provided to residents was not an experimental intervention. Therapy given to residents was similar
to what stroke survivors living in the community would receive from the NHS. Overall, tolerance of the OT
provided to participants was very good, resulting in no adverse events occurring that were attributable to
the intervention. There was a higher incidence of falls among participants in the intervention arm. It is a
possibility that, by facilitating an increase in functional activity, it may have led to an increased risk of
falling. However, according to recently published figures,108–110 the average fall rate of residents in
long-term institutional care varies from 1.45 to 2.50 per annum. This suggests the quarterly fall rate of
0.18 recorded in the intervention arm is below the previously observed parameters.
Generalisability
The large sample size, the geographical distribution of different types of care home, the involvement of a
large number of qualified therapists and the inclusion of all stroke survivors, regardless of cognitive and
communication impairments, increase the potential for generalisability of the observed results across all
UK care homes. The baseline participant characteristics, including age, level of comorbidity, cognitive
impairment and incidence of depression observed in the present study, are similar to rates recently
reported in another large cluster RCT carried out in UK care homes.111
Research in context
The neutral results observed in the OTCH trial concur with results observed in other RCTs conducted in a
care home setting. These trials assessed the benefit of activity-based interventions at reducing levels of
depression, and incidence of falls.111,112 Collectively, these neutral findings suggest that we may be
expecting too much from this predominantly frail population with a high prevalence of dementia and
depression and with low autonomy to respond to activity-based therapies (see Figures 2 and 3 in relation
to levels of severe disability). It seems more appropriate to seek alternative care approaches to ameliorate
disability for this very inactive patient group. The established OT intervention has good evidence of efficacy
when administered to patients in their own homes.34 This suggests that the barriers to success are more
attributable to the care home environment and the care home population. Furthermore, the suitability and
application of a patient-centred goal-setting approach in this population may require further scrutiny.
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Currently, patient-centred care does not have a universally accepted definition or accepted methods of
how it can be measured for adherence.113
A changing role of care homes is acknowledged in a report from the Centre for Policy and Aging.16
Residents are being admitted to care homes with a higher level of dependency and more complex care
needs than ever before.26 In the census of UK Bupa (The British United Provident Association Limited)
care homes in 2012, 87% of residents were classed as having high-support needs and total dependency.16
Providing care for residents with high-support needs requires careful consideration of the care home
environment. The therapists delivering the OTCH intervention in the participating care homes reported that
the use of adaptive equipment and environmental modifications (e.g. the installation of bed levers, grab
rails or raised toilet seats) was highly variable.
Future work
In order to advance the level of care currently provided to care home residents, future research should
identify applicable criteria to promote an enabling environment where possible. The emphasis in this
population is suggested to be about providing care for residents with high support needs for a short
period towards the end of life. Further research is needed to demonstrate how the care home environment
can be suitably modified to tackle these needs. A key factor in promoting an enabling environment is
minimising health-related complications caused by inactivity (such as urinary incontinence and pressure
sores). In addition, further work is needed in measuring health-related complications in this population in
order to identify problems early.
Conclusions
The neutral results from this Phase III cluster randomised trial are deemed robust and conclusive. The trial
was geared towards evaluating whether or not there is sufficient evidence to support an improved NHS
provision of OT for care home residents with stroke-related disabilities. The clinical and health economic
evidence presented here does not support commissioning a routine OT service in this population of care
home residents. There may be benefit for residents with less severe limitations on functional activity;
however, these residents were in the minority of the sampled population of stroke survivors. It appears
justified to suggest that referrals of care home residents with stroke-related disabilities for OT may be of
benefit on an individual basis if left in the hands of the health professional initiating the referral. OT as
a service for stroke survivors still able to live in their own home has good evidence of success.34,37 However,
the benefit of this style of therapy as a routine service was not evident for stroke survivors resident in UK
care homes.
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Sandwell; Belmont Residential Care Home, Preston; Bentley Court Care Home, Wolverhampton; Birch
Green Care Centre, Skelmersdale; Birds Hill Nursing Home, Poole; Birds Hill Starling, Poole; Bloomfield
Court, Tipton; Bluebell Nursing Home, Southsea; Bournville Grange, Birmingham; Bridgewood Mews,
Tipton; Broadgate Care Home, Nottingham; Brompton Lodge, Rhos on Sea; Brookvale Care Home,
Solihull; Burkitt Care Home, Nottingham; Cams Ridge Nursing & Residential Care Home, Fareham; Cann
House, Plymouth; Carpenter Place Care Home, Birmingham; Chalgrove Care Home (Edwardian), Poole;
Chalgrove Care Home (Tudor), Poole; Chelston Park Nursing and Residential Home, Wellington; Chorley
Lodge Residential Care Home, Chorley; Churchfield Christian Care Centre, Nottingham; Churchfield Court
Care Home, West Bromwich; Cole Valley Nursing Home, Birmingham; Compton Manor Care Home,
Coventry; Cordelia Court Care Home, Coventry; Cosham Court Nursing Home, Portsmouth; Courtfield
Lodge Nursing & Residential Home, Ormskirk; Croft Manor Residential Care Home, Fareham; Crossways,
Walsall; Crown Meadow Nursing Home, Sandwell; Crystal Hall Residential & Nursing Home, Preston;
Cuerden Grange Nursing Home, Preston; Cuerden Grange Rest Home, Preston; Davlyn House,
Stoke-on-Trent; Deerwood Grange Nursing Home, Sutton Coldfield; Digby Manor Care Home, Erdington;
Down House, Plymouth; Druids Meadow Residential Care, Birmingham; Dunkirk Memorial Home, Taunton;
Eastleigh Nursing Home, Minehead; Edgbaston Beaumont Care Home, Birmingham; Edward House,
Nottingham; Elizabeth House Care South, Poole; Elm House, Nottingham; Eryl Fryn Nursing & Residential
Home, Llandudno; Evedale Care Home, Coventry; Eversleigh, Wolverhampton; Farehaven Lodge, Fareham;
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Frethey House Care Home, Taunton; Giltbrook House Nursing Home, Nottingham; Godiva Lodge Care
Home, Coventry; Greenfield Nursing Home, Preston; Greville House Care Home, Sutton Coldfield;
Hallcroft, Nottingham; Hamilton House Care Centre, Portsmouth; Haulfre, Beaumaris; Hawthorne Lodge,
Nottingham; Hazel House Nursing Home, Leyland; Heartlands Care Home, Birmingham; Heathlands Care
Home, Poole; High Pastures Nursing Home, Deganwy; Holmpark Care Home, Birmingham; Ivy House Care
Home, Birmingham; Kelvedon House, Wednesbury; Keresley Wood Care Centre, Coventry; Kingland House
Residential Home, Poole; Kinmel Lodge, Kinmel Bay; Knoll House, Wolverhampton; Lake View Nursing
Home, Chorley; Landermeads Nursing Home, Nottingham; Langdale Nursing Home, Gosport; Leabrook
House Nursing Home, Sandwell; Lilliput House Care Home, Poole; Llys Eilian, Colwyn Bay; Longdean
Lodge, Portsmouth; Lucton House Care Home, Birmingham; Lyme Valley House, Newcastle-under-Lyme;
Maple Dene Care Home, Birmingham; Marian House Nursing Home, Sutton Coldfield; Mary Street Care
Home, Birmingham; Meadow House Residential Home, Portsmouth; Meadowbank Nursing Home, Bamber
Bridge; Meadowside/St Francis, Plymouth; Melbourne House Care Home, Coventry; Merafield View,
Plymouth; Merry Hall Nursing and Residential Care Home, Fareham; Moorcroft, Llandudno; Moorhaven
Care Home, Taunton; Moorlands Nursing Home, Nottingham; Moundsley Hall Nursing and Residential
Home, Birmingham; Mountbatten Nursing Home, Taunton; Neville Williams House, Birmingham; New Day
Nursing Home, Birmingham; New Milton Nursing Home, Stoke-on-Trent; Northcott House Nursing &
Residential Care Home, Gosport; Oakland Grange, Southsea; Oaklands Care Centre, Birmingham;
Oakwood Rest Home, Erdington; Olivet Christadelphian Care Homes, Birmingham; Orchard House Nursing
Home, Sutton Coldfield; Osborn Manor, Fareham; Park House Nursing Home, Nottingham; Park Manor
Care Home, Poole; Parkfields, Wolverhampton; Parkwood House Nursing Home, Plymouth; Parkwood
House Residential Home, Plymouth; Patricia Venton Centre, Plymouth; Peel House Nursing and Residential
Home, Fareham; Pelsall Hall, Walsall; Perry Locks Nursing Home, Birmingham; Pine Meadows Care Centre,
Leek; Plas Gogarth, Llandudno; Plas Gwilym, Caernarfon; Plas Gwynfa Nursing Home, Abergele; Plas y
Bryn Nursing Home, Caernarfon; Priestly Rose Care Home, Erdington; Prince of Wales Care Home, Shirley;
Priory Grange, Rhos on Sea; Queen Anne Lodge, Southsea; Queenswood Methodist Homes for the Aged,
Nottingham; Radnor House Care Home, Birmingham; Rayner House, Solihull; Richmond Hall, Walsall;
Robert Harvey House Care Home, Birmingham; Rosemary Lodge Nursing Home, Birmingham; Roxton
Nursing Home, Sutton Coldfield; Ruksar, Wolverhampton; Russell Churcher Court, Gosport; Rylands,
Newport; Sant Tysilio Nursing Home, Llanfairpwll; Seaview Residential Care Home, Southsea; Selbourne
Court Care Home, Coventry; Selly Park Care Centre, Birmingham; Sherwood Court, Preston; Silverbirches,
Birmingham; Silverdale Nursing Home, Newcastle-under-Lyme; Solent Cliffs Nursing & Residential Care
Home, Fareham; Somerset Abbeyfield, Taunton; South View Lodge, Hesketh Bank; Southern House,
Abergele; Sovereign House Nursing Home, Coventry; Springbank Nursing Home, Stoke-on-Trent;
Springfield Court Nursing Home, Aughton; Springfield House Nursing Home, Codsall; Springfield Nursing
Home, Chorley; Springfield Residential Home, Nottingham; Springholme Care (Anglesey) Ltd, Pentraeth;
St Agnes’s Care Home, Erdington; St Bernards Residential Care Home, Solihull; St Catherine’s Residential
Home, Sutton Coldfield; St Joseph’s Home, Birmingham; St Martin’s Nursing Home, Sutton Coldfield;
St Paul’s Convent, Birmingham; St Ronan’s Nursing and Residential Care Home, Southsea; St Vincent
House, Gosport; Staddon Lodge Residential Care Home, Poole; Stennards Leisure Home, Birmingham;
Stratford Court Care Home, Birmingham; Sunrise Operations Tettenhall Ltd (Assisted Living),
Wolverhampton; Sunrise Senior Living Solihull, Solihull; Sycamore House Care Home, Nottingham; Talbot
View, Bournemouth; Tamar House, Plymouth; Templeman House, Bournemouth; Thalassa Nursing Home,
Gosport; The Beaufort Care Home, Coventry; The Carlton Care Home, Nottingham; The Field House Care
Home, Birmingham; The Firs Nursing Home, Nottingham; The Friendly Inn, Birmingham; The Gables Care
Home, Sutton Coldfield; The Grange, Nottingham; The Green Nursing Home, Birmingham; The Grove,
Solihull; The Haven Nursing Home, Coventry; The Herons, Nottingham; The Manor House, Stone; The Old
Vicarage, Long Eaton; The Orchard, Wednesbury; The Poplars Nursing Home, Sandwell; The Priory Nursing
and Residential Home, Shirley; The Priory, Telford; The Regency Nursing Home, Southsea; The Ridings,
Birmingham; The Shrubbery, Codsall; Torr Home Nursing, Plymouth; Torr Home Residential, Plymouth;
Tudor House Care Home, Birmingham; Uplands Nursing Home, Birmingham; Valley View, Plymouth;
Victoria Gardens Care Home, Coventry; Wellesley House Nursing Home, Wolverhampton; Winsor Nursing
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Home, Minehead; Woodcote Hall, Newport; Woodcroft, Colwyn Bay; Woodland Villa Nursing Care Home,
Plymouth; Woodland Villa Residential Care Home, Plymouth; Woodside Grange Care Home, Rhos on Sea;
Wrottesley Park House Nursing Home, Wolverhampton; and Wyndeley Grange Nursing, Sutton Coldfield.
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Appendix 1 General practitioner’s letter
requesting confirmation of participant eligibility
Study Number:  REC 09/H1210/88                                             
 
Study Title     ‘CLUSTER RANDOMISED CONTROLLED TRIAL OF AN OCCUPATIONAL 
THERAPY INTERVENTION FOR RESIDENTS WITH STROKE IN UK CARE-HOMES (ACRONYM- 
OTCH).’  
 
Dear «PM_Title» «PM_surname» 
 
«PracticeName» has previously been notified of patient/s involved in the above research trial.  
The patient/s have consented to take part in the trial and agreed you should be notified of 
such. Copy of signed consent form/s enclosed. 
 
We would be grateful if you would verify their eligibility for the trial by completing the 
enclosed GP Confirmation Form to confirm diagnosis of stroke or TIA. Please complete for 
all patients listed even if they have moved away from your practice or have passed away. 
Alternatively please contact us to arrange a convenient time to gather the information over 
the telephone. In addition it would also be appreciated if you were to provide us with a copy 
of their current prescription medication for completeness of our records. This information 
will be anonymised upon receipt; however, should you wish to oversee this, please write the 
appropriate Participant ID (to be found on the GP confirmation form and Consent Form) on 
the corresponding medication list.  
 
We enclose a freepost envelope for the return of the completed GP Confirmation Form and 
prescription medication details and would very much appreciate their return by (insert 
required date) 
 
Should you have any queries please do not hesitate to contact a member of the team 
otherwise we look forward to hearing from you in due course. 
 
Yours sincerely,  
 
OTCH Trial Manager 
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GP practice diagnosis form returned to the research team 
 
GP CONFIRMATION FORM – «PracticeName» 
RETURN COMPLETED FORM TO THE OTCH STUDY TEAM IN THE 
REPLY PAID ENVELOPE SUPPLIED 
COMPLETED BY: 
Name.................................................... 
Position................................................. 
Date....................................................... 
PLEASE COMPLETE AND RETURN FOR ALL PATIENTS LISTED 
REGARDLESS OF WHETHER THEY HAVE SUBSEQUENTLY LEFT THE 
PRACTICE OR PASSED AWAY.  RETURN COMPLETED FORM TO THE 
OTCH STUDY TEAM IN THE REPLY PAID ENVELOPE SUPPLIED 
Participant 
ID 
Care Home Patient on 
QOF 
Stroke 1 
Register?  
( ) 
If no, what evidence 
of stroke or TIA is 
detailed in medical 
history (please 
complete) 
Copy current 
prescription 
enclosed ( ) 
«ID» «HomeName»    
 
 
«ID» 
 
«HomeName»    
«ID» 
 
«HomeName»    
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Appendix 2 Occupational therapy information
leaflet
What is Occupational Therapy?
Occupational Therapy helps a person to achieve health and well-being through taking part in everyday
tasks, such as dressing.
The therapist’s knowledge of adapting activities and surroundings is used to help people achieve the
things they want to do and promote safety.
What will it involve?
The Occupational Therapist will be working with residents to help them carry out day-to-day activities
such as:
l Moving around the home
l Dressing and grooming
l Washing, bathing or showering
l Eating and drinking
The OT in Care Homes study
At the start of the study homes will be divided into 2 groups, one group will receive the services of an
occupational therapist for about 10 weeks. The other group will continue as before during the study but
will receive staff training at the end.
Full details of the study are available from
[contact details removed]
What would happen if I take part?
A plan will be agreed between the resident and the occupational therapist/s. The aim is to help the
resident achieve what they want to do. It will not involve anything they do not want to work on. It may
include any of the following:
l Information and advice
¢ Ways of managing both for the resident and their carers
l Activity and treatment
¢ Relearning ways of doing activities or trying new methods
¢ Activities aimed at improving the residents’ abilities, they may be asked to practice
between sessions
¢ Techniques to Increase/maintain mobility
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l Equipment to help them manage
¢ Walking aids
¢ Equipment to help the resident with activities such as washing and eating.
l Home adaptations
¢ Advice on layout of room furniture for ease of use
¢ Advice to reduce hazards
¢ Supply grab rails
l Wheelchairs
¢ Advice on mobility, posture and comfort
l Seating
¢ Dining room chair
¢ Armchair
l Health and safety promotion
¢ Reducing the risk of falls
¢ Increasing/maintaining activity levels
l Referrals
¢ Referrals can be made to other specialists according to the residents’ wishes and needs
Benefits of taking part
It is hoped that the time spent with the therapists will help the residents’ mobility and give them more
choice over their day to day activities, in a safe and knowledgeable way.
For further information about Occupational Therapy please contact:
[contact details removed].
APPENDIX 2
NIHR Journals Library www.journalslibrary.nihr.ac.uk
76
Appendix 3 Participant information sheet
Study Title ‘Cluster randomised controlled trial of an
occupational therapy intervention for residents with stroke in
UK care-homes’
Study Number: REC09/H1210/88
What is the purpose of the study?
This 4 year-long study is being carried out to assess the value of providing a targeted course of
occupational therapy to people living in a residential or nursing home after stroke. This service has been
found to be of value to people living in their own homes, and to people after a stroke. It has been found
to be helpful in terms of improving their independence, their ability to take part in everyday activities, and
their mobility. However, occupational therapy is less readily available to people living in residential or
nursing homes.
Why have I been chosen?
The service is being provided in the way that it would if it were part of the National Health Service (NHS)
or Social Services. Consequently, many of the residents of your home are being invited to take part.
Do I have to take part?
It is up to you to decide whether or not to take part. If you do decide to take part you would be given
this information sheet to keep and be asked to sign a consent form. If you decide to take part you are still
free to withdraw at any time and without giving a reason. This would not affect the standard of care
you receive.
What would happen to me if I take part?
All the homes that participate in the study will either receive the service of an occupational therapist or not
for a three month period (on top of any services the home currently receives). However, the computer will
randomly decide, as if by the toss of a coin, whether your home receives the therapy.
What do I have to do and what does the therapist do?
If you decide to take part, you will be assessed four times-at 0 months, 3 months, 6 months and finally at
12 months. You may be seen by an occupational therapist, who will deliver therapy according to your
needs. The assessments will ask you various questions about your day to day activities. The initial
assessments will also look at your communication and clarity of thought.
The therapists providing the service will ask you about your ability to take part in day to day activities and,
if the therapist feels that he/she can help you to keep your mobility and or prevent you from losing your
independence, they will suggest one of a number of things to help. This may include:
l Providing a piece of equipment or adapting something (such as raising the height of your chair)
l Providing advice
l Providing activities, which he/she will practice with you and ask you to continue to practice
between visits
l Providing exercises for you to practice.
The therapists will arrange a time that is convenient for you and this would not restrict your lifestyle in any
way. The therapists providing the therapy would be visiting your place of residence for about 3 months,
but as an individual you may only be seen a few times (depending on your needs).
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What are the disadvantages or risks of taking part?
The services of an occupational therapist are not thought to put individuals at risk. The therapists would
not ask you to do things that you do not want to and you are free to stop at any time. At worst, the
services the therapist offers may not have any measurable benefits.
What are the advantages of taking part?
We hope that we can demonstrate that the services of an occupational therapist would be helpful to
people living in either residential or nursing homes after a stroke. However, this cannot be guaranteed.
The information we get from this study may help us to help people participate in day to day activities more
easily and maintain this ability for a longer period of time.
What if new information becomes available?
This is the largest study of its kind and will add to our knowledge, but other studies may be necessary
before practice is changed. If information becomes available from other work, it will add to our
knowledge, but this study will continue as planned.
What happens when the research study stops?
The occupational therapy service provided by this study will stop when the study finishes. However, the
services provided by Social Services and the NHS will continue unaffected.
What if something goes wrong?
If you are harmed by taking part in this research project, there are no special compensation arrangements.
If you are harmed due to someone’s negligence, then you may have grounds for a legal action but you
may have to pay for it. Regardless of this, if you wish to complain about any aspect of the way you have
been approached or treated during the course of this study, the normal NHS complaints mechanisms may
be available to you.
What if there is a problem?
If you have a concern about any aspect of this study, you should ask to speak to the researchers who will
do their best to answer your questions. If you remain unhappy and wish to complain formally, you can do
this by contacting [contact details removed].
Will my taking part in this study be kept confidential?
All information which is collected about you during the course of the research will be kept strictly
confidential. Any information about you which leaves the hospital/surgery will have your name and address
removed so that you cannot be recognised from it. Your General Practitioner (GP) and other therapists
responsible for your care would be notified that you are taking part in the study (with your permission).
What will happen to the results of the study?
The results of the study will be presented to stroke survivors, NHS and Social Services staff and will be
published in a scientific journal. Neither the presentations nor publications will identify individuals or
homes who participated in the study.
Who is organising and funding the research?
The study is being funded by the National Institute for Health Research, part of the NHS.
Who has reviewed this study?
Coventry research ethics committee has reviewed this study.
Who do I contact for further information?
Please contact [contact details removed] for more information. You will be given a copy of the information
sheet and a signed consent form to keep.
Thank you for reading this.
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Appendix 4 Participant consent form
 
 Pt ID:    
 
CLUSTER RANDOMISED CONTROLLED TRIAL OF AN OCCUPATIONAL THERAPY 
INTERVENTION FOR RESIDENTS WITH STROKE IN UK CARE-HOMES 
(ACRONYM - OTCH).  
  
Care Home:   
GP Practice:  
Name of Researcher   :                       
   
  Please initial box to indicate agreement  
  
1 I confirm that I have read and understood the information sheet dated 4th September 2010, 
version 3.0 for the above study and have had the opportunity to ask questions.   
 
 
2 I understand that my participation is voluntary and that I am free to withdraw at any time,  
without giving any reason, without my medical care or legal rights being affected.   
 
 
3 I understand that relevant sections of my medical notes and data collected during the study 
may be looked at by individuals from the OTCH coordinating centre, from regulatory 
authorities or from the NHS Trust, where it is relevant to my taking part in this research. I 
give permission for these individuals to have access to my records.  
 
 
4 I agree to my GP being contacted and informed about my participation in this study.  
 
 
5 I agree to take part in the above OTCH study.    
  
(Original to be kept in care home records; one copy for patient; one copy for 
researcher site file)  
               
 
 
   
 
 
  
______________________               ___________                   
____________________  
Name of Patient                   
  
 Date   Signature  
______________________               ___________                   
____________________   
Name of person taking consent      
  
 Date   Signature  
DOI: 10.3310/hta20150 HEALTH TECHNOLOGY ASSESSMENT 2016 VOL. 20 NO. 15
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Sackley et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
79

Appendix 5 Consultee information sheet
S tudy Number: REC09/H1210/88
Study Title ‘Cluster randomised controlled trial of an
occupational therapy intervention for residents with stroke in
UK care-homes (acronym – OTCH).’
Invitation
Your relative (it could also be a friend or someone you care for, but for brevity this document will use the
term ‘relative’) is being invited to take part in a research study. Before you decide whether you agree
to their participation it is important for you to understand why the research is being done and what it will
involve. Please take time to read the following information carefully and discuss it with care home staff,
friends, relatives and health care professionals if you wish. Ask us if there is anything that is not clear or if
you would like more information. Do take the time to consider this request.
Who can act as a consultee?
Where people cannot take the decision to consent to be involved in a research project then a consultee
must be appointed. A consultee can either be ‘personal’ or ‘nominated’. A personal consultee is someone
unconnected with the research who knows the potential research participant in a personal capacity and is
able to advise on the person’s wishes or feelings. This can be a friend, family member or court appointee.
A ‘nominated’ consultee’ is someone unconnected with the research, appointed by the researcher, to
advise the researcher about the person’s wishes and feeling in relation to the project. This can be another
health-care worker but they must not have any connection with the study. Before a nominated consultee
is appointed, the researcher will take all reasonable steps to identify a personal consultee.
What is the role of the consultee?
The consultee advises the researcher on what the participant’s wishes and feelings would be if they were
able to consent for themselves, and on whether they should take part. The consultee does not give
consent, only advice. The responsibility to decide whether the participant should be entered into the
research lies ultimately with the researcher. Consultees will be provided with information about the
research project and will be given the opportunity to discuss it and their role as consultee. All consultees
must be able to understand their role and be willing to undertake it.
How do I find out more if I am approached to be a consultee?
Further information is available in the Department of Health’s ‘Guidance on nominating a consultee for
research involving adults who lack capacity to consent’.
http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAn dGuidance/DH_083131
This is also available from the research team, please ask if you would like a copy.
What is the purpose of the study?
This four year-long study is being carried out to assess the value of providing a targeted course of
occupational therapy to people living in a residential or nursing home after stroke. This service has been
found to be of value to stroke survivors living in their own homes. It has been found to be helpful in
terms of improving their independence, their ability to take part in everyday activities, and their mobility.
However, occupational therapy is less readily available to people living in residential or nursing homes.
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Why has my relative been chosen?
The service is being provided in the way that it would if it were part of the National Health Service (NHS)
or Social Services. Consequently, many of the residents of this care home are being invited to take part.
Does my relative have to take part?
We would like you to think very carefully about whether or not this person would have wanted to join the
study. If your opinion is that he/she would have decided to take part, you would be given this information
sheet to keep and be asked to sign a form indicating your view allowing your relative to participate in
the study. If you later decide that he/she no longer wishes to take part, please inform us and he/she will be
withdrawn from the study. You do not need to give a reason and it will not affect the standard of care
your relative receives.
What will happen to my relative if they take part?
All the homes that participate in the study will either receive the service of an occupational therapist or not
for a three month period (on top of any existing services the home receives). However, the computer will
randomly decide, as if by the toss of a coin, whether their home receives the therapy.
What does my relative have to do and what does the therapist do?
If you indicate that your relative would like to take part, they will be assessed four times-at 0 months
(initial assessment), 3 months, 6 months and finally at 12 months by a researcher.
Your relative may be seen by an occupational therapist, who will deliver therapy according to their needs.
The assessments will cover questions about day to day activities. The initial assessments will also look at
their communication and clarity of thought.
If your relative’s care home is allocated the service of an occupational therapist, the therapists providing
the service will ask them about their ability to take part in day to day activities. Then, if the therapist feels
that he/she can help them with their mobility and other day to day activities, they may suggest a number
of things that could be helpful. This may include:
l Providing a piece of equipment or adapting something (such as a non-slip mat to stop their plate
moving around the table)
l Providing advice
l Providing activities, which he/she will practice with the resident and ask them to continue to practice
between visits
l Providing exercises for your relative to practice.
The therapists will arrange a time that is convenient for your relative and this would not restrict their
lifestyle in any way. The therapists providing the therapy would be visiting the care home for about
3 months, but as an individual your relative may only be seen a few times (depending on their needs).
What are the disadvantages or risks of taking part?
There is no evidence that the services of an occupational therapist put individuals at risk. The therapists
would not ask your relative to do things that he/she would not want to do. Your relative is free to stop at
any time. At worst, the services the therapist offers may not be effective and so your relative would have
no benefit from their visits.
What are the advantages of taking part?
We hope that we can demonstrate that the services of an occupational therapist would be helpful to
people living in a care home after a stroke. However, this cannot be guaranteed. The information we get
from this study may help us to help people participate in day to day activities more easily and maintain this
ability for a longer period of time.
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What if new information becomes available?
This is the largest study of its kind and will add to our knowledge, but other studies may be necessary
before practice is changed. If information becomes available from other work, it will add to our
knowledge, but this study will continue as planned.
What happens when the research study stops?
The occupational therapy service provided by this study will stop when the study finishes. However, the
services provided by Social Services and the NHS will continue unaffected.
What if something goes wrong?
If your relative is harmed by taking part in this research project, there are no special compensation
arrangements. If they are harmed due to someone’s negligence, then they may have grounds for legal
action but they may have to pay for it. Regardless of this, if you or your relative wish to complain about
any aspect of the way you have been approached or treated during the course of this study, the normal
NHS complaints mechanisms may be available to you.
What if there is a problem?
If you have a concern about any aspect of this study, you should ask to speak to the researchers who will
do their best to answer your questions. If you remain unhappy and wish to complain formally, you can do
this by contacting [contact details removed].
Will their taking part in this study be kept confidential?
All information which is collected about your relative during the course of the research will be kept strictly
confidential. Any information about them which leaves the hospital/surgery will have their name and
address removed so that they cannot be recognised from it. Your relative’s General Practitioner (GP) and
other therapists responsible for their care would be notified that they are taking part in the study (with
their permission).
What will happen to the results of the study?
The results of the study will be presented to stroke survivors, NHS and Social Services staff, and will be
published in a scientific journal. Neither the presentations nor publications will identify individuals or
homes who participated in the study. (If you would like copies of the publications please inform
[contact details removed] at the address below).
Who is organising and funding the research?
The study is being funded by the National Institute for Health Research, part of the NHS.
Who has reviewed this study?
Coventry research ethics committee has reviewed this study.
Who do I contact for further information?
Please contact [contact details removed] for more information.
You will be given a copy of the information sheet and a signed consent form to keep.
Thank you for reading this.
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Appendix 6 Consultee declaration form
Pt ID:   
 
CLUSTER RANDOMISED CONTROLLED TRIAL OF AN OCCUPATIONAL 
THERAPY INTERVENTION FOR RESIDENTS WITH STROKE IN UK CARE-
HOMES (ACRONYM - OTCH). 
  
Care Home:   
GP Practice:  
Name of Researcher: Professor Catherine Sackley  
 
I (Consultee 
name)________________________________________________________________  
  
of (Address): 
____________________________________________________________________  
  
________________________________________________________________________ 
  
agree to the participation of (Participant’s name)  
 
________________________________________  
  
of (Address):___________________________________________into the OTCH Trial 
                           
  Please initial box to indicate agreement  
1 I the above named consultee have been consulted about the above named 
articipant’s participation in this research project. I have read and understand the 
consultee information sheet dated 4th September 2010, version 3.0 for the above 
study. I have had the opportunity to ask questions about the study and 
understand what is involved. 
2 In my opinion he/she would have no objection to taking part in the above study.  
3 I understand that I can request he/she is withdrawn from the study at any time, without 
giving any reason and without his/her care or legal rights being affected.   
4 I understand that relevant sections of his/her care record, medical notes and data   
collected during the study may be looked at by responsible individuals from the OTCH 
coordinating centre, from regulatory authorities or from the NHS Trust, where it is 
relevant to their taking part in this research.  I agree these individuals can have access 
to the above named participant’s records.  
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5 I agree to their GP or other care professional being informed of their participation in 
the study.  
______________________               ___________                     ____________________  
Name of Consultee                  Date  Signature  
     
Please indicate if   personal 
consultee     
or   
nominated consultee     
     
Relationship to patient:  ________________________________________  
 
______________________               ___________                   
____________________   Name of person taking consent       Date                                 
Signature  
 
(Original to be kept in care home records; 1 copy for patient; one copy for researcher 
site file)  
  
OTCH Consultee Declaration Form v2.0 04Sept10.doc    
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Appendix 7 Demographic front sheet
Patient Details: 
 
Forename       Surname  
Pt ID  
 
Gender:     Male    Female          Date of birth (dd/mm/yyyy)  _ _ / _ _ / _ _ _ _ 
 
Ethnicity: 
White Mixed Asian or Asian Birtish 
 British  White & Black Caribbean  Indian 
 Irish  White & Black African  Pakistani 
 Any other white background  White & Asian  Bangladeshi 
   Any other mixed background  Any other Asian background 
      
Black or Black British Other Ethnic Groups   
 Caribbean  Chinese   
 African  Any other ethnic group   
 Any other Black background  Not stated   
 
 
Next of Kin: 
Name ..     Relationship  
Tel      ..
 
Address 1  
Address 2  
Town  
County  
Postcode  
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Residence details: 
 
Name of Home  
Contact Person  
Contact Person 
Tel 
 
Address 1  
Address 2  
Town  
County  
Postcode  
Date of admission d     d     /     m     m     /     y     y     y     y 
 
 
Medical details: 
 
GP  Address 1  
Surgery  Address 2  
Surgery Code  Town  
Tel  County  
Fax  Postcode  
 
 
Stroke details:
 
Suspected 
Stroke/TIA 
  Confirmed 
Stroke 
 Confirmed TIA  
Date of  last Stroke   
 
  
What side of the body has the stroke affected? 
Right side  Left side   Bilateral  
D D M M Y Y
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Appendix 8 Current medication
Current Medication Dose (mg) Frequency * Date started 
(dd/mm/yy) 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
* Frequency: daily, weekly, monthly, prn, twice weekly, bd, tds, qds, asd. 
Medical history: 
     
Does the patient have any of the following medical conditions? 
 
· Cardiovascular disease   Yes   No 
 
· Respiratory disease   Yes   No 
        
· Hepatic disease     Yes   No 
 
· Gastrointestinal disease   Yes   No 
 
· Renal disease    Yes   No 
        
· Urological conditions   Yes   No 
 
· Neurological disease   Yes   No 
  
· Musculoskeletal problems  Yes   No 
 
· History of falls    Yes   No 
 
· Dermatological    Yes   No  
·  
· Other                                                                        Specify    
__________________________________  
 
                                                                                                                   
                                                                                                                  
____________________________________                                                                                                 
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Appendix 9 Initial participant interview
Initial participant interview 
Information gained from ……………………………………….  
Name of OT ……………………………………………………… 
Date ……………………… 
Patient Consent to Initial Interview …………………………..   
Identification checked ……………………..  
Communication issues ………………………….. 
Orientation – Time    -Place    -Person 
Floor – knee height:…………………… 
 
Overview of daily routine – what do you do on a typical day? 
 
 
 
 
Individual Daily Activities 
Do you get out of bed? If not why not? By yourself or with help? How are you 
helped? Any adaptive equipment used? Bed height? Condition of equipment? 
 
 
 
 
How do you get around? By yourself or with help? How are you helped? Any 
equipment used? Do you tend to stay in your room or go to communal areas? 
Condition of equipment? 
 
 
 
 
How do you manage with transferring on/off chair? By yourself or with help? How 
are you helped?  Type of chair? Chair height? Condition of equipment? 
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How do you have a wash? Where do you have a wash? By yourself or with help? 
How are you helped? Any adaptive equipment used? Condition of equipment? 
 
 
 
 
How do you get dressed? By yourself or with help? How are you helped? Any 
adaptive equipment used? Condition of equipment? 
 
 
 
 
Are you able to eat and drink? By yourself or with help? How are you helped? Any 
adaptive equipment used? Condition of equipment? 
 
 
 
 
How do you manage going to the toilet? Can you get there in time? Can you 
transfer on/off toilet/commode? By yourself or with help? Pads, catheter, self-
managed or with help? Toilet height? Condition of equipment? 
 
 
 
 
What do you enjoy doing as a leisure activity? Do you need help to do this? 
 
 
 
 
What is the most important thing for you to be able to do? 
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Appendix 10 Treatment log
A t each visit please record the approximate time in minutes spent on each of the areas below:
 
   Category of intervention 
  
 
 
Assessment 
and goal 
setting 
 
Communication 
Including listening to 
residents’ concerns or 
life story, information 
giving (to residents, 
staff or relatives), 
referrals to other 
agencies and ordering
equipment 
 
ADL training 
 
Transfers and 
mobility 
Including aspects of 
wheelchair provision if 
directly concerned with 
mobility rather than 
seating 
 
Adaptive 
equipment, 
seating, postural 
management and 
environmental 
adaptations 
Including 
preventative 
interventions, such 
as wheelchair 
cushions and palm 
protectors 
 
Other 
Including 
treating 
impairments 
directly and the 
use of leisure 
activities 
 
Total 
  
Date 
Cognitive Functional Cognitive Functional 
V
is
it 
1           
2           
3           
4           
5           
6           
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Appendix 11 Occupational Therapy intervention
for residents with stroke living in UK Care Homes
training workbook
OTCH training workbook 
 
INTRODUCTION 
Within the UK about 25% of people with stroke move directly from acute care to a care home 
(residential or nursing). Of all care home admissions 20% - 40% have stroke as their 
admission diagnosis. Stroke is a cause of severe disability in care home residents.  
The overall aim of the OTCH study is to evaluate the effectiveness of a targeted course of 
occupational therapy (with provision of adaptive equipment, minor environmental 
adaptations and staff education) for people with stroke living in a care home.  
This training workshop was developed by Joanna Fletcher-Smith, Kerry Steel, Karen Lett and 
Claire Edwards on behalf of the ‘OTCH study’ team. The training was developed especially 
for staff working in care homes (both nursing and residential) with residents who have had a 
stroke. We hope that you will find it both informative and useful.  
As carers and health workers one of our challenges is to enable people to continue to 
participate in activity. Activity is essential to human existence, health and wellbeing. It can 
restore, maintain and improve physical and mental health. Activity that has purpose and 
meaning is a basic driving force. This need to carry out activity does not lessen as we grow 
older but the effects of ageing and disability (e.g. stroke, arthritis, and eyesight and hearing 
problems) can make participating more difficult.  
Individual personality, life history, interests and beliefs influence our choice of activity 
throughout our lives. Activity defines who we are and how we see ourselves in relation to 
those around us, i.e. family, local community and the wider society.  
This workbook and the workshop are intended to increase your understanding of stroke and 
how it affects a person’s ability to carry out daily activities. We will focus on the importance 
of promoting and supporting meaningful activity for your residents.  
What is purposeful and meaningful activity? 
Activity: Series of linked actions by an individual which take place on a 
specific occasion during a set period of time for a particular reason.  
Purposeful: Designed; intentional; directed towards a goal or end result; 
having meaning.  
Meaningful: Full of meaning, significant. An activity is meaningful if it is 
intentional and if it has some significance for the person carrying it out. 
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WORKSHOP LEARNING OBJECTIVES 
 
 
This workshop aims to equip you with a basic understanding of: 
 the main causes of stroke 
 the common effects of stroke 
 the importance of activity for maintaining health and well-being 
 how you can support residents with stroke to participate in activity   
 
 
CONTENTS 
 
What is a stroke?          
What causes a stroke?          
What is a TIA or ‘Mini Stroke’?                   
The effects of stroke?          
Activity           
Giving and receiving care        
Participation in activity          
Weakness or paralysis          
Caring for the affected arm and shoulder       
Positioning someone with weakness or paralysis      
Swallowing problems (dysphagia)        
Communication problems after stroke       
Visual problems after stroke         
Cognitive problems after stroke        
Supporting mobility and transfers        
Supporting people in activity         
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WHAT IS A STROKE? 
 
A stroke is a “brain attack” 
 
In order for the brain to function, it requires a constant blood supply.    
This provides vital nutrients and oxygen to brain cells. 
 
A stroke happens when the blood supply to part of the brain is cut  
off and brain cells are damaged or die.  
 
WHAT CAUSES A STROKE? 
 
There are two main causes of stroke: 
 
1. Clot (infarct) 
 
 A clot causes a blockage in the blood flow and results in ischaemia (some death to the area 
of the brain where the clot has occurred).  A clot (also known as an infarction) is caused 
either by a thrombus (blockage) that occurs due to a build up of debris within the artery of the 
brain, or an embolism which is a clot that originates from somewhere else in the body.  
Ischaemic strokes account for 83% of strokes. 
 
2. Bleed (haemorrhage) 
A bleed is also referred to as a haemorrhagic stroke.  This happens when an artery in the 
brain bursts (aneurysm) and blood bleeds into the brain, either due to the pressure in the 
artery being too high or because of a weakness in the artery wall.  Haemorrhagic strokes 
account for the remaining 17% of strokes 
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WHAT IS A TIA OR ‘MINI STROKE’? 
 
TIA stands for Transient Ischaemic Attack 
 
Transient = passing through 
Ischaemic = some death to the area of the brain 
Attack = short & sudden 
 
The symptoms of a TIA: 
 
• are exactly the same as stroke  
• may only last 30 seconds 
• resolve within 24 hours 
 
A TIA is a warning!  If you suspect one of your residents is having a TIA, treat it as a 
medical emergency and phone 999.  If left untreated, a TIA can lead to a stroke. 
 
WHAT ARE THE EFFECTS OF STROKE? 
 
TASK ONE:  Please list in your workbook any effects of stroke that you have seen in 
your residents or that you know about… 
 
....................................................................................................................................................... 
 
....................................................................................................................................................... 
 
....................................................................................................................................................... 
 
....................................................................................................................................................... 
 
...................................................................................................................................................... 
 
....................................................................................................................................................... 
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THE EFFECTS OF STROKE 
Compare your own list of the effects of stroke to the one below: 
 Physical pain 
 Weakness or paralysis to one side of the body 
 Poor balance 
Problems with sensation 
 Difficulty swallowing 
Tiredness or difficulty sleeping
 Difficulty understanding people or communicating (aphasia) 
 Visual problems 
 Cognitive problems (mental processing) 
 Incontinence (Bladder and bowel problems) 
 Emotional problems (anxiety, depression, anger, sadness) 
 
There may be more effects of stroke than you knew about. The effect of a stroke is dependent 
upon where the damage in the brain occurs:- 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The consequences of a stroke may vary from person to person. The location and extent of the 
damage to the brain, timely medical treatment and any subsequent rehabilitation may impact 
on a person’s abilities to resume their previous roles and activities.  Disability is associated 
with being unable to perform those daily living tasks previously undertaken. 
Frontal lobe:  
thinking 
planning 
organising 
problem solving 
emotions  
behaviour control 
memory  
movement  
Temporal lobe: 
memory 
understanding 
behaviour 
hearing 
speech 
vision  
 
Parietal lobe: 
language 
reading 
perception 
sensation  
Cerebellum: 
balance 
coordination 
 
Occipital lobe: 
vision  
 
Brain stem:  
blood pressure 
breathing 
consciousness 
 heartbeat 
 swallowing  
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A DAY IN THE LIFE OF… 
 
TASK TWO (A):  Briefly list all the things you did yesterday 
 
8 am  ................................................................................................................ 
9 am  ................................................................................................................ 
10 am ............................................................................................................... 
11 am ............................................................................................................... 
12 noon ............................................................................................................ 
1 pm  ................................................................................................................ 
2 pm  ................................................................................................................ 
3 pm  ................................................................................................................ 
4 pm ................................................................................................................. 
5 pm ................................................................................................................. 
6 pm ................................................................................................................. 
7 pm ................................................................................................................. 
8 pm ................................................................................................................. 
 
TASK TWO (B): Now think of one of your residents and briefly list all the things 
they did yesterday 
 
8 am  ................................................................................................................ 
9 am  ................................................................................................................ 
10 am ............................................................................................................... 
11 am ............................................................................................................... 
12 noon ............................................................................................................ 
1 pm  ................................................................................................................ 
2 pm  ................................................................................................................ 
3 pm  ................................................................................................................ 
4 pm ................................................................................................................. 
5 pm ................................................................................................................. 
6 pm ................................................................................................................. 
7 pm ................................................................................................................. 
8 pm ................................................................................................................. 
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Our days are made up of various activities.  Some are productive tasks such as doing the 
grocery shopping, laundry, ironing and cooking meals; some are social activities such as 
having coffee with a friend.  There are recreational or ‘leisure’ activities that we participate in 
such as swimming, reading a magazine or watching TV.   
These activities are often linked to certain roles that we have in life.  We may have certain 
caring activities that we perform in the role of partner or parent, such as preparing meals and 
doing the family’s laundry. We may also have the role of daughter/son, 
colleague/worker/volunteer, or friend. 
It is important for all of us to have a sense of purpose and meaning in life.  It is vital that we 
value residents’ life experience and life history and recognise the roles that they have played 
in their lives, so that we can try to provide activities that are relevant, purposeful and 
meaningful to them. 
What do your activities say about you (your roles) and the residents activities say about their 
roles?  How have their lives changed as a result of stroke or other diseases of ageing, and 
coming to live in a care home? 
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ACTIVITY 
Activity is: 
• A basic driving force 
• Essential to existence, health and wellbeing 
• Can maintain and improve physical and mental health  
What we do (activity) helps to define who we are. Our individual personality, life history, 
interests, values and beliefs influence our choices about the activities in which we choose to 
participate. The effects of stroke or other diseases of ageing may affect a person’s ability to 
participate in activity but the drive (or desire to participate in activities) often remains! 
 
How do care home residents spend their time? 
An observational study undertaken in local care homes by the University of Birmingham in 
2004 found the following: 97% of the residents’ day was spent sitting, either with their eyes 
open or their eyes closed.   
 
 
 
 
 
 
 
 
 
The risks associated with inactivity are: 
 
• Stiffness and weakness 
• Reduced stamina and endurance 
• Reduced bone density through non weight-bearing 
• Constipation 
• Low mood 
• Pressure sores, contractures and deformities 
• Decline in mental ability 
• Increased risk of falls 
 
97.0% 
0.3% 
1.7% 
1.0% 
sitting  
(eyes open or 
closed) 
walking 
without  
assistance 
standing 
walking with 
assistance 
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 GIVING AND RECEIVING CARE 
 
Task three is designed to enable you to feel what it is like to lose your independence when 
carrying out daily activities; the second part of the task shows how small changes in your 
approach can increase someone’s feeling of control with an activity.   
 
TASK THREE (A):  With a partner choose one of the following activities (feeding or 
washing) and answer questions below: 
 
• Feeding – with a partner and using the materials provided, take turns to feed each other. 
 How does it feel to be fed by another person? 
 How does it feel when your control and choice is removed?  
 
• Washing – with a partner and using the materials provided, take turns to wash each other’s 
face. 
 How does it feel to be washed by another person? 
 How does it feel when your control and choice is removed? 
 
................................................................................................................................................ 
 
................................................................................................................................................ 
 
................................................................................................................................................ 
TASK THREE (B): Using the same activity, now  try guiding your partner’s hand to 
enable them to feed/wash themselves.   
 
Briefly describe how this feels: 
 
…….…….............................................................................................................................. 
 
................................................................................................................................................ 
 
................................................................................................................................................ 
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PARTICIPATION IN ACTIVITY 
 
Activity is not about “all or nothing”.  Supporting someone to take part in activity increases 
their control and choice. A person may be able to participate in an activity even if they cannot 
complete the whole task.  Anything that supports a person to perform an activity is likely to 
increase their feeling of control and choice.  
 
Try breaking down the activity into a series of actions and the skills required to perform the 
activity.  Usually activity is made up of a series linked actions. To participate the person may 
only be able to achieve one of the actions but is still participating and exercising control and 
choice. What can you do to support the person? Adaptive equipment may help. 
 
COMMON STROKE EFFECTS, AND STRATEGIES TO TRY 
WEAKNESS OR PARALYSIS 
 
Weakness (hemiparesis) or paralysis (hemiplegia) to one side of the body 
Hemiparesis or hemiplegia refers to the weakness or paralysis to one side of the body and can  
lead to poor balance when sitting and standing. 
 
Right side brain damage = left hemiplegia 
Left side brain damage = right hemiplegia  
 
The severity of weakness varies from person to person. Some individuals experience total 
paralysis to one side of the body, others have only a slight weakness to one side of the face, 
the face and one arm, or weakness in the arm and leg.   
 
Problems with sensation  
The person may also have accompanying loss of sensation in their affected side. 
 
Sensation is the information the brain receives from the body about how things feel, such as 
rough, smooth, cold, hot, sharp and blunt. The sensation of light/deep touch may be reduced. 
Affected limbs may be at risk of injury due to reduced sensation.   
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CARING FOR THE AFFECTED ARM AND SHOULDER 
 
Shoulder subluxation after stroke 
 
A subluxation is a partial dislocation of a joint. Shoulder subluxation is typically caused by 
weakened muscles and connective tissue around the glenohumeral (ball and socket) joint of 
the shoulder.  When the muscles are too weak to hold it in place, the head of the humerus 
bone slides out of the glenoid fossa (the concavity in the head of the scapula that receives the 
head of the humerus to form the shoulder joint). The gap between the head of the humerus 
and the shoulder socket can be about the width of two fingers.  
A subluxation can be exacerbated by years of people pulling on the arm when using it to 
move the individual. A subluxed (partially dislocated) shoulder will cause pain to the 
individual and is a condition that can be prevented by good positioning and supporting the 
weight of the affected arm both during activity and at rest. 
 
Key strategies to manage weakness or paralysis to one side of the body: 
 
• Always support the weight of the affected arm (when seated, lying in bed, and 
transferring) 
• If you see an individual’s affected arm hanging by their side, place it in a 
supported position, on the arm rest, on their lap or resting on a cushion.   
• Avoid pulling on the affected arm when helping with washing and dressing or 
when transferring. 
• Use pillows, cushions or rolled up towels to help support the person when seated. 
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POSITIONING SOMEONE WITH WEAKNESS OR PARALYSIS 
 
Good supportive positioning after stroke is important to: 
 
 promote comfort 
 prevent complications (such as pressure sores) 
 enable optimum levels of activity  
 promote safe swallowing 
 
When seated aim for hips, knees and ankles to be at 90 degrees  
 
The following points should be considered when selecting a chair for the resident to sit in: 
 
• If the chair is too low:
 
– It is very difficult to stand/sit 
– It requires more effort 
– there is more pressure going through sitting bones 
– it is uncomfortable and can cause pressure sores  
 
• If the chair is too high: 
 
– There is risk of pressure under the thighs, particularly just 
above the knees 
– the person is not able to put feet on the floor 
– sitting balance is more difficult 
– it is uncomfortable and increases risk of drop foot/stiff ankles 
 
• If the chair is too deep: 
 
– it causes slumping in chair and the cushion to rub behind the knees 
– it may cause bottom to slide forwards and person can slip onto the  
floor 
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• If the chair is too shallow: 
 
– the thighs are not supported 
– sitting becomes uncomfortable 
 
• The width of the chair: 
 
– should be wide enough to sit comfortably while  
– undertaking activities such as reading & writing 
– should be narrow enough to make use of the arm rests 
 
•  Pressure cushions: 
– are designed to work with the bottom back in the  
chair and weight evenly distributed along thighs 
– do not work properly if a person is not positioned  
properly in the chair. 
 
• Poor  positioning: 
 
– can lead to limited functional skills ( eg feeding, reading, personal grooming)   
– can lead to contractures, muscle wasting, and loss of sitting balance skills 
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 SWALLOWING PROBLEMS (DYSPHAGIA) 
 
The muscles of the mouth and tongue can be affected by stroke, causing difficulty in 
swallowing.  Difficulty swallowing presents a RISK of: 
 
• Choking 
• Chest infections 
• Pneumonia 
 
Dysphagia, or trouble swallowing, may  
involve one or more of the following: 
• Chewing. 
• Tongue movement. 
• Preparing food for swallowing. 
• The actual swallow movement. 
 
Key strategies to manage swallowing difficulties: 
 
• Make sure the person is sitting as upright as possible when eating or drinking. 
• Ensure the person remains upright for 15-20 minutes after eating and drinking. 
• Avoid noise and any distractions during mealtimes. 
• Sipping iced water or sucking on icepops or ice lollies before a meal may stimulate 
the swallowing mechanism. 
• Smaller mouthfuls of food or drink may help. 
• Watch and encourage the person to chew their food well. 
• Ensure a strong swallow between each mouthful.  The person may need to swallow 
again or cough to clear the throat before taking a second swallow. 
• Fatigue may affect a person’s ability to swallow.  Smaller meals taken more often or 
with snacks between meals may help with this problem. 
• Look out for signs swallowing difficulty.  If someone is drooling or coughing at 
mealtimes this could be a sign of swallowing problems.  A referral to speech and 
language therapy for a swallowing assessment may be required. 
• Ensure food and drinks are given at the correct consistency.  Is the person on a pureed 
diet? Should their drinks be thickened? 
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COMMUNICATION PROBLEMS  
 
Communication problems (aphasia) after stroke are common and affect around a third of 
people with stroke. 
 
Communication problems after a stroke often result from damage to the parts of the brain 
responsible for language, but the ability to control the muscles involved in speech may also 
be affected. The specific problems experienced by the individual will depend on the extent of 
the damage and which area of the brain has been affected.  For most people, the area of the 
brain mainly responsible for aspects of language is located in the left hemisphere (side).  This 
means that damage in this region can affect the ability to speak, understand, read and write.  
 
Types of communication problems: 
 
Difficulty understanding or “getting the message in” = Receptive aphasia 
Difficulty expressing oneself or “getting the message out” = Expressive aphasia 
Difficulty controlling the muscles involved in speech / “slurred speech” = Dysarthria 
Memory lapses and difficulty with concentration can also affect communication. 
 
There are many different ways in which the ability to communicate may be affected but, 
generally, the problems are related either to speaking, or understanding what other people are 
saying. Do not assume that a person with communication problems also has cognitive 
problems! 
 
Imagine not being able to understand those around you... 
 
Key strategies to help get the message IN (Receptive aphasia): 
 
 Ensure person has glasses/ hearing aid on as appropriate 
 Slow down your pace of speech 
 Write down key words for the person to see 
 Keep sentences simple – one idea per sentence 
 Repeat and rephrase 
 Summarise and recap regularly 
 Use drawings & diagrams to convey ideas 
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 Use natural gesture 
 Use ‘communication ramps’ and props (eg photos, maps, newspapers)  
 
Imagine being able to understand what other people say to you but being unable to speak... 
 
Key strategies to help get the message OUT (Expressive aphasia):  
 
 Encourage use of pen & paper to write/draw key points 
 Encourage person to make use of words/drawings you have written down (point, 
underline, cross them out) 
 Don’t rush, be silent & give extra time 
 Ask questions – move from general areas to more specific topics 
 Check you are understanding correctly (“Have I got this right?”) 
 Use props and ramps 
 Don’t pretend you understand  
 
VISUAL PROBLEMS AFTER STROKE 
 
Visual problems are common, (affecting up to 2/3 of stroke survivors).  Depending on the 
area of the brain affected, visual problems may include: 
 
Central vision loss 
 
 
 
 
 
 
Visual field loss  
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There may be eye movement problems as well as visual processing problems.  Processing 
problems may include impaired depth perception and difficulty locating objects e.g. 
misjudging the position of a cup and pouring water over its edge rather than into it, or over-
reaching for an object. 
 
We rely on our vision when carrying out many daily activities.  Visual problems will 
therefore impact on a person’s ability to carry out activities safely and independently.  
 
COGNITIVE PROBLEMS AFTER STROKE 
 
There are some more “hidden” effects of stroke that may affect a person’s  
mental functioning or “cognition”. 
 
Cognitive problems include difficulties with attention and concentration,  
memory problems, and difficulty in making sense of the World around them.  People can 
also have difficulty recognising common everyday objects and may be unable to work out 
sequences of movement required to carry out a daily task such as dressing.  A person’s 
ability to plan, problem solve, organise, initiate and function in socially acceptable ways 
can all be affected.  People may also experience emotional problems such as anxiety, 
depression, anger or sadness. 
 
SUPPORTING MOBILITY AND TRANSFERS 
 
Encourage normal movement wherever possible.  Use the correct and appropriate moving 
and handling techniques if assistance is required - avoid drag lifting and pulling.  Consider 
the environment in which any equipment is to be used. 
 
• Walking aids 
– Different types of walking aid offer different support to facilitate walking 
People’s needs can change over time therefore the type of walking aid should 
be reviewed regularly 
– Walking aids should be serviced regularly  
(i.e. Ferrules, brakes, clips etc) 
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• Height of walking aids 
– Distance between wrist bone and ground when person stands in regular 
footwear with arms held loosely at their side, for sticks and frames. 
• Size of base of walking aid 
– The wider the base of support, the more stable the walking aid 
 
• Wheelchairs 
– Wheelchairs should be adjusted to suit the user 
(i.e. cushions, height of footrests) 
– Positioning and posture is important as with seating 
in chairs 
  
• Transfers 
– Encourage normal movement 
– Use correct moving and handling techniques if assistance is required 
– Avoid drag lifting and pulling  
– Support the affected arm 
 
• Standing up 
– Position walking aid in front of chair, advise person to:- 
– Move bottom to front of chair 
– Check feet position; feet back, slightly apart 
– Push down on the arms of the chair: do not  
pull up on walking frame! 
– Lean forward: bring shoulders over knees (or  
  nose over toes) 
– Once standing hold walking aid, tuck in bottom, straighten knees and stand tall  
 
Moving and handling should be according to risk assessment. When helping people: assess 
the situation and refer to moving and handling policy/advisor within the home. 
 
• Sitting down 
• Advise person to:- 
– Stand in front of chair with walking aid 
– Feel for the chair on back of legs 
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– When ready, let go of aid and feel for arms of chair 
– Use arms of chair to lower into seat  
          Once person is seated, the walking aid can be moved within reaching distance  
 
• Hoisting 
– Always use the appropriate hoists and slings for the task, person’s ability, and 
needs 
– Have the correct number of people present to undertake task  
 
TASK FOUR: With a partner try the following: 
 
1. Standing up from a high chair 
2. Standing up from a very low chair 
3. Try standing up with feet out in front of you 
4. Try standing up without bending forward 
   
SUPPORTING PEOPLE IN ACTIVITY 
 
What can you do to improve life after stroke for people in your care? 
 
 When working with a person, encourage activity as soon as possible and whenever 
possible.   
 
 By creating the conditions where activity is encouraged and expected, a person’s 
feeling of choice, control and well-being can be maintained or restored.  
 
 Encourage people to maintain as much independence as possible when undertaking 
any activity. 
 
 Create conditions to enable people to achieve maximum independence.   
 
Can a person: 
 be supported physically or positioned better in order to perform the task? 
 be supported to start or finish the task? 
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 be prompted or directed through a task – verbally, visually or with suitably placed 
prompts e.g. handed articles of clothing in the correct order for dressing, given 
garments the right way up? 
 
 Demonstrate aspects of the task on each occasion. 
 
 Change or encourage aspects of the task to be changed to accommodate weakness or 
paralysis, e.g. a person may use teeth to pull something instead of affected hand. 
 
 Use adaptive equipment - equipment can bridge the gap between the skills needed to 
do the task and the skills of the person. 
 
Consider the following when working to promote participation and increase independence in 
activities:  
•      Expectation  - expect the person to participate 
•      Motivation – be enthusiastic about the person’s ability to participate 
•      Opportunity –offer the choice to participate on every occasion 
•      Time – allow enough time for the person to participate 
•      Supervision – prompt rather than do when appropriate 
•      Encouragement and confidence building 
•      Reinforcement of correct use of equipment and techniques 
 
Something to be aware of…..Tiredness  
Those tasks that were once easy may now require continuing effort to perform.  Overtiring a 
person can lead to poor performance, increased tone in affected limbs and reduced motivation. 
 
Equipment 
There is a variety of equipment available to assist people to participate in activity.  
Equipment can bridge the gap between the skills required to perform a task and the skills 
available to the person.  Equipment to assist a person to participate in daily activities should 
only be used by the person for whom it has been assessed and provided.  Equipment should 
be checked and maintained regularly, according to the manufacturer’s instructions 
People with limited mobility or impaired physical abilities can have difficulty standing and 
sitting. Relatively inexpensive equipment can be provided to assist with these issues, such as 
chair raisers, bed raisers, raised toilet seats and various types of rails. 
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Chairs - Aim for hips, knees and ankles to be at 90 degrees 
 
Sensory equipment 
The RNID and RNIB provide information and advice on equipment for those who are hearing 
or visually impaired.  This may include the use of hearing aid loops for a room or to use with 
a TV, vibrating alarm clocks or pagers for hearing impaired residents.  Speaking clocks or 
watches and liquid level indicators may be of benefit to visually impaired residents.  
 
Dressing 
Encourage people to consider their choice of clothing. Minimising the need for buttons, zips, 
rear fastening garments, laces etc can increase someone’s ability to manage dressing.  Loose 
top socks are also available.  Dressing while sat in a chair may be safer than sitting on the 
side of the bed. Dressing the bottom half may be easier and safer undertaken on the bed, 
especially if the person has poor standing balance.  To dress on the bed the person may have 
to be able to lift their bottom off the bed (bridge) to pull up pants etc.  A full length mirror 
provides feedback to the person about their position and how they look. 
 
Dressing upper body- lay garment over the knees with neck furthest away from the body 
with the sleeves hanging down outside the knees. Put the affected arm into the appropriate 
arm hole and push garment beyond elbow then either put remaining arm in arm hole and pull 
over the head or pull over head and then place the unaffected arm through the arm hole. 
 
Undressing upper body-gather and grasp the garment at the back of the head and pull it over 
the head, then remove arms from the sleeves, usually unaffected side first. 
Dressing lower body-consider the use of adaptive equipment to place garments over the toes 
(helping hand, dressing sticks, braces, pull ups).  If able ask the person to cross the affected 
leg over the unaffected leg to reach over the toes on the affected leg.  Place garments over 
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toes then uncross legs and put garments over toes on non-affected leg.  Many people will find 
this difficult but some may be able to manage it.  
 
Undressing lower body- Lay on the bed to remove garments or stand and let clothes drop 
past knees, sit to remove feet from within clothes.  Consider use of adaptive equipment. 
 
Environment, room layout and clutter 
Consider the layout of the furniture within the room with the person/ their family in relation 
to their needs e.g. position of the bed- consider if the person can have their walking aid 
within easy reach, get in/out of bed independently, especially if the person can only get in/out  
on one side of the bed, and is the lighting better in one part of the room.  Keep the room 
clutter free i.e. rubbish bins, movable tables, shoes, trailing alarm button cord.  Consider the 
abilities and needs of the person i.e. access to alarm button, access to armchair with frame. 
 
Positioning 
Poor positioning can limit functional skills, such as feeding, reading or personal grooming.  It  
can also lead to contractures, muscle wasting and a loss of sitting balance skills. Also,   unless 
specially assessed and issued most pressure cushions are designed to work with the person’s 
bottom back in chair and their weight evenly distributed along the thighs.  Poor positioning 
can reduce the effectiveness of the pressure cushion. 
 
Personal care 
For people who have the use of one hand only, support them to put the soap in a soap dish or 
on a dry cloth and wipe the flannel over the soap or alternatively use a soap dispenser.  
Motion sensor soap dispensers are now more readily available.  To wring out the flannel, 
show the person how to put the flannel around the tap and twist it or use a small flannel and 
squeeze it out with one hand.  A suction nail brush or suction denture brush can be used to 
prevent the brush moving whilst a resident cleans teeth and nails.  There is a variety of 
adaptive equipment to assist people with all aspects of personal care. 
 
Eating 
There is a variety of special adaptive cutlery to assist people with eating, depending upon the 
problem e.g. larger handles, angled cutlery, swivel and weighted handles, combined knife and 
forks. Plate-guards or special plates can be used to prevent food falling off the plate or make 
it easier to locate the food when using one hand to eat. Non slip matting prevents the plate 
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from moving. Ensure the food is placed within the person’s field of vision.  Ensure the person 
is positioned to facilitate access to the food and eating. Within the limits of their sitting 
balance people should be sat upright. 
 
And finally….Encourage meaningful activity whenever possible. Allow people to maintain 
as much independence as possible by creating conditions that enable each person to achieve 
maximum independence while remaining safe. 
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Appendix 12 Information for occupational
therapists delivering interventions for Occupational
Therapy intervention for residents with stroke living in
UK Care Homes trial
What does the study involve?
This study aims to look at the effects and value of a targeted course of occupational therapy on people
living with stroke in nursing and residential homes.
What will my assessment consist of?
Your assessment will be the same as you would conduct on any other patient. You will have access to the
baseline outcome measures (Barthel index and Rivermead mobility score) to help inform your assessment
and develop a patient specific treatment plan. You can use information from family and carers to inform
your assessment if the patient has difficulties in communicating.
What treatments will I be expected to offer?
You will be offering all the usual interventions that you provide as an occupational therapist. The
interventions you will be offering will address the performance of a task, the environment in which the
task is conducted, and help address any impairments that may limit the performance of the ADL’s.
These interventions could involve:
l task-specific practice
l supplying aids/adaptations to the environment/help to simplify the task
l delivering specific therapeutic interventions
l educating carers in encouraging/assisting the patient.
Is there anything I shouldn’t do?
The aim of this study is to look at the role of occupational therapy in improving function for people post
stroke so some interventions such as reminiscent therapy and relaxation groups are not within the remit of
this study.
The outcome measures will highlight the main functional difficulties of the patients so treatment goals can
focus on these key areas of functional difficulties.
Does education of carers/family count as a treatment?
Yes, any time spent on this activity counts as part of an intervention. There is space to record this in the
treatment log. Discussions with other members of staff or agencies (such as the GP) are also to be
included in the treatment log.
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How do I record my interventions?
All interventions are split into types and times spent on each intervention needs to be recorded for each
contact with the patient.
What if the patients’ needs change during treatment?
The aim is to provide the patients with standard occupational therapy care so, as the patients’ needs
change, you can adapt you treatments to address patient specific needs as you would do with any
other patient.
What equipment can I supply?
You can supply the adaptive equipment you would supply as an occupational therapist if it will benefit the
patient i.e. grab rails, toilet raises, cutlery, mobility aids, seating, etc. There is the possibility of funding
small pieces of equipment through the study if it is not available through the normal routes.
Where do I write my notes?
You may be required to write in the patients’ notes at the nursing home.
You will also have your profession specific notes that you will need to keep securely in a locked cabinet at
your normal place of work.
How much time can I spend with each person?
This is dependent on the individual goals you have set with the patient and what interventions will best
suit their needs. As mentioned previously, the aim of this study is to provide a typical occupational
therapy intervention.
What happens if a patient gets hurt?
If a patient falls during a treatment or if the equipment provided fails it is described as an adverse event.
All adverse events need to be reported to the study co-ordinator so they can be logged. You may also be
required to complete the documentation used by the care home for reporting falls/injuries.
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Appendix 13 Screening and outcome measures
Mini-Mental State Examination
The MMSE was used to assess the cognitive function of patients.75,87 The evaluation uses a series of
12 questions and tests in which patients are assessed in terms of their memory, language, attention and
orientation. The test is scored out of 30, 30 being the maximum. A score between 0 and 20 is indicative of
cognitive impairment.
Sheffield Screening Test for Acquired Language Disorders
The Sheffield Screening Test for Acquired Language Disorders was used to assess the severity of
communication problems in study participants and to identify those with aphasia.74 The test involves a
10-item questionnaire which is divided into two parts: one assessing receptive skills and one assessing
expressive skills. The test is scored from 0 to 20, with 20 signifying no impairment. Participants scoring
< 15 are considered to have a language disorder.
Barthel Index of Activities of Daily Living
The BI consists of a questionnaire which scores the patients’ ability to complete 10 activities.76,77 The
assessment consists of questions related to self-care activities (feeding, grooming, bathing, dressing, bowel
and bladder care, and toilet use), and mobility-based activities (ambulation, transfers and stair climbing).
The results of the questionnaire are added to provide a measure of independence ranging from 0 to 4
(very severe), 5 to 9 (severe), 10 to 14 (moderate), 15 to 19 (mild) and 20 (completely independent).
Rivermead Mobility Index
The RMI was used to evaluate the effectiveness of occupational therapy on the mobility of patients.79,83
The index is delivered using a 15-item yes/no questionnaire which focuses on ambulation but also assesses
the participant’s ability to run, stand unsupported, use stairs, and bathe unsupervised. Positive responses to
each question are scored with 1 point, up to a maximum of 15.
Geriatric Depression Scale
The GDS is a screening test for depression in the elderly in which patients answer ‘yes’ or ‘no’ to questions
which refer to how they felt over the preceding week, and can be delivered using either a long-form
(30 questions) or a short-form (15 questions) questionnaire.84,85 For the short version with 15 questions,
scores of 0 to 4 are considered normal; 5 to 8 indicate mild depression; 9 to 11 indicate moderate
depression; and 12 to 15 indicate severe depression.
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EQ-5D-3L
The European Quality of Life EQ-5D (EQ-5D-3L) is a standardised measure of HRQoL, developed by the
EuroQol Group in order to provide a simple, generic measure of health for clinical and economic
appraisal.95,99,114 The EQ-5D descriptive system comprises the following five dimensions: mobility, self-care,
usual activities, pain/discomfort and anxiety/depression. Each dimension has three levels of scoring (3L; no
problems, some problems, extreme problems) and is expressed as a digit (1, 2 or 3). The digits for the five
dimensions are combined in a five-digit permutation describing the respondent’s health state (e.g. 11121
moderate pain and discomfort, 13111 extreme problems with self-care). The study used the EQ-5D-3L
measure to conduct an assessment of HRQoL and an economic evaluation.
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Appendix 14 Adverse events reporting form
Adverse Events Reporting Form  
 
Pt ID: 
  
This form should be completed and distributed to the data monitoring 
committee.  
  
Participant ID                     
  
DOB    
Randomisation   
(Delete as appropriate)  
Occupational therapy / control  
Evaluation of events   
 
 
 
 
 
Severity    
 
Outcome    
 
Action 
taken  
  
  
  
Medically important event (details of event and subsequent actions)  
  
  
 
     
Relevant medical history:    
    
    
     
Narrative of Events:  
                D  M  D M Y Y
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Appendix 15 Summary of participants moving
home during the course of the trial
TABLE 43 Summary of participants moving home during the course of the trial
Time point
Randomisation arm
OT Control
Number of participants moved during trial 21 16
Last follow-up at baseline 1 (died) 0
Last follow-up at 3 months 1 (died) 0
Last follow-up at 6 months 2 (1 died and 1 lost) 0
Last follow-up at 12 months 17 16
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Appendix 16 Data tables for Figures 2 and 3
Data table for Figure 2
TABLE 44 Baseline BI scores as a function of baseline RMI scores
BI score
(0–20)
RMI score (0–15) Count
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Grand total
0 125 13 3 1 142
1 88 26 10 1 1 126
2 56 27 6 4 2 95
3 33 18 9 5 1 66
4 33 13 14 5 1 1 67
5 15 14 2 11 2 1 2 47
6 18 16 11 4 2 1 1 1 54
7 9 10 6 6 3 3 5 3 1 46
8 2 9 7 8 6 3 2 5 1 1 1 1 1 47
9 4 6 3 3 8 2 1 1 4 1 1 34
10 4 3 5 5 3 3 4 2 2 2 1 1 1 36
11 3 1 5 5 2 5 4 5 3 3 2 1 1 1 1 42
12 1 3 1 6 1 6 1 1 1 21
13 1 5 3 4 4 7 2 3 2 2 1 34
14 1 1 4 1 5 2 5 3 5 2 2 2 33
15 1 1 3 5 3 2 4 4 1 1 25
16 3 1 11 6 2 3 3 2 31
17 2 3 2 4 2 2 1 1 17
18 1 1 4 3 3 2 1 2 1 2 20
19 1 1 2 1 2 2 1 2 12
20 1 2 1 6 7 17
Count
grand
total
386 161 83 68 37 42 33 56 29 33 23 16 20 10 6 9 1012
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Appendix 17 Occupational Therapy intervention
for residents with stroke living in UK Care Homes
health-care resource usage questionnaire: 12 months
OTCH Healthcare Resource Usage Questionnaire: 12 months 
 
 
 
 
Pt ID:  Citrix entry:  Participant  Consultee 
 
 
We would like to know how much use you have made of the health and social 
services over the last 6 months. If you are not exactly sure, we would rather have your 
best guess than no information at all.  
 
 
1. Over the last 6 months, have you suffered from a fall that resulted in injury 
and/or medical attention? 
      No, please go to question 3       
     Yes, please give details:  
 
a) Did you see your GP?    No            Yes        How many times 
____________             
 
Dates of fall (day/month/year):    
         
1st fall   ; please give details:  
 
2nd fall   ; please give details:  
 
3rd fall   ; please give details:  
 
b) Were you seen by Ambulance Staff?  No         Yes        How many times -
_________ 
 
Dates of fall (day/month/year):       
 
1st fall   ; please give details:  
 
2nd fall   ; please give details:  
 
3rd fall   ; please give details:  
  
D D M M Y Y
« « « « « «««
DOI: 10.3310/hta20150 HEALTH TECHNOLOGY ASSESSMENT 2016 VOL. 20 NO. 15
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Sackley et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
131
2. Primary care and social services: over the last 6 months, have you used the 
services of any of the following: if yes, how many times, 
Type of service No Yes 
If yes: 
Number of visits 
1.  GP visit?    
2.  District / Practice nurse?     
3.  Physiotherapist?     
4.  Social worker?     
5.  Chiropodist visit?    
6. Speech or language therapist?    
7. Using hearing services / Audiologist 
visit? 
   
8. Optician visit?    
9. Dietician visit?    
10. Dentist visit?    
11. Psychiatrist visit?    
12. Community psychiatric nurse?     
13. Activity services?    
14. Day care outside home?    
15. Others (please specify)    
 
2a. Primary care and social services: over the last 12 months, have you used the 
services of an occupational therapist: if yes, how many times, 
Type of service No Yes 
If yes: 
Number of visits 
1. Occupational Therapist    
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3. Hospital Episodes: over the last 6 months have you been to hospital for any 
reason (include falls)?  
    No                 Yes, please give 
details:______________________________________________ 
Outpatient visit (please go to 3a) or A & E (please go to 3b); In patient (please go to 
3c) 
 
3a. Hospital outpatients 
Episode* Name of 
Hospital 
Reason for the 
Appointment 
Speciality  Number of 
appointments* 
1st  
 
    
2nd  
 
    
3rd  
 
    
* episode means a visit or group of visits related to a particular problem. Please 
write down how many appointments you have had for each episode.  
 
3b. Accident & emergency (or A&E please include visits which took place 
immediately before any admissions to hospital). 
Episode Name of 
Hospital 
Reason for visits Is this because of a 
fall? 
1st  
 
   
2nd  
 
   
3rd  
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3c. Hospital Inpatient 
Episode Name of hospital   Ward 
Speciality  
Reasons for 
Admission 
No. of nights* 
1st  
 
    
2nd  
 
    
3rd  
 
    
* If you were treated as a day patient (day case), then please write 0 under “number of 
nights” Being a day patient means needing a hospital bed for tests or surgery for a half 
day or full day, but not needing to stay overnight.  
 
4. In the last 6 months did you buy any aid or adaptation paid for by yourself or 
by a friends or relative? (E.g. walking frames, grab bars, stair lift, wheel chair) 
 
List Type of aid or adaptations Cost to you (£s) 
a   
b   
c   
d   
 
5. During the last 6 months, approximately how much additional money have 
you spent on travel (e.g. taxis, car park fees and public transport) because of 
your stroke’s disease?  
    None                 
     Yes, I have spent £  
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6. Do you have to pay for your stroke’s disease medication? 
    No                 
     Yes, I have spent £             per month 
 
7. If you would like to tell us about any other costs incurred because of your 
condition over the last 6 months, please write them here. 
     No                
      Yes, please give details:    
DOI: 10.3310/hta20150 HEALTH TECHNOLOGY ASSESSMENT 2016 VOL. 20 NO. 15
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Sackley et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
135

Appendix 18 European Quality of Life-5
Dimensions, 3 Levels health profile
TABLE 46 Proportion of levels 1, 2 and 3 by EQ-5D-3L dimension and assessment point
EQ-5D-3L dimension Level
Assessment point
Baseline 3 months 6 months 12 months
Mobility Level 1 11.9 11.0 10.5 11.1
Level 2 44.5 40.3 39.1 31.9
Level 3 43.5 48.7 50.5 57.0
Self-care Level 1 12.6 10.9 9.4 9.6
Level 2 29.8 29.9 28.9 27.0
Level 3 57.6 59.2 61.7 63.5
Usual activities Level 1 16.0 18.3 23.4 18.2
Level 2 30.1 32.3 27.7 32.4
Level 3 53.9 49.4 48.9 49.4
Pain/discomfort Level 1 46.9 51.4 53.7 52.9
Level 2 45.7 40.4 38.1 40.9
Level 3 7.4 8.3 8.1 6.2
Anxiety/depression Level 1 46.5 53.0 55.3 54.4
Level 2 45.0 36.6 36.8 37.8
Level 3 8.5 10.4 7.9 7.8
Level 1, no problems; level 2, some problems; level 3, severe problems.
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